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- 	 ABSTRACT 
High-field NMR.. spectroscopy has been applied to the study of 
two enziiies in the porphyrin pathway and the reactions which they 
catalyse. Porphobi.Tinogen (PBG) deaminase and uroporphyrinogen III 
(uro.'gen: III) cosynthetase:are.. the. two enzymes responsible for the 
formation of the porphyrin macrocycle. and the action of these enzymes 
in the: conversion of.PBG, [2,1l -13C] -PBG.and 13,5 -13 C].-PBG.to urogen 
LII has.. been: studied: by 1 H and. ' 3 C.NMR. The principal intermediate 
which accumulated was., the correspondingly labelled. hydroxymethylbilane 
(HMB)... The complete 1 H and 13C. NMR' assignment of PBG.is presented, 
and an analysis. made. of the effects of pH on the chemical shifts of 
selected resonances'. 
The procedures. for the generation of enzyme-substrate complexes 
using [2',ll-13C]-PBG'. and [1,5-13C]-PBG with deaminase,. and the methods 
emp.loyedfor' their - purification are described.. Use of 13C NMR in an 
attempt to detect the substrate. bound to the enzyme revealed that the 
linewidhs must be inordinately large. The complex' was found to dis-
proportionate with time when stored at 25°C. However, enzyme-bound 
uro'gen I was. detected, both in the intact protein, and in the oligo-
peptides from'. tryptic digestion and peptide mapping. 
The; synthesis of [5-2H],-ALA.  and [5-3H]-ALA and their conversion 
to the corresponding PBGby the action of partially purified ALA - 
dehydratase are: described'. The isolation and purification of ALA 
dehydrátase, PBG deaminase (to. homogeneity) and uro'gen III cosynthe-
tase from R., spheroides are covered. 
The first detection of' an enzyme-substrate complex by 3 H NMR is 
described, using [3H]-PBG  as the substrate and deaminase as the enzyme. 
The linewidths were found to be extremely large, and dependent upon 
temperature, giving chemical shifts which allowed tentative conclusions 
to be made, as. to the nature of the nucleophilic g,roup on the enzyme 
to which the substrate binds. The catalytic competence of this complex 
was also demonstrated, by displacing bound [3H]-PBG with unlabelled 
PBG. During the resultant formation of [3H]-uro'gen I, a transient 
low-intensity signal was detected which has been tentatively assigned 
to the highly reactive exomethylene pyrrolenine species, proposed in 
several mechanistic schemes for porphyrin biosynthesis. Nechanistic 
interpretations of these results are also'presented. 
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SYMBOLS AND ABBREVIATIONS 
A acetate side-chain (-CH 2CO2H) 
ALA 5-aminolaevulinic acid 
ALAD ALA dehydratase 
ALAS ALA synthetase 
AQ acquisition time 
A absorbance at a particular wavelength " x " x 
C . 	 uro'gen III cosynthetase. 
CD' circular' dichroism 
CoA coenzyme A 
CSA chemical 	shift anisotropy 
o deuterium 
o PBGI deaminase 




OP decoupler power 
chemical 	shift of. nucleus ax" 	in parts per million 
(ppm), directly or indirectly referenced to ThS, 
TSP or p-dioxane 
ES enzyme-substrate complex 
extinction coefficient of a particular wavelength "x" 
FAB-MS fast atom bombardment mass spectroscopy 
FID free induction decay 
FT Fourier transform 
gyromagnetic ratio (for nucleus ax") 
GB Gaussian broadening 
Ii Planck's constant h, divided, by 211 
HMB hydroxymethylbilane 
HPMD high performance mixing device 
IR' infrared. 
nj 	(A-B) n-bond coupling, constant between nuclei A and B 
K dissociation constant of enzyme-inhibitor complex 
(the inhibitor constant) 
concentration of substrate giving half maximal 
velocity (the.Michaelis constant') 
KPhos potassium phosphate buffer 
LB line broadening 
- 	 wavelength of absorbance maximum (UV) 
max 
MS mass. spectroscopy.. 
M'r relat.ive.molecular mass . 
MOE. nuclear Overhauser effect 
wavelength of absorbance maxima (IR) 
max 
NAD.(P)H -nicotinamide adenine dinucleotide (phosphate) 
NMR nuclear' magnetic resonance (spectroscopy) 
MS number of transients (scans) 
NZP 	' number of points removed from the start of an FID 
P propionate side-chain (-CH2CH2CO2 H) 
PBG porphobi 11 nogen 
optimum pH for maximal enzyme activity 
p1 isoelectric point 
PW. pulse width 	("flip angle") 
RD relaxation delay 
RF. 	. 	' radio frequency (electromagnetic radiation) 
V 
Rf 	 retention factor (TLC) 
v.i 
SAM 	 S-adenosylmethionine. 
SI size.of data. table, 	in datapoints X 10 3 (K) 
SW: . spectral 	width 
t time in minutes. 
ti half-life in minutes 
I tritium 
I 	•. temperature- in °C 
spin-lattice relaxation time 
T1DD dipole-dipole. spin-lattice relaxation time 
12. . 	 spin-spin relaxation time 
time in - milliseconds 
correlat.ion time 
TMS . 	 tetramethyTsilane (Me4Si) 
Iris tris(hydroxymethyl )arninomethane 
TSP sodium 3-(trimethylsilyl)-3,3,2,2-tetradeutero- 
- 	
.- prpionate (Me 3SiCD2CD2CO2Na) 
UV ultraviolet 	. 
Vmax velocity of an enzyme reaction when saturated 
with substrate 
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1.1 General Introduction 
Man and many other forms of life owe their continued existence 
in part: to a family of molecules.. called porphyrins.. They are also 
known as the.life. pigments, since in addition to being highly 
coloured,, the porphyrin pigments occupy a role of central importance 
to most living organisms. Furthermore, these pigments are inter-
related as tetrapyr'roles, and there are. many similarities, between 
them. Principally,, each contains a metal atom fixed within a macro-
cyclic nucleus composed of four five-membered heterocyclic rings. 
Each metal confers upon the. macrocycle its. own distinctive colour: 
iron,. the deep red colour of haem (1)., as found in haemoglobin; 
magnesium, the green colour of chlorophyll (2); and cobalt, the 
red-purple colour of Vitamin B 12 (3). 
It is small wonder then, that over the last century scores of 
chemists, biochemists and biologists alike have tried to unravel the 
mechanisms by which Nature builds such molecules. As early as 1880 
Hoppe-Seyler 1 suggested that haem and chlorophyll were related to 
one another. During the 1920's and 1930's, a tremendous number of 
basic. studies on the chemistry of haem and chlorophyll were carried 
out.. The work by Wil1sttter and his colleagues 2 established that 
haem and chlorophyll were both tetrapyrroles. Fischer and his 
colleagues 3 refined, this. work by defining the. structure and position 
of the various side-chains attached to the tetrapyrroles, allowing 
a clearer, distinction to be made between the two compounds. In this 
way Fischer established the structure of haem, which he later con-
firmed by total synthesis in 1929. In contrast, chlorophyll, 
although its structure was known in 1934, was not synthesised until 
1960. 
3 
HAEM (1) 	 CHLOROPHYLL a (2) 
2 
NH 2 
eO''o OHh( 'T 
HO 
VITAMIN B12 () 
It was not until 1948 that Vitamin B 12 was isolated, and 
chemical studies on its composition demonstrated that it too was a 
tetrapyrrole and thus related to haem and chlorophyll. However, its 
structure proved to be more elusive, since the corrin ring was 
4 
unexpected in that. its Rings A and 0 are directly bonded, in contrast 
to the porphyrin ring,, in which the same attachment. is mediated by 
a methi.ne group. Its. structure was elucidated principally by 
Hodgkin and several other"teams of workers in.1955, 51 and its 
total synthesis, accomplished nearly 20 years later by Woodward12' 
and. Eschenmoser) 3 is. undoubtedly one of the. most significant 
landmarks of modern synthetic. organic chemistry. 
Since' a: large number of excellent reviews 148 exist on the 
biosynthesis of. porphyrins, this chapter will be restricted to the 
tremendous. developments that have taken place over the last 10 years. 
For this purpose, the next section will highlight, the salient 
features of porphyrin biosynthesis. Subsequent sections will give 
a more detailed history of each. step leading to the porphyrin macro-
cycle,, and a brief look at the metabolic events beyond. 
1.2' The Type III Problem Delineated 
The biosynthesis of porphyrins takes place in many living 
systems, and occurs by the route shown in Scheme 1.. Considering 
their'moderately complex structures, it is astonishing that haem (1), 
chlorophyll (2) and Vitamin B 12 (3) have such humble origins as. that 
of glycine (5) and succinyl-coenzyme A (4). However, glycine and 
succinyl-CoA condense to give 5-aminolaevulini.c acid.. (ALA, 6). Two 
molecules of ALA further condense to give the monopyrrole porpho-
bilinogen (PBG, 7), .which pol.ymerises to give, the reduced porphyrin 
uroporphyrinogen III (uro'gen III, 8). 	. 
There are four possible isomers of uro'gen, differing in their 
arrangements' of the .acetate and. propionate side-chains around the 
URO'GEN 
5 
rCO2 H 	 CO2H 
I 	 + 	
ALA 
COSCoA 	NH 2 Synthetase 
(4) 	 ()  
1CO2 H 
4  2<  ALA dehydratase 
NH 2 
ALA() 
10 	 8 
CO 2H CO2H 
Ibri 
H 2N H 
PBG(Z) 
Here and elsewhere: 
D= PBG deaminase 
C= Uro'gen1j cosynthetase 
SCHEME 1 
URO'GEN 1J() 
periphery of the tetrapyrrole macrocycle, designated types I, II, 
III, and. IV. The same possibilities obviously occur for the uro-
porphyrins as well (e.g., uroporphyrin I (12)). 
URO'GEN 1(9) URO'GEN U (19) 
Here and elsewhere: 
A = -CH 2CO 2H 
P -CH 2CH 2 COH 
UROPORPHYRIN I g) URO'GEN 17 (ii) 
 
Prirna.facie it is. a curious thing that the type III isomer 
predominates in living sytems, the type I isomer occurring in the 
shells of an oyster Pinctada vulgaris, 2° and in the urine of patients 
suffering, from congenital porphyria, while the type II and type IV 
isomers are not known in any living systems. In the type III 
isomer, the. 0 ring would appear to have been rearranged so that the 
propionate side-chains in.the'C and.D rings l'ie.adjacentT. Thus it 
seems as if Nature has evolved in such a way as to assemble the 
type III porphyrin, when the simplest chemical pathway would lead 
to the type I isomer. For straightforward head-to-tail polymerisa-
tionof PBG (7) might. lead one to expect the type I' isomer to 
predominate, and it has even been suggested 21 that Nature forms 
the unexpected isomer. This,. however, is to misstate the enigma. 
It has been well established 22 that the polymerisation of PBG (7) 
in' acidic conditions gives rise to a statistical mixture whose 
composition is invariably 50:25:12.5:12.5 types III:IV:II:I. If 
the implications of the results from prebiotic chemistry 23 are to 
be believed, along with the discovery of porphyrins on meteorites, 24 
then it seems reasonable to suppose that porphyrins occurred early 
on in the primeval Earth's history. There is evidence that corrins 
may even have predated the porphyrins. 25 Thus it is not unreasonable 
to suggest that Nature evolved its biochemical architecture to 
optimise the synthesis of the statistically most favoured isomer, 
since it was already the most abundant. This point will become all 
the more apparent when the individual enzymes in the metabolic 
pathway are examined in detail later in the chapter. 
The problem of how it is that the type III porphyrin predominates 
both in vivo and in vitro has puzzled Man for the last 35 years, and 
7 
is known as the Type III Problem.. It encompasses not, only the. 
intriguing mechanisms. by.which the type. III isomer: is formed both 
chemically and enzymically by rearrangement..of the D ring, but also 
howc the tetrapyrrole nucleus, is built up from the monopyrrole PBG. 
To fully realise the importance of.the Type III. Problem, we have to 
be aware of the significance of uro'gen.. III. (Scheme 2). 
A large proportion. of the animal kingdom.rel.ies upon the haem 
of haemoglobin to. transport oxygen 'around. the body,. and this oxygen 
is produced as a result'. of the actions of chlorophyll on the aerial 
carbon.dioxide producedby animals,, in the process of photosynthesis - 
a process necessary for the plant's continued existence.. This mutual 
ecological interdependence becomes all the more fascinating when we 
realise, that both chlorophyll and haem have as their common bio-
synthetic precursor uro'gen. III,. as indeed do the bacteriochlorophylls, 
the cytochromes., the suiphite and.nitrite reductases, and Vitamin B 12 . 
Thus the understanding of the biosynthesis of uro'gen III is 
central to our understanding of the biosynthesis of a wide range of 
essential molecules. Furthermore, that understanding can only come 
from a detailed study of' the Type III Problem, and it is studies 
directed towards this goal that form the basis of this thesis. 
1.3 The Use ofNMR in Biological Studies 
With the advent, of Fourier-transform (FT) nuclear magnetic reso-
nance (NMR) spectroscopy, its use. and applicability to the study of 
biomolecuTes has gained in recent years. In the field'of porphyrin 
metabolism it is used quite. extensively, and since it is also the 
technique of choice for much of the work presented in Part II, it is 
appropriate to. discuss some of its capabilities. 
PROTOPORPHYRIN 
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/\ 
URO'GEN liii 
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I-IAEMOGLOBIN 	 CHLOROPHYLLS 
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SCHEME 2 
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The basic theory of NMR.is covered by a. number of excellent. 
texts263° and also its use in biological research. 335 This 
section will be concerned with the use of NMR to study biological 
macromolecules with specialreference to the nuclei H and 	C. 
Other nuclei used in biological NMR are listed in Table 1.1, along 
with some of their NMR properties. A more detailed summary of NMR 
relaxation is given in Appendix 1. 
Some of the types of biomolecules of interest here which are 
amenable to study by NMR are proteins, enzyme-inhibitor complexes, 
and much more recently, enzyme-substrate complexes. Much of the 
early work in the study of proteins by 13  C,NMR was performed by 
Allerhand, 36 who found that the resolution of the carbon resonances 
is greatly affected by the freedom of rotation of the carbons under 
observation. The backbone carbons of proteins tend to exhibit broad 
resonances, whereas relatively free side-chain carbons yield sharp 
lines. This also explains why denatured proteins show much sharper 
lines, due to the gains in degree of freedom. The increased resolu-
tion obtained with denatured protein is also due to the elimination 
of chemical shift non-equivalence caused by folding of the poly-
peptide chain. Sharp resonance lines in protein spectra also arise 
from non-protonated carbons, due to the inherently longer T2 values. 
Increasing the molecular weight of the protein also results in an 
increase in linewidth, since the protein tumbles more slowly and 
thus has a longer correlation time 
In many protein studies, high resolution spectra may be obtained 
at moderately low field strengths, and indeed only sp 3 carbons 
benefit from higher field strengths. This can be explained by the 
contribution of CSA to the relaxation mechanism for rion-sp 3 carbons 
TABLE 1.1. NMR properties of biologically relevant nuclei.ä 
Natural 	Magnetic 	Gyromagnetic 	Quadrupole 	NMR 
Spin 	Abundance Momentb Ratio 	 Moment FrequencyC 	Relative d 
Isotope 	I/ti y/10 rad 1' s_i 	Q/10 28 m2 	/MHz 	Receptivity 
1 
'H 1/2 99.985 4.8371 26.7510 - 	 300.133 1.000 
(500.135) 
2 H 1 0.015 1.215 4.1064 2.73 x 10 	46.073 1.45 x 
(76.775) 
3H 1/2 <l06 5.1594 28.5335 - 	 320.121 l.2l>'o ' 
(radioactive) (533.294) 
112 1.108 1.2162 6.7263 - 	 75.473 1.76 x 10 
(125. 767) 
15N 112 0.37 -0.4901 -2.7107 - 	 30.416 3.85 x 10_ 6 
(50.684) 
170 5/2 0.037 -2.2398 -3.6266 	-2.60 x 10_ 2 	40.687 1.08 x 10 
(67.801) 
19F 112 100 4.5506 25.1665 - 	 282.407 0.8328 
(470.56) 
23Na 3/2 100 2.8610 7.0760 0.12 	 79.388 9.25 x 10 2 
(132.290) 
1/2 100 1.9581 10.829 - 	 121.513 0.0663 
(202.490) 
aData taken from Ref. 	28; bData listed are the maximum observable values; CFrequency  given for a 7.0497 1 
instrument, with values for a 11.7470 T instrument in parentheses; dThe  receptivity is the sensitivity of a 




at field strengths >4 T. 	 By the same token, however, the contribu- 
tion of dipolar relaxation is low for non-protonated carbons at high 
field strengths, and extremely significant for protonated carbons. 
The assignment of specific resonances in a high resolution 
spectrum of a protein is not an easy task, particularly as much over-
lapping can occur, and the chemical shifts will reflect alsothe 
local environment of the particular residue. Synthesis of model 
peptides provide a useful way of assigning specific resonances, and 
Table 1.2 shows the chemical shifts for all theamino acid carbons 
in model peptides. 
Other methods for probing the structure of proteins by NMR 
includes covalent modification using 13C-enriched reagents. In 
this way Nigen and co-workers 38 ' 39 found multiple carboxymethylation 
of myoglobin and mono-carboxymethylation of ribonuclease A when 
these enzymes are reacted with [2-13C]-bromoacetate. By comparison 
with model compounds, the multiple resonances observed with the 
myoglobins can be assigned to carboxymethylation of histidine, 
lysine and terminal amino groups. Many other examples of this 
technique of modifying proteins with 13C-enriched molecules can be 
found in the literature, 4044 but perhaps a more subtle approach has 
been the use of inhibitors, which are capable of binding to the 
active site of the enzyme, thereby providing an active site probe. 
Rich and co-workers45 analysed the 13 C NMR of an adduct between 
pepsin and a pepstatin analogue. When a carboxyl enriched ketone 
analogue of pepstatin was used, it was found to bind to pepsin, 
giving rise to a new signal consistent with the formation of a 
tetrahedral adduct. Similarly, recent work in this laboratory 46 ' 47 
has made use of 13C-enriched inhibitors to study the active sites of 
12 
TABLE 1 .2. 13 C chemical shifts of the common amino acid residues in 
neutral D20.a 
Amino Acid 
Residue 	C=0 	cC 	ac. 	yC 	6C 	cC 
Gly 	 172.7 	43.5 
Ala. 	 175.8 	50.8 	17.7 
Val 	 174.9 	60.7 	30.8 	19.3 
18.5 
Ile 	 174.8 	59.6 	36.9 	25.4 	11.3 
15.7 
Leu 	 175.9 	53.6 	40.5 	25.2 	23.1 
21.6 
Ser 172.6 56.6 62.3 
Thr 172.7 60.2 68.3 20.0 
trans . 175.2. 61.6 30.6 25.5 48.2 
Pro{ 
cis 61.3 33.1 23.2 48.8 
Asp 174.2 52.7 39.8 178.4 
Glu 174.8 54.9 28.9 34.6 182.8 
Lys 174.7 54.4 27.5 23.1 31.8 40.5 
Arg 175.0 54.6 28.8 25.7 41.7 157.6 
Asn 173.1 51.5 37.7 175.6 
Gin 174.0 54.1 28.1 32.2 179.0 
Met 	. 175.0 53.9 31.0 30.7 15.0 
Cys 175.7 57.9 26.0 
Ring carbon atoms 
Trp 176.7 56.7 27.4 C2,C5 126.0,122.9 






TABLE 1.2. continued 
Amino Acid 
Residue C0 ctC C' yC 	- (SC 
Ring carbon atoms 








His 172.6 53.7 28.0 C2 135.2 
C4 118.7 
C5 130.3 
aData taken from Ref. 31, p. 175, and chemical shifts are expressed 
in ppm relative to TMS,c (for linear oligopeptides of the type 
H-Gly-Gly-X-Gly-Gly-OH or TFA-Gly-X-L-Ala-OCH 3 , where X is the amino 
acid given in the table. 
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trypsin and papain. Interestingly, it was found that while quater-
nary carbons at 7 T gave a linewidth of ca. 10 Hz, mono-protonated 
carbons show a linewidth of Ca. 50 Hz, and methylene carbons around 
100 Hz. This is obviously due to the effect of protons. Recently 
this has been circumvented48 by replacing the protons with deuterium 
atoms. This decreases the dipolar relaxation effects, and the scalar 
coupling only amounts to some 30 Hz for a -CD and 45 Hz for a -CD 2 . 
Even more difficult than the study of enzyme-inhibitor complexes, 
is the study of enzyme-substrate complexes. Two general techniques 
may be employed here: (i) for multisubstrate enzymes, incubate with 
only one substrate enriched with. 13C; (ii) for monosubstrate enzymes, 
"freeze out" the adduct by use of low-temperature., or cryoenzymological 
techniques. Later in this thesis we shall see examples of technique 
(i) as applied to one of the enzymes in the porphyrin pathway. 
Technique (ii) is one of the most difficuTt techniques, and it has 
been used in this laboratory 49 to characterise the acyl intermediate 
formed by papain and [carboxyl -13C] - N - benzoylimidazole. 
The use of 1 H NMR to study biomolecules is in a sense more 
difficult than 13C NMR. While 1 H NMR is considerably more sensitive, 
this is a disadvantage with proteins, which possess large numbers of 
protons falling in the range 0-12 ppm, as opposed to 13C where the 
range is 0-300 ppm. No selective enrichment can be made, and 
assignment of the resonances is often very difficult. Perhaps the 
greatest value of 1 H NMR in the study of proteins has been its use 
in the study of the pH dependce of selected residues. More 
recntly, the application of NOE-difference spectroscopy and 2-
dimensional NMR techniques has enabled workers to determine valuable 
information about the secondary and tertiary structure of proteins.50'5'1 
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The ability to study proteins in detai.l by NMR provides a 
powerful method for probing the subtleties of enzyme-reaction 
mechanisms. This is particularly important for the porphyrin 
pathway, in which many of the enzyme reactions have complex 
mechanisms which are little understood.. Such investigations will 
be outlined in more detail in Part II. 
1.4 Porphyrin Biosynthesis 
The pathway depicted in Scheme 1 shows the results of some 
classic studies in porphyri.n biosynthesis. The nature of some of 
the enzymic intermediates, involved in haem biosynthesis was inferred 
from labelling studies by Shemin and co-workers around 1950.19 
Similarly, Granick 52 found that chlorophyll biosynthesis followed 
such a route in the early stages, using mutants of Chiorella. 
Shemin 53 subsequently demonstrated the formation of corrins from 
the same initial building blocks. 
1.4.1 The. Biosynthesis of ALA 
(I) Biosynthesis in animals and bacteria. 
As mentioned in Section 1.2, ALA (6) in animals and 
bacteria is formed from the condensation of glycine with succinyl-
CoA by the action of ALA synthetase.. The mechanism of this enzyme 
has largely been established by Akhtar and his colleagues, 5456 and 
is shown in Scheme 3. By a series of elegant chiral labelling 
studies, Akhtar showed that the first step in the enzymic reaction 
is the binding of glycine to the cofactor pyridoxal phosphate, via 
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forms (19) which condenses with succinyl-CoA to give the intermediate 
(20). This species was shown to decarboxylate, giving (22) and not 
1-amino-2-oxoadipate (21), the latter being able to decarboxylate 
non-enzymically to give ALA. Using [3H]-glycine Akhtar proved, by 
determining the chirality of the ALA produced, that decarboxylation 
must take place on the enzyme surface. The species (22) thus 
generated becomes subsequently protonated, incorporating a proton 
from the medium and yielding ALA via (23). 
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(ii) Biosynthesis in plants. 
The biosynthesis of ALA in plants occurs by an altogether 
different route from that of animals and bacteria. This pathway is 
often known as the C 5 pathway, since when Beale and his co-workers 
first proposed it, 57 glutamate was found to be elaborated into ALA. 
The details of the mechanism for the sequence of enzyme-reactions 
which convert glutamate into ALA are not fully understood, and there 
is still considerable uncertainty between the postulated mechanisms. 58 
Perhaps one of the most viable mechanisms is shown in Scheme 4. 
,CO 	 ® 2H CO2H 	 /c02 
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SCHEME 4. (i) Glutamate transaminase; (ii) A phosphorylase; 
(iii) A reductase; (iv) ALA transaminase. 
Whether or not the enzymes act in a multi-enzyme complex has been 
the subject of recent speculation. 58 ' 59 However, the essence of 
the mechanism includes transamination of glutamate (24) to give 
2+ 
2-oxoglutarate (25) which after phosphorylation by an Mg -dependent 
enzyme, reduction by an NADPH-dependent enzyme gives 4,5-dioxovalerate 
(DOVA, 27). The conversion of DOVA (27) into ALA is cata1ysed.by a 
well-characterised 59 ' 60 enzyme, 4,5-dioxovalerate:alanine trans-
aminase (sometimes called DOVA or ALA transaminase) in a classic 
transaminase reaction. 
Many of the enzymes in the C 5 pathway have also been detected 
in animals and bacteria. While the picture for ALA biosynthesis in 
higher plants seems fairly clear, the extent to which this pathway 
operates in animals and bacteria is as.yet uncertain. Further work 
is needed in order to establish the contributions from both pathways. 
1.4.2 The Biosynthesis of PBG 
The transformation of ALA (6) into PBG (L) is mediated by the 
action of the enzyme ALA dehydratase (sometimes called PBG synthetase). 
The enzyme catalyses a typical Knorr reaction between two molecules 
of ALA, involving aldol condensation, dehydration and Schiff's base 
formati on. 
Studies by Shemin and co-workers 663 established that the 
substrate molecule becomes covalently attached to the enzyme via a 
Schiff's base with the c-NH 2 of a lysine residue. Further stereo-
chemical investigations by Abboud and Akhtar64 confirmed that the 
pro-R hydrogen originally present at C-5 of ALA is lost stereo-
specifically during PBG formation. These results were consistent 
with the hypothetical mechanism put forward by Shemin. 63 Later 
66 
investigations by Jordan and Seehra 
65, 	
revised the original idea 
that the first molecule of ALA to bind to the enzyme gives rise to 
the half of the molecule with the acetate side-chain. Using both 
[ 14C]- and later [13C]-ALA  in single-turnover experiments, Jordan 
showed that.the. first ALA molecule to bind gives rise to the half 
of PBG with the propionate side-chain, as shown in Scheme 5. The 
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single-turnover technique involves incubating the enzyme initially 
with a small quantity of labelled ALA, and then following through 
with a large excess of unlabelled substrate. 
The mechanism outlined in Scheme 5 shows the speculations of 
Jordan66 which are consistent with the experimental data. The 
exact details for the mechanism currently await the application of. 
such techniques as 13C NMR and X-ray spectroscopy. 
1.4.3 The Biosynthesis of Uro'gen III 
Of all the problems in porphyrin biosynthesis, it is the bio-
synthesis of uro'gen III that has attracted the most attention. Since 
it is also the focal point for the studies to be described in Part 
II, it will be examined in some detail. 
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The pioneering studies of Bogorad, Granick and Rimington 67 ' 68 
established the cooperative effort of two proteins,. differing in 
their stability to. heat, in the transformation of PBG (7) into 
uro'gen III (8). The heat-stable enzyme is known as PBG-deaminase 
(also called by a variety of.other names., including uroporphyrinogen 
I synthase, HMB synthase., and also simply "deaminase", to which it 
* 
will be referred hereafter.) 	The thermally labile enzyme, which 
was found to be completely inactivated when heated at 55°C for 30 
minutes, is known as uroporphyrinogen III cosynthetase (hereafter 
referred to as hlcosynthetaseH).  It was found that deaminase catalyses 
the condensation of four molecules of PBG in the formation of one 
molecule of uro'gen I and four molecules of ammonia. Cosynthetase, 
however, shows no catalytic activity when incubated with either 
PBG (7) or uro'gen I (9) (see Scheme 6). This adds a new dimension 
PBG(7) 
. , M~ D ~-C 
URO'GEN 	 X 	UROGEN I(?) 
C 
SCHEME 6 
to the Type III Problem as delineated, in section 1.2, for here are 
two enzymes which when acting together give the biologically useful 
* 
The IUB has recently recorniiended the name "HMB synthase", but as 
will be revealed by the work presented here, this name no better 
represents the enzyme's function than does uroporphyrinogen I 
synthase. However, the name PBG deaminase is non-committal as to 
the nature of the product of the enzyme, and is therefore the name 
employed throughout this thesis. 
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isomer, and when acting separately, give rise to the biologically 
useless isomer. 
Deaminase was first isolated from spinach leaves in 1955.69,70 
Since then it has been purified from a. number of sources, and some 
of its properties are summarised in Table 1.3. From such data, it 
is generally accepted that deaminase. is a monomer with Mr = 37,000. 
The values for the Michaelis constant (Km)  show that the enzyme has 
a high affinity for P8G. The enzymes from all sources show strong 
non-competitive inhibition by suiphydryl reagents such as p-chloro-
mercuric benzoate, mercuric chloride, and N-ethyl maleimide. These 
effects can. be reversed by dialysis with thiol reagents such as 0.1 M 
cysteine, dithiothreitol or -mercaptoethanol . . Competitive inhibition 
has been demonstrated using analogues of PBG, such as opsopyrrole-
dicarboxylic. acid (32) (K i = 0.28 mM) and iso-porphobilinogen (33) 
(K 	0.51 mM). 8083 When other pyrrole analogues were used, it was 
B
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TABLE 1.3. Properties of PBG deaniinase ([C 4.3.1.8). 
Max. Spec. 
Source of 	 Activitya  
Enzyme 	 Mr/daltons 	 PH opt 	 PI 	 Km(PBG)/M 	 /Umg - 	Ref. 
R. spheroides 35-36,000 7.8-8.0 4.46 4 x 10 27 71 
(p11 	7.8-8.0) 
36-39,000 7.6 	(Phos) - 1.3-2 x 10 5 128 72 
(pH 7.6) 
Bovine liver - 7.4 - 5 x 10 6 0.01 73 
Wheat germ 38-40 3 000 8.2 	(Phos) 4.2-4.5 5 
15b 
74 
Spinach leaves 38-40,000 8.1 c 4.2-4.5 7.2 	x 08b 75,76 
(pH 8.2) 
Euglena gracilis 39-43,000 7•08•1d - 7 x 10 	ore 6.0, 	218
f 
77 
1.95 x 10 
Human 20-30,000 7.4 (Phos) - 1.3 	x 10 16 78 
erythrocytes 
8.2 	(Iris) (pH 7.4) 
37,000 8.0 	(Iris) 6.2 6 x 2.34 79 
(pH 8.0) 
ai 	= 1 	jiniol 	uroporphyrin produced per hour at 37°C. Note that lu is also. used, which is defined as 1 	nmol 
uroporphyrin produced per hour. 	biu = 1 pmol 	PBG consumed per hour - see Ref. 76; 	cFrom Ref. 	70; dF rom 
Ref. 	17, 	p. 	77 eFrolfi  Ref. 	125; 	From Ref. 	136; 9 From Ref. 	75. N) 
23 
found that PBG c-carboxylic acid (34) had no effect, 84 both the 
ethyl analogue of PBG (35) and the acidic pyrrole (36) acted as 
competitive inhibitors, and the dimethyl ester of (36) showed no 
inhibitory effect. 78 Finally, PBG-imidazole (37) and its two 
methylated derivatives (38) and (39) showed no effect. 85 Such 
results clearly point to the involvement of one or both carboxyl 
groups in binding, 78 and some degree of tolerance to the nucleo-
philic group attached to C-li. 
The only reported amino acid analysis of deaminase is shown 
in Table 1.4, for the human enzyme. To date, no sequencing infor-
mation on the enzyme has been published. 
Cosynthetase was first isolated from wheat germ in 1958.70  It 
proved more difficult to purify, in particular to separate it from 
deaminase. This fact, coupled with the lack of a simple, accurate 
assay method until recently, has resulted in scant information on 
the enzyme. Furthermore, as we shall see, many of the studies of 
this enzyme have employed a deaminase-cosynthetase mixture, which 
is why our mechanistic investigation will be unable to focus on 
each enzyme in turn. 
Some of the properties of cosynthetase are summarised in Table 
1.5. Early assay methods for the enzyme relied upon separating the 
uroporphyrin I and III isomers. Complete and reproducible separa- 
tion has only recently been achieved using HPLC methods, either of 
pro 
the den vatised 4porphyrins,
91,92 the uroporphyri n octamethyl 
esters, 9395 or the uroporphyrin free acids. 96 ' 97 Much more 
recently, a rapid assay method has been reported which does not 
involve separating type I and III isomers.98 
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TABLE 1 .4. Amino acid composition of human deaminase.a 
Mol/37,000 g 	 Nearest Integer! 
Amino Acid 	 of Protein 37000 g of Protein 
Aspartic acid 36.4 36 
Theonine 18.0 18 
Serine 20.7 21 
Glutamic acid. 40.1 40 
Proline 12.0 12 
Glycine 29.9 30 
Alanine 22.9 23 
Valine 17.0 17 
Half cystine 2.4 2 
Methionine 0.1 0 
Isoleucine 15.0 15 
Leucine 39.1 39 
Tyrosine 1.0 1 
Phenylalanine 7.8 8 
Lysine 16.7 17 
Histidine 3.4 3 
Arginine 10.2 10 
Tryptophan 0.0 0 
aDa ta  taken from Ref. 79. 
TABLE 1.5. Properties of uro'gen III cosynthetase (EC 4.2.1.75). 
Source of 
Enzyme Mr/daltons PH0t 
Max. 	Spec. 
Activitya 
p1 	 Km(HMB)/M 	/Umg' Ref. 
Wheat germ 60-65,000 - 6.1-6.7 	 - 	 - 75 
- 8.2 - 	 - 	
- 86 
Spinach leaves - - - 	 - 	
- 76 
Mouse spleen 33-60,000 8.5 - 	 - 	
- 87 
Human erythrocytes - - - 	 - 	
- 88 
R. spheroides 30,000 7.8 4.6-4.8 	 - 	 82 89 
(15,000 subunit) (Phos or Iris) 
E. gracilis - - 
- 	 11.3 x 	io - 90 
a 
lU = 1 Pmol of uro'gen III per hour. 
Ui 
26 
Initial views about the action of deaminase and cosynthetase 
favoured an association between the two proteins, 75 ' 78 ' 99 with 
cosynthetase even operating as a "specifier protein". This stems 
from the observation that the rate of consumption of PBG by deaminase 
is increased by added cosynthetase at low substrate concentrations. 87 
Apart from one report, 10° one of the striking features of uro'gen I 
or III biosynthesis was the absence of formation of any detectable 
free intermediates. For at least a decade no experimental answers 
were forthcoming and this generated a flow of speculative thinking. 
Some 25 different hypothetical mechanisms as to the nature of the 
rearrangement were proposed during this period. 101 Work over the 
last ten years has served to eliminate a large majority of these, 
and now only variations on one mechanism, put forward by Mathewson 
and Corwin 102 in 1960, remain favoured. In this mechanism (see 
Scheme 7) a linear tetrapyrrole is assembled and then intramolecular 
PBG 	







SCHEME 7. Mathewson and Corwin mechanism for uro'gen III formation. 
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rearrangement of one PBG unit gives rise to uro'gen III via a "spiro" 
intermediate (41). 
While the Mathewson and Corwin mechanism is favoured now, up 
until the early 1970's almost all the proposed mechanisms seemed 
tenable. Studies of the Type III Problem then focused on two main 
questions: (i) What is the timing of the rearrangement? (ii) What 
is the nature of the rearrangement? The discovery that the action 
of deaminase on PBG in the presence of ammonium ions or hydroxylamine 
led to the accumulation of oligopyrroles, 99 ' 103 stimulated consider-
able interest in the first question. Interest settled upon the 
possible intermediacy of di- or tri-pyrrôles in porphyrin biosynthe-
sis, and this gave rise to intense synthetic effort in three groups 
in Buenos Aires, 104 ' 105 Cambridge, 17 ' 106 and Yale) 07 For some time 
results were inconclusive due to anomalous incorporations and non-
enzymic reactions of these species. The reader is directed to 
17 reviews of this period of research for further information) 6 ' 
Since the timing of the rearrangement could take place in theory 
at any level between monopyrrole and tetrapyrrole, the search for 
free intermediates continued. The possibility for the intermediacy 
of tetrapyrroles, or bilanes as they are also known, was recognised 
quite early on by Radmer and Bogorad 108 in 1972, when they isolated 
a substance whose structure they inferred to be that of aminomethyl-
bilane (40). 
(4p) R H 
(43)R rHO 
(44) R MeO 
Further credence to. this observation came a. year later, when 
Davies and Neuberger 71 reported. the detection of polypyrroles which 
accumulated when the enzyme and PBG were incubated, in the presence 
of amines of the type RNH 2 , where R=H, HO, or MeO. These were 
identified as.tetrapyrroles by a variety of techniques, and it was 
found that aminomethylbilane (40) released ammonia onon-enzymic 
cyclisation to give uro'gen I. Likewise, the other two tetra-
pyrroles (43, 44) released the corresponding bases on cyclisation. 
Furthermore, the lack of accumulation of any oligopyrroles other 
than bilanes seemed strong evidence in favour of the latter's 
intermediacy in porphyrin biosynthesis. 
In the same year as the observations of Davies and Neuberger, 
Battersby and his col'leagues 109 ' ° turned their attention to the 
second question, what is the nature of the rearrangement? By ele-
gant use of 13C. NMR, Battersby showed that the porphyrin D-ring is 
rearranged intramolecularly. He did this by incubating [2,11- 13C]-
PBG (45) with deaminase-cosynthetase in a coupled enzyme system from 
avian erythrocytes and bovine mitochondria, which produces proto-
porphyrin IX (47-50), analysed as its ester. The [2,11- 13C]-PBG 
was available from [5- 13C]-ALA (46) by the action of ALA dehydra-
tase, 11 ' and the crucial step was to dilute this PBG five-fold with 
unlabelled PBG prior to conversion to protoporphyrin IX. 13 C NMR 
analysis in the presence of praseodymium shift reagent revealed 
three doublets' with 3J = 5.5 Hz and one with 1 J = 72 Hz. The 
latter was assigned to C-iS (50) on the basis of rational synthesis 
of 13C-labeiled protoporphyrins, 214  and thus establishing that 
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Although the timing of the rearrangement appeared to be at the 
tetrapyrrole level, the first test of this came in 1975 by Mi11er 
et al. 5 in Stuttgart. He found that incubating [4- 14C]-ALA with 
a cell-free extract from ClosUtidiwn tetanQmorphum in the presence 
of aminomethylbilane (40) resulted in significant radioisotopic dilu-
tion over the blank run without bilane, when the product cobyrinic 
acid (16) was isolated. Shortly afterwards the Cambridge group 
confirmed unequivocally using 13C NMR that the rearrangement takes 
30 
place after head-to-tail combination of. four PBG units. They 
synthesised aminomethylbilane 6 ' 7 bearing two dIfferent 
labelling patterns (51, 53), incubated each with deaminase-cosynthetase 
from Euglna gracilis, and analysed the isolated coproporphyrin III 
esters (52,. 54) by 13C NMR. 8 ' 119 Use of. praseodymium shift reagents 
again enabled a distinction between the. two products. Coproporphyrin 
(52) showed a doublet ('J = 72 Hz) which was strongly affected by 
shift reagent, indicating ° that it corresponds to C-15, whereas 
coproporphyrin (54) also showed a doublet (Li = 72 Hz) but this was 









of these NMR observations had already been provided by total 
synthesis of the protoporphyrins.° 
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These results, especially, using the labelling pattern depicted 
in (54), proved. beyond doubt that intramolecular rearrangement takes 
place at the tetrapyrrole exactly as in Mathewson and Corwin's 
hypothes.is . . Further studies by the Cambridge group in 1978,120,121 
using synthetic isomeric aminomethylbilanes bearing one or more rings 
inverted", showed that the unrearranged bilane (40) served as the 
best substrate for the Euglena enzyme system, in contrast to a 
report from Frydman et al. 
,l22 
 where such bilanes did not serve as 
substrates at all. Such results led Battersby to conclude 120 that 
the aminomethylbilane (40) was the enzymic intermediate between PBG 
and uro'gen III. 
123 	 ' 	13 Also in 1978, Scott and co-workers 	in Texas presented C 
NMR evidence for the direct observation of a transient free inter-
mediate, which they called pre-uroporphyrinogen or pre-uro'gen. 
They incubated [11 1  3C]-PBG  with highly purified deaminase from 
R. spheroides in' the NMR tube, and watched the formation of uro'gen 
I. Raving characterised the spectra of PBG and uro'gen I, when the 
enzymic reaction was allowed to proceed until 47% of the PBG had 
been consumed (11 minutes), a set of new signals appeared at 21.85-
22.15 ppm and 54.78 ppm. As the reaction proceeded to completion 
these signals disappeared, and the meso carbon atoms of uro'gen I 
appeared at 21.63 ppm. When purified cosynthetase was added, none 
of these signals were observed and the uro'gen III signal increased 
proportionally. 
These results were rationalised in terms of five possible 
structures for the intermediate (40, 41, 55-57). Since uro'gen III 
was formed at the expense of pre-uro'gen, it presumably served as a 
substrate fo.r cosynthetase and suggested that it was formed from a 
tetrapyrrole. The signals were thus consistent with (55) as a 
possible structure, especiall.y since acid or base treatment of 
WA 
X = OH , HYDROXYMETHYLBILANE (55) 	 UROGEN I TAUTOMER (5 
X= NH 2 (40) 
N-ALKYL" 7) 	 SPIRO" (41) 
pre-uro'gen gave only uro'gen I. The aminomethylbilane (40) was 
discounted on the basis of chemical shift, since a 13CH2NH2 in such 
a system would be expected to give a signal at 34.6 ppm. Of the 
four structures (41, 55-57), note that the uro'gen I tautomer (56) 
might be expected to arise from chemical cyclisation of a tetra-
pyrrole prior to uro'gen I formation. However, the uro'gen I 
tautomer (56) was ruled out when [2,11-3C]-PBG served as a substrate, 
since no 13C- 3C coupling was detected at 54.78 ppm, as required for 
structure (56). No distinction could be made between the remaining 
structures, (41), (55) and (57), due to the instability of pre-urogen 
(t 1 = 4 minutes at 37°C, pH 8). 
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Further evidence that pre-uro'gen acted as a..substrate for 
cosynthetase was provided by. the same group, 124 when deaminase-free 
solutions of pre-uro'gen (obtained by filtration through a membrane) 
were incubated with cosynthetase and the products analysed by HPLC 
as their porphyrin esters. Thus Scott and co-workers were able to 
show that the enzymes deaminase and cosynthetase act in tandem and 
not in association with one another. 
These observations stimulated a period of intense research by 
both the Texas group and the Cambridge group. The first rejoinder 
from Cambridge reported 125 the observation that there was a clear 
lag in the formation of uro'gen I from aminomethylbilane (40). The 
lag was even more evident when consumption of PBG by deaminase, and 
production of uro'gen I, was determined. No such lag was observed 
when deaminase-cosynthetase.was used. To study the nature of the 
intermediate that must account for the lag, the Cambridge group 
generated the intermediate from [ll-13CJ-PBG, adjusted the pH to 
>12, and analysed the species by 3C NMR. They found signals at 
24.46 ppm and 57.21 ppm, which probably arose. from the same species 
as the Texas group were studying, taking into account shift 
differences due to referencing. The same signals were also 
obtained without pH adjustment, but were much shorter-lived (t 1 = 
4 minutes at 37°C, pH 8.25). These results were interpreted as 
evidence for the hydroxymethylbilane (55), on the basis of 3C NMR 
analysis of hydroxymethylpyrrole. The hydroxy analogue (58) of 
P () 
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[2,11- 13c]-PBG was found to give a signal. corresponding to HO-CH 2 - 
pyrrole at 57.27 ppm (pH >12), and furthermore.. found to act as a 
good substrate for deaminase-cosynthetase. -L±ke the Texas group, 
addition of deaminase-cosynthetase to the intermediate produced 
enhanced quantities of uro.'gen III, which led Battersby to support 
the view that the two enzymes associate in some way rather than 
acting independently. 
In order to validate the earlier work with .aminomethylbilane, 
the Cambridge group also showed that incubation of [ll -13CJ - PBG 	j 
15 	+ 	
1 
with deaminase in the presence of NH4 resulted in the formation 
of the "trapped' 1 intermediate 15NH2 - 13CH2 -bilane, which exhibited a 
doublet at 38.3 ppm ('J  ( 13C- 15N) = 3.68 Hz). Non-enzymic runs with 
synthetic [aminomethyl 3C]-bilane and.' 5NH4 showed no indication 
of nucleophilic displacement of the amino group. 
The foregoing picture became somewhat more complicated when 
the Texas group reported evidence 126 in favour of the N-alkylated 
macrocycle (57) for the structure of pre-uro'gen. They made use of 
13 and 15N NMR to. analyse the pre-uro'gen generated as before using 
[ll- C, l- 1315N]-PBG. The 13C NMR spectrum revealed a doublet at 
54.78 ppm ( 1 J ( 13C- 15N) = 6 Hz) where previously the non- 15 N species 
showed a singlet, when run at 0°C after a 3 minute incubation of 
[11- 13C, 1-15N]-PBG with deaminase at 37°C. On heating to 37°C, 
the signals disappeared with concomitant formation of uro'gen I. 
When the 15N NMR spectrum was obtained, a resonance at 155.7 ppm 
assigned to the ring D pyrrole nitrogen appeared as a doublet 
( 15N- 13C) = 6 Hz). Further observations with synthetic amino-
methylbilane (40) obtained from Frydman's laboratory, supported 
Frydman's view 122 that it is not a substrate for cosynthetase, for 
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it was unaffected. by purified cosynthetase. Furthermore, it could 
be detected in pre-uro'gen preparations, presumably due to trapping 
of the Antermediate with ammonium ions. This was corroborated when 
an ammonia-consuming enzyme system (glutamate dehydrogenase, a-keto-
glutarate, NADH) was added, and no aminomethylbilane formed. It was 
suggested that the same trapping mechanism could give rise to the 
hydroxymethylbilane also. 
The Cambridge group rapidly responded 127 ' 128 by reporting the 
total synthesis of hydroxymethylbilane (55) (hereafter referred to 
as HMB) and its incorporation into uro'gen III. Furthermore, its 
chemical, spectroscopic and quantitative enzymic properties were 
identical to the. HMB generated enzymically. It served as a substrate 
for deaminase-free cosynthetase in an identical manner to the 
enzymically generated HMB. Further evidence against the involvement 






was synthesised, and its 13C NMR spectrum at pH 8.0 showed a doublet 
at 42.00 ppm, some 12 ppm to higher field than pre-uro'gen, with a 
one-bond 1 J ( 13C- 15N) of 2.4 ± 0.1 Hz, both at pH 8.25 and >12. 
From this, the 6 Hz doublet observed in Texas was seen as an artefact. 
Further observations by the Texas group 129 helped to clarify 
the situation, when under conditions of high concentrations of enzyme. 
and substrate, a resonance at 54.78 ppm (37°C, pH 8.2) exhibiting 
two-bond coupling ( 2J ( 13C- 15N) = 1.8 ± 1 Hz) was detected. Thus 
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it was clear that at pH 8-12 and 37°C, both groups were handling the 
same species, namely HMB (55). However, that the 6 Hz doublet may 
be an artefact was discounted since it had been repeatedly observed 
with both 4.7 T and 7..0 T spectrometers. The anomalous chemical 
shift and coupling constant could be explained if it is recognised 
that the N-alkyl macrocycle (57) at 0°C is conformationally distinct 
from the model N-alkyl species (59). The reason why the Cambridge 
group failed to detect the 6 Hz coupling could be explained as a 
result of their spectra not being recorded at pH 7-8.5 and 0°C. 
Therefore, the Texas group concluded that HMB represents the nuclec-
philic trapping of an exomethylene pyrrolenine species with water 
at 37°C, and it is this latter species that represents the true 
substrate for cosynthetase. 
The Cambridge group then reported 13° their findings at pH 7-8.5 
and 0°C. Incubation of [11- 13C, 1-15N]-PBG with deaminase at 37°C 
and pH 8.25 for 7 minutes, cooling to 0°C, and then recording the 
NMR spectrum at 4°C revealed no signs of any 6 Hz coupling. 
Again the doubletat 57.1 ppm ( 1 J ( 13C- 15N) = 2.4 Hz) was observed. 
When hydroxylamine was added to the enzyme-free solution of bilane, 
and deaminase subsequently added, the hydroxylamino derivative (43) 
of HMB accumulated, representing the nucleophilically trapped 
version of a more reactive species, such as an exomethylene 
pyrrolenine (60, see Scheme 10). 
It is worth pausing at this point in 1980 in the chronology of 
events surrounding the discovery of the free intermediate between 
PBG and uro'gen III, to note that this is where the work to be 
described in Part II of this thesis commenced. The two working 
hypotheses held by both Cambridge 131 and Texas 132 groups in 1980 
(_ . , 0/\  
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SCHEME 11. Scott's mechanism for uro'gen III formation (1980). 
N. 
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are summarised in Schemes 10 and 11. In Battersby's mechanism, PBG 
units are built up into a linear tetrapyrrole on the surface of the 
enzyme (X group is unknown) which becomes free from the enzyme as 
HMB (55), a species in equilibrium with the exomethylene pyrrolenine 
(60). HMB is then the substrate for cosynthetase.., in acknowledgement 
of the fact that the enzymes act in tandn, and forms uro'gen III 
via the Spiro species (41) originally proposed by Mathewson and 
Corwin. In contrast, in Scott's mechanism the species that comes 
off the surface of the deaminase is the exomethylene pyrrolenine (60), 
which at 0°C could form the N-alkyl species (57), while at 37°C forms 
HMB (55) which could go via any one of (57), (41) or (56) to give 
uro'gen III. Clearly a sustained NMR effort is required if any other 
intermediates are.to be detected, allowing a clearer definition of 
the mechanism to be made. 
Strong evidence against the intermediacy of an N-alkyl structure 
came late on in the research presented here, in 1983 from Gossauer 
and Scott, 133 when they reported the total synthesis of a close 
analogue (61) of the proposed structure (57). Analysis of the 
() 
putative methylene by natural abundance 13C NMR showed a doublet at 
41.52 ppm with a one-bond 1 1 ( 13C- 15N) of 10.7 Hz. This suggests 
that the 6 Hz coupling may perhaps be an artefact from say, tempera-
ture variations in the NMR spectrometer. However, its repeated 
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observation in a number of spectrometers, and with 13C and 15N, 
suggests that some effect was observed' that is not yet understood. 
More detailed studies on deaminase have recently cast light 
upon the action and mechanism of the enzyme, and this has served to 
direct the research described in the latter half of Part II. The 
order of assembly of the four units was investigated independently 
by Battersby and co-workers 13436 and Jordan and Seehra) 37 ' 138 
Battersby's group employed relatively large amounts of deaminase-
cosynthetase toensure complete loading of the first binding site 
of the enzymes using unlabelled PBG. Flushing through with 
[ll -1 '3C] - PBG gave uro'gen III which was isolated as its copro-
porphyrin III ester for analysis, by 
l H NMR using europium shift 
reagents. Integration of the resulting triplets gave an accurate 
method for quantifying the amount of 13C in the molecule. It was 
found to be in the order C-20 > C-5 > C-lU > C-15, suggesting 
clearly a logical order of formation of A, B, C and then D rings. 
Jordan's experiments used a similar single-turnover technique 
in which 1, 2 or 3 molar equivalents of [2,11-14C]-PBG was 
initially mixed with 1 molar equivalent of deaminase. Excess 
unlabelled PBG was then used to complete the turnover to uro'gen III, 
and the product isolated using a 'coupled enzyme system, as proto-
porphyrins IX (13). Chemical degradation of the protoporphyrin IX 
yielded two different well-characterised maleimides whose specific 
radioactivity could then be determined (see Scheme 12). The ethyl-
methylmaleimide (62) thus obtained arises solely from the A and B 
rings of.the porphyrin, and likewise the haematinic acid (63) arises 
from the C and D rings. The results proved that the rings were 
assembled in the order A, B, C and then D. 
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Following the report from Anderson and Desnick 79 in 1979 of the 
identification by gel electrophoresis of five catalytically competent 
forms of human deaminase, representing native enzyme and one, two, 
three and four bound PBG units, Jordan and Berry' 39 investigated the 
generation of similar enzyme-substrate complexes using [3,5 -14 C] -- PBG 
and deaminase from R. sphroides in a rapid mixing device. Gel-
filtration on G-50 Sephadex yielded radioactively labelled protein, 
which would not result from pre-treatment of the deaminase with 
opsopyrroledicarboxylic acid (32) or boiling the enzyme. The 
catalytic competence of the complex was demonstrated by adding 
excess unlabelled PBG and generating 14 C-labelled uro'gen I. The 
complex was found to be remarkably stable, suggesting a covalent 
linkage between enzyme and PBG, a fact further corroborated when 
SDS treatment failed to displace radioactivity. Hydroxylamine, 
however, displaced radioactivity both in the active and in the 
SDS-denatured complexes, presumably by nucleophilic displacement. 
42 
Jordan and co-workers 140 ' 141 went on to identify the existence 
of four bands by gel-electrophoresis again representing, as in the 
case of the complexes of Anderson and Desnick, the native enzyme 
and enzyme-substrate complexes bearing one, two and three bound PBG 
units. Interestingly, no complex corresponding to bound tetrapyrrole 
could be detected.. Using this method for the generation of complexes 
bearing [14C]-PBG,  and the rapid-turnover technique described above, 
Jordan was able to elegantly prove that each band did indeed 
represent the enzyme-substrate complexes that initially seemed 
likely. 
The identification and characterisation of such enzyme-substrate 
complexes, and the discovery that they are unusually stable clearly 
suggests that a technique such as NMR could be profitably applied 
to probe the structure of the active site of this relatively little 
studied enzyme. 
1.4.4 TheLater Stages of Porphyrin and Corrin Biosynthesis 
As indicated in Scheme 2, uro'gen III represents the divergence 
point for porphyrin and corrin biosynthesis. The biosynthesis of 
haem from uro'gen III is shown in Scheme 13. For further details of 
each step, the reader is directed to Reference 14 which provides an 
excellent account of the later stages of porphyrins and corrin bio-
synthesis. 
Chlorophyll branches from the haem pathway at protoporphyrin IX, 
as shown in Scheme 14. 
Finally, corrin biosynthesis follows probably the most complex 
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it was established 53 ' 99 that ALA, PBG and methionine are involved in 
the biosynthesis of cobyrinic acid (16), and that cobyrinic acid is 
elaborated to vitamin B 12 , 142 Scott confirmed 143 ' 144 that uro'gen 
III is incorporated into vitamin B 12 , using whole cells of 
P. shermanii. Further work showed that uro'gen III is incorporated 
without rearrangement. 145 
Parallel studies in three laboratories' 46148 revealed that of 
the eight methyl groups arranged around the periphery of the corrin 
macrocycle, seven are derived from methionine, or more properly 
5-adenosyl methionine or SAM, and one from ALA. Furthermore, 
Battersby14815° and Scott 151 showed that the pro-R methyl group at 
C-12 of B 12 (3) is derived from methionine. Proof that all the 
seven methionine-derived methyl groups are transferred intact came 
simultaneously from the laboratories of Arigoni, 152 Battersby153 
and Scott. 154  
45 
An insight into the sequence of methylation of uro'gen III came 
with the discovery 155 of sirohydrochiorin (14), the determination of 
its structure, 5658 and its successful incorporation into cobyrinic 
acid. 15659 This was also confirmed when Mifller 160 ' 161 isolated 
Faktors I (67), II (14) and III (69) from P. sherincznii, and Faktor 
II showed all the physical characteristics of (14). It seems likely 
that the actual biosynthetic intermediate is the reduced dihydro-
sirohydrochlorin. With the structure of Faktor I rigorously 
assigned, 161 ' 162 the next step on the pathway to cobyrinic acid came 
with the determination 156 ' 163 of the structure of Faktor III (69). 
This was seen obviously to be a trimethylisobacteriochlorin at the 
outset, but the position of the third methyl group proved difficult 
to assign. 6466 The problem now remains, what are the other 
methylated (from SAM) intermediates on the cobyrinic acid pathway? 
So far, no light has been shed on this area. 
The extrusion of C-20 of Faktor III to give the corrin macro- 
167 
cycle was originally thought 	to come off as the C 1 unit of 
formaldehyde. However, there is now strong evidence 168 that it comes 
off as a C 2 unit, possibly as acetic acid, with the C-20 methyl group 
still attached. Despite even more recent evidence based on acetic 
169-171 acid trapping experiments, 132, 	and also a precedence from 
Eschenmoser's synthetic studies, 172 there is really little evidence 
that the liberation of acetic acid is an enzyme-catalysed event. 
Indeed from Eschenmoser's work, it seems possible that the acetic 
acid could be lost spontaneously, and this is borne out by the large 
amounts of acetic acid seen in the blank runs. 132 ' 697 ' Further 
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CHAPTER 2 
NMR STUDIES OF URO'GEN BIOSYNTHESIS 
2.1 Introduction 
At the time when this research commenced, three questions within 
the Type III Problem remained in doubt or unanswered: (i) What is 
the nature of the intermediate produced by the action of deaminase 
on PBG, and is it the true substrate for cosynthetase? (ii) How is 
the linear tetrapyrrole bound and assembled on the surface of deami-
nase? (iii) What is the mechanism by which cosynthetase catalyses 
the inversion of the D ring to give uro'gen III? The work described 
in this chapter makes use of high-field high-resolution NMR instru-
mentation in an attempt to address questions (i) and (iii). Investi-
gations into question (ii) will be considered in subsequent chapters. 
The working hypothesis held in this laboratory (see Scheme 11) 
did not allow an. unequivocal decision to be made between the pro-
posed intermediates in the transformation of PBG into uro'gen I or 
III. Also, Battersby's mechanism (see Scheme 10) left uncertainty 
as to the true substrate for cosynthetase - was it HMB (55) or the 
exomethylene pyrrolenine (60), since they are supposed to be in 
equilibrium with one another? Accordingly, it was felt that NMR 
might provide a means for detecting other transient species as the 
enzymic reactions proceeded. 
2.2 1 H NMR Studies 
Initial studies attempted to make use of the inherent sensi-
tivity of 1 H NMR to detect any unusual species as PBG is converted 
to uro'gen I by deaminase. The proposed exomethylene pyrrolenine 
(60), while known to be highly reactive in model systems, 173 might 
exhibit a unique olefinic 'H resonance, even if fleetingly. 
Since PBG lactam (70) was readily available in this laboratory 




PBG lactam (. 9) 
alkaline hydrolysis provided easy access to large quantities of P8G. 
Deaminase was purified from R. sphero-ides by methods similar to 
those described in Chapter 3. omitting the electrophoresis step, by 
Dr. R. C. Davies. 
In a typical experiment, PBG (2mg) was dissolved in D 20/Na2CO 3 
and mixed with deaminase (100 U) in the NMR tube at4°C. Spectra 
were then recorded at 4°C, with a time-interval of 3 minutes between 
spectra over the course of 5 hours. Such a 300 MHz 1 H NMR time-
course is shown in Figure 2.1. For this experiment the deaminase 
was dialysed against several changes of 99% 020  phosphate buffer at 
pH 8.0, and the residual HOD resonance suppressed by homonuclear 
irradiation. We can clearly see the initial signals of PBG, assigned 
in Table 2.1, being lost as uro'gen I formation takes place. Here 
it was hoped that the exomethylene species (60) might be detectable, 
but no olefinic resonance was observed. Later literature precedents 175 
suggested that such a species would exhibit a chemical shift Ca. 
4.9 ppm, which would be unavoidably obliterated by the HOD signal. 
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FIGURE 2.1. 300 MHz 1 H NMR time-course of PBG and deaminase, pH 8.0, 4°C. 
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C-7 '2.41 (2H, t) 
C-6 2.67 (2H, t) 
C-9 3.41 (2H, s) 
C-li 4.16 (2H, s) 
C-2 	 6.69 (1H, s) 
alnternaily referenced to TSP. 
However, additional signals of lower intensity than substrate 
or product can be seen at 4.4 and 6.4 ppm, corresponding to the 
H0-CH2 -pyrrole and pyrrole-H of HMB (55), respectively. These 
assignments were confirmed when compared with a sample of synthetic 
HMB prepared by Dr. I. Ichinose (see Figure 2.2). 
The effect of pH on the chemical shifts of PBG was also examined, 
since it was felt that there maybe some spread of shifts at different 
pH values, due to the three ionisabie groups of PBG. Figure 2.3 
shows a 300 MHz NMR study of PBG at a wide range of different pH 
values. For this experiment, PBG (ca. 3 mg) was dissolved in 0.1 M 
99% D 20-phosphate buffer at pH 7.27, and titrated with 0.2. M NaOD 
in 99% D20  measuring the pH directly. The pH values are uncorrected 
for D2 0, and the sample was referenced using a coaxial insert of 1% 












FIGURE 2.2. 300 MHz 1 H NMR spectra of PBG, HMB (synthetic) and uro'gen III, pH 8.0, 25°C. 
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FIGURE 2.3. 300 MHz T H NMR spectra of PBG at various 
pH's, 25°C. 
susceptibility differences. As with the other 1 H work, the HOD 
resonance was suppressed by homonuclear irradiation, and the residual 
line omitted from Figure 2.3 for clarity. The most interesting 
feature of Figure 2.3 is the severe broadening of the aminomethylene 
protons near the PKa  of the amino group, which is reported to be 
176 10.1. 	This is presumably due to a rapid equilibrium between the 
53 
protonated and deprotonatedaminomethylene species, resulting in 
an averaged, broadened resonance. As the pH is raised to a point 
where much of the amino group is deprotonated, the methylene reso- 
nance reappears some 0.05 ppm upfield to where it appears at pH 7.27. 
Additionally, two low intensity peaks at 1.1 and 3.4 ppm appear at 
both alkaline and acidic pH. These probably represent decomposition 
products, since by this stage the sample had become highly coloured. 
Further interpretations of the effect of pH changes on PBG are 
presented in Section 2.6. 
2.3 Synthesis of 13C-Labelled ALA 
If we again consider the mechanistic hypothesis held in this 
laboratory (Scheme 11), clearly the question as to the mechanism of 
cosynthetase might be approached by appropriate 13C-labelling studies. 
For example, [5-13C]-ALA (45) would afford a sample of HMB (72) 
which, on transformation into uro'gen III, could allow a choice to 
be made between the proposed intermediacy of the uro'gen I tautomer 
(74) and the other two species (73 and 75), since it has a unique 
sp 3 carbon (see Scheme16). Additionally, if the exomethylene 
species (71) occurred at NMR detectable concentrations, the sp 3 
carbon of PBG might be seen changing to an sp 2 carbon. 
On the other hand, a distinction between the spiro intermediate 
(81) and the other two species (79 and 80) could be made using HMB 
(78) derived from [4-13C]-ALA (76) (see Scheme 17). Thus taken 
together, these two labelling patterns would allow a distinction to 
be made between all three proposed intermediates. 
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The initial requirement was therefore samples of [5- 13C]- and 
[4-13C] -ALA, which could then be converted into [2,11- 13C]- and 
[3,5-13C] - PBG, respectively, by the action of ALA dehydratase. The 
method employed for the synthesis of E5-13C]-ALA was essentially 
that of Battersby et 	
i ll 
 with certain modifications (see Scheme 
18). The most significant modification occurs in the conversion of 
the 5-hydroxy-2-piperidone (86) into 5-oxopiperidone (87), in which 
the order of addition of reagents for the Pfitzner and Moffat oxida-
tion is critical, and the reaction does not work if the published 
order of addition is followed. Hydrolysis of the 5-oxopiperidone 
(87) affords ALA hydrochloride, but here care is needed, since 
refluxing HCl starts to decompose ALA after Ca. 4 hours. Such 
decomposition products have been the subject of a recent study. 177 
The method used for the synthesis of [ 4-13C] -ALA was essentially 
that of Mitta et al. 178 outlined in Scheme 19. The only modification 
introduced here was the use of refluxing 6 M HC1 •to hydrolyse the 
esters, decarboxylate, and hydrolyse the phthalimido group. The 
recommended mixture of HOAc and HCl was found to yield large amounts 
of impurities, which could be readily circumvented using 6 M HC1 for 
5 hours. Again, over-refluxing at this stage led to decomposition 
of ALA. 
With moderately large quantities of [4- 13C]- and [5 -13C] -ALA 
in hand, the isolation and purification of ALA dehydratase could be 
approached as a means to generate [3,5- 13C]- and [2,11-3C]-PBG. 
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2.4 Isolation and Purification of ALA Dehydratase 
For most of the preparations of PBG throughout this work, the 
ALA dehydratase employed was partially purified from R. spheroides. 
In certain special situations, further purification was necessary, 
but in general the procedure followed the steps in Figure 2.3. 
Sonication of Rhodopseudomonas spheroides. 
Centrifugation at 35,000 g. 
Centrifugation at >60,000 g. 
Ammonium sulphate precipitation (20-35%). 
Centrifugation at 16,000 g. 
Gel-filtration on G-100 Sephadex. 
Concentration on Amicon PM-10 Ultrafilter. 
Chromatography on DEAE-cellulose. 
Concentration on Amicon PM-10Ultrafilter. 
FIGURE 2.3. Isolation and purification of ALA dehydratase. 
This procedure is a modification of the methods of Shemin and 
co-workers. 179 In a typical preparation, 100 g of wet cells were 
suspended in phosphate buffer (300 cm 3 , 0.05 M, pH 7.6) and sonicated. 
After low- and high-speed centrifugation, and ammonium sulphate 
precipitation, a crude pellet was obtained (by centrifugation), 
which was redissolved in Tris buffer (0.01 M, pH 8.0) and applied 
to a freshly equilibrated G-lOO Sephadex. column. The gel-filtration 
step helps to remove contaminating deaminase, as shown in Figure 2.4, 
the presence of which would seriously lower the yield of PBG in a 






















FIGURE 2.4. The purification of ALA dehydratase on G-100 Sephadex. 
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After concentration by ultrafiltration, the pooled enzyme activity 
was applied to a freshly equilibrated DEAE-cellulose column, and 
eluted with a salt gradient of 0.05 M to 0.5 M KC1 in Iris buffer 
(0.01 M, pH 8.0) (see Figure 2.5). The pooled enzyme activity 
(usually Ca. 450 U) was used for PBG preparations. The method for 
assay of enzyme activity was that of Burnham and Lascelles) 80 
2.5 Synthesis of 13C-Labelled PBG 
In a typical PBG preparation, partially purified dehydratase 
(ca. 200 U) was pre-incubated at 37°C in the presence of cysteine 
(0.01 M) and MgC1 2 (0.01 M), in nitrogen-degassed phosphate/NaHCO 3 
buffer (0.1 M, pH 8.0). [13C]-ALA (50 mg) was dissolved in the same 
buffer, adjusted to pH 8.0 and added to the enzyme. Incubation was 
continued at 37°C under nitrogen, and the reaction monitored by 
removing aliquots and assaying for PBG using modified Ehrlich's 
reagent.' 81 The reaction was largely complete in 2 hours, and 
stopped by addition of CuSO4 solution. The precipitate was removed 
by centrifugation, and the supernatant containing the PBG lyophilised. 
The lyophilate was redissolved in water, adjusted to pH 6, and then 
chromatographed on Dowex 2 acetate. This afforded, after lyophilisa-
tion of the acetate buffer, pure PBG acetate salt in Ca. 60% isolated 
yield. The acetate salt thus obtained was used for most of the NMR 
work described here. 
2.6 Complete 13C NMR Assignment of PBG 
While the assignment of the 13C resonances for [2,11 -13C] - PBG 
at pH 8.0 is relatively straightforward, C-2 displaying a resonance 
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FIGURE 2.5. The purification of ALA dehydratase on DEAE-cellulose. 
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at 116.1 ppm and C-il at 34.4 ppm, the assignment of [3,5- 13C]-PBG 
at. pH 8.0 is not so clear. As can be seen from Figure 2.7, assign-
ment of the resonances at 120.6 and 122.5 ppm is impossible without 
recourse to selective 1 H-decoupling experiments. When these were 
performed, as shown in Figure 2.8, the resonance at 120.6 ppm clearly 
arises from C-5, and the one at 122.5 ppm from C-3. 
These selective 'H-decoupling experiments led us to investigate 
unlabelled PBG, whose complete 13 C NMR assignment had not been made. 
The results of these experiments are shown in Table 2.2. 




C-6 21.7 (t) 
C-9 32.8 (t) 
C-il 34.4 (t) 
C-7 38.2 (t) 
C-2 . 	 116.1 (d) 
C-4 117.4 (s) 
C-5 120.6 (s)b 
C-3 	. 122.5 (s) 
C-8 181.1 (s) 
C-10 183.0 (s) 
alnternally referenced to p-dioxane, S= 66.5 ppm. 
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FIGURE 2.7. 13 C NMR of [3,513c]PBG, pH 8.0, 25°C. 
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FIGURE 2.8. 1 H-decoupling experiments on [3,5- 13C]-PBG, pH 8.0, 25°C. 
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Further investigations on [3,5-13C]-PBG. revealed that C-5 is 
sensitive to the PKa  of the amino group in the side-chain, much as 
was found for the C-li protons in Section 2.2. Figure 2.9 shows the 
effect of varying the pH on [3,5-13C]-PBG. From such a pH titration, 
we can obtain a value for the pKa  of the amino group (see Figure 2.10) 
which is somewhat higher than the value of 10.1 mentioned previously. 
This difference can be attributed to the fact that a given nucleus 
may not exhibit marked changes in chemical shift at all pKa  values, 
which can give rise to inaccurate pKa  values. 182 The fact that the 
carbon 	to the amino group is affected more than the a-carbon has 
been the subject of much theoretical speculation) 8285 For 
example, the effect has been observed in lysine, in which the S-
carbon shifts some 4.66 ppm dOwnfield on deprotonation of the c-NH 2 . 
Shifts were also observed in similar compounds such as c-aminocaproic 
acid (4.23 ppm downfield) and hydroxylysine (3.56 ppm downfield). 182 
It also occurs in simple linear alkylamines such as pentylamine which 
exhibits a downfield shift of 5.96 ppm at the 	carbon on deprotona- 
tion of the amino group. 185 Aromatic amino acids such as phenyl-
glycine show quite a dramatic shift of 7.95 ppm downfield for C-i of 
the phenyl ring. Batchelor et al.' 85 have rationalised the shifts in 
terms of a uniform linear electric field, the effect of which they 
call "LEES". The direction of this field effect depends largely 
upon the polarisability of the C-X bond under study, which obviously 
affects the shielding of the carbon atom, and also its orientation. 
Although this effect can be expected to fall off with distance, and 
indeed the uniform field effect contributions fail off monotonically 
with distance from the amino group, the anomalous S-shifts have been 
rationalised in terms of field gradient effects. The charge density 
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FIGURE 2.9. 75.5 MHz 13C NMR spectra of [35- 13C]-PBG at various pH's, 22°C. 
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FIGURE 2.10. Titration curve for [3,5 -13C] -PBG. 
on a carbon atom depends upon the sum of the field gradient and the 
uniform field effects. Batchelor et al. suggest, that the field 
gradient effect dominates in s-shifts of carbons next to amino groups. 
With aromatic amino acids, suchas PBG, the bridgehead carbon 
which is 	to the amino group is thought to be affected on deprotona- 
tion, due to the orientation of the aromatic ring. However, confor-
mation must also play an important part on this shift. To investigate 
this possibility, the tentative 13  C NMR asstgnment of PBG lactam (70) 
was determined (see Table 2.3). The lactam can be regarded as an 
extreme conformational case of ion pairing between the ionised 
carboxyl ate and the protonated amino function. If deprotonation 
gives rise to large downfield shifts arising also because of confor-
mational changes, then we can imagine that the lactam would exhibit 
a chemical shift at C-5 upfield from species I. As we can see from 
TABLE 2.3. The 13C NMR assignment (tentative) of PBG lactam. 
(3 , 7 







C-3, C-5 119.26 
C-10 174.30 
C-8 182.84 
alnternally referenced to p-dioxane, 6 C = 66.5 ppm. 
bThese are tentative assignments. 
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Table 2.3, C-5 in the lactam occurs at 119.26 ppm, some 3 ppm upfield 
from C-5 of PBG. Of course, these observations do not prove that on 
deprotonation of the amino group,. the conformation of PBG in solution 
is such that the acetate and aminomethyl side-chains are much further 
apart. In forming a lactam, the orieritationof the a- and s-carbon 
atoms have much more stringent. requirements. However, a conforma-
tional effect seems likely to be a dominant feature in determining 
the shift at C-5 due to deprotonation of the amino group in PBG, 
since even in aromatic systems, a shift as large as 9.4 ppm has not 
been reported. Furthermore, the C-li proton resonance is probably 
so broad in the 1 H NMR spectrum ofPBG at pH 10.3 (see Figure 2.3) 
because of a rapid equilibrium between two conformers. 
2.7 13C NMR Studies using f2,11- 13C1 -PBG 
Preliminary investigations were conducted using small quantities 
of substrate (2 mg) and enzyme (Ca. 20 U) in a 5 mm NMR tube, 
observing 3C at75.5 MHz. In these experiments spectra of HMB (73), 
uro'gen I and uro'gen III were characterised. Since the transforma-
tion ofHMB into uro'gen III might involve initial formation of an 
exomethylene species, [2,11- 13C]-PBG was used to generate a sample 
of HMB by the action of deaminase, and then cosynthetase (purified 
by Dr. R. C. Davies) and mercaptoethanol were added. In this case 
no trapped species were observed, and the final spectrum showed 
natural abundance mercaptoethanol and enriched uro'gen III. 
Since no new intermediates were detected in these comparatively 
small-scale experiments, they were repeated using larger quantities 
of deaminase in a 10 mm NMR tube. In order to establish optimal NMR 
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conditions, a sample of [2,11-13C]-PBG (2 mg) was incubated with 
deaminase (26 U) at 37°C for two hours, freeze-dried and redissolved 
in nitrogen-degassed D 
2 
 0 (2 cm 3 ). This sample of uro'gen I was 
studied under various decoupler conditions as shown in Figure 2.11, 
since it was considered to be the best model for whatever inter-
mediates might accumulate. 
Gated decoupling is usually employed in situations where the 
heating effects of decoupling need. to be minimised. The decoupler 
is switched on only during the RE pulse and subsequent acquisition 
time, and then switched off for a variable time T. It was found 
that for uro'gen I, 0.8 watts 1 H-decoupling power (12 H in Bruker 
notation) was the most suitable, and continuous decoupling did not 
seriously impair signal-to-noise, which would arise from significant 
heating effects. This was an advantage, since no time would be 
wasted while the decoupler is switched off, as in the case of gating, 
during a kinetics time-course in which detectab'e intermediates may 
be short-lived. Under these decoupling conditions, the pulse width 
(or 'flip-angle') was varied in an attempt to optimise the acquisi-
tion parameters. Here the object was to acquire the maximum data 
(i.e., signal-to-noise) in the minimum time. 
Usingthese NMR conditions,uro'gen I was characterised at pH 
8.0, 25°C, as shown in Figure 2.12. The spectrum differs slightly 
from the published one. 186 The meso carbons occur as a doublet 
centred on 21.81 ppm ( 1 J ( 13C- 13C) = 50.3 Hz) with the line in the 
centre of the doublet corresponding to isolated 13C atoms (34%). 
This arises because the starting ALA was 90% enriched in 
resulting in 90% X 90% = 81% enrichment in 13C in PBG. In uro'gen I 
we are concerned only with two PBG units lying adjacent, and the 








6H 	9H 	12H 	15H 
FIGURE 2.11. 75.5 MHz 13C NMR spectra of [2,113C]-PBG-derived uro'gen I under various decoupler 
conditions, with and without gating, pH 8.0, 25°C. 
N) 
3H 	6H 	9" 	12H 	15H 
150 	 100 	 50 	 0 ppm 
FIGURE 2.12. 75.5 MHz 13 C NMR spectrum of [2,11- 13C]-PBG-derived uro'gen I, pH 8.0, 25°C. 
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odds of two 13 C atoms being directly bonded in that situation would 
be 81% X 81% = 65%. The ct-pyrrolic carbons show a similar doublet 
centred on 124.12 ppm ('J ( 13C- 13C).= 50.3 Hz). The other 50 Hz 
doublets visible in thespectrum arise from a small amount of uro'gen 
III contaminating the sample. This is due to a minute presence of 
cosynthetase in the deaminase used to prepare the uro'gen I. 
Similarly, uro'gen III was prepared from [2,11-13CJ-PBG and 
analysed by 13C NMR. The spectrum is shown in Figure 2.13, which 
differs slightly from the published one. 186 However, we can clearly 
distinguish a doublet centred on 20.68 ppm ( 1 J ( 13C- 13C) = 50.0 Hz) 
arising from C-5 and C-la, on which is superimposed a triplet 
( 1 J ( 13C- 13C) = 50.0 Hz) centred on 20.68 ppm, due to C-15, and a 
broad singlet from C-20 also at. 20.68 ppm. The pattern for the 
pyrrolic carbons (C-4, C-7, C-14 and C-16) is less easy to interpret. 
We would expect C-4 and C-9 to give rise to doublets as with uro'gen 
I, and C-14 and C-16 to appear as a doublet of doublets either 
completely superimposed or displaced slightly from one another. 
Such a pattern can be distinguished in Figure 2.14, in which a 
doublet centred on 123.47 ppm corresponds to C-4 and C-9, and a 
broad doublet centred on 123.63 ppm corresponds to C-14 and C-16. 
It should be noted that this interpretation differs from the one 
presented in the literature, 186 in which a two-bond 13C coupling 
was suggested to be of the order of 7.5 Hz. In heterocycles such 
as uro 1 gen I or III, the two-bond 13C coupling could be expected 
to be of the order of 4 Hz (see Section 2.8). Such a doublet 
( 2 J ( 13C- 13C) = 4 Hz) arising from 13C in C-14 and C-16 but not at 
C-15 would be expected to occur at very low relative intensity, 
hardly distinguishable from the noise, since only 11.6% of the 
i-h-i 
J:5OHz 
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sample could contain 13C atoms in these positions. but not at C-15. 
It is, however, surprising that the published spectrum failed to 
resolve the doublet arising from C-4, C-9 and the doublet arising 
from C-14, C-16, since they are separated by some 17.5 Hz. 
With the optimum NMR conditions rigorously established, the 
search for new transient intermediates could begin. In the first 
instance, [2511-13C]-PBG (5 mg) in pyrophosphate-D 2 0 buffer (pH 8.5) 
was incubated with deaminase (400 U) for 3.5 minutes at 37°C, 
adjusted to pH 12 with NaOH, and cooled. This was studied in the 
NMR for 36 minutes at 4°C (see Figure 2.14), and from this spectrum, 
tentative assignments could be made (see Table 2.4). We can see 
from Figure 2.14 that some PBG remains, and some urotgen I has 
can be identified. Interestingly, residual PBG occurs at 34.87 and 
113.48 ppm. When [2,11-13C]-PBG was studied by 13C NMR at pH 12, 
it was found that C-il occurs at 35.35 ppm as opposed to 34.4 ppm 
at pH 8.0, and C-2occurs at 113.64 ppm as opposed to 116.1 ppm at 
pH 8.0. Also present in the spectrum of HMB is another peak very 
close to C-li of PBG at 34.68 ppm, which represents a small amount 
of aminomethylbilane. 
To this sample of HMB, purified cosynthetase (20 U) in phosphate 
buffer (pH 8.0) was added and sufficient 3 M HC1 to bring the pH 
back to 8.0. Spectra were then recorded at 4°C every 4.5 minutes 
over 2 hours-, and the full time-course is shown in Figure 2.15. 
Even when blocks of spectra are added together, such as in Figure 
2.16, no new intermediates are detectable. Note that the residual 
peaks which remain throughout the spectra occur at 33.77 and 112.74 
ppm, corresponding to aminomethylbilane which is not acting as a 
substrate for cosynthetase. 
100 	 50 	 20 ppm 
FIGURE 2.14. 75.5 MHz 13  C NMR spectrum of [2,11-13C]-PBG-Jerived  HMB at pH 12, 4°C. 
-4 
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TABLE 2.4. The 13C NMR. assignment (tentative) of 
[2,1 1-'3C]-PBG-derived HMB. 
'3c 	 ô,ppma 
C-15 	 20.7 
C-b 0 	 21.1 
C-20 	 53.8 
C-19 	 112.5 
C-14 	 123.1 	(d, 	1 J (' 3C- 13C) = 50 Hz) 
C-9 	 123.9 	(d, 	1 1 ( 13C- 13C) = 50 Hz) 
C-4 	 125.7 	(d, 	1 J ( 13C- 13 C) = 50 Hz) 
alndirectly referenced to p-dioxane, 5 = 66.5 ppm. 
JL 




FIGURE 2.15. 75.5 MHz NMR spectra of full time-course of {2,11-13C]-PBG-derived HMB with cosynthetase, 





100 	 50 
	
20 ppm 
FIGURE 2.16. 75.5 MHz NMR spectra of [2,11- 13C]-PBG-derived HMB with cosynthetase, pH 8.0, 4°C. 
m. 
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With the comparative lack of success in the detection of new 
intermediates using [2,11-13C]-PBG, attention turned to [3,5- 13C]-
PBG which being quaternary labelled, might afford agreater chance 
of detecting some transient species. 
2.8 13C NMR Studies using [3,5 -13C]- PBG 
Preliminary investigations were conducted with [ 3 ,5 -13C] -PBG 
(2 mg) in pyrophosphate-D 20 buffer (pH 8.0), in a 5 mm NMR tube. 
Again optimum decoupling conditions were established, where it was 
found that 0.8 W (12 H) continuous decoupling gave rise to the most 
satisfactory spectra. Here the two-bond couplings were readily 
resolved ( 2J ( 13C- 13C) = 4 Hz). This same sample was split into 
two parts, one being used to generate a sample of uro'gen I, and 
the other being used to make uro'gen III. Both uro'gen samples were 
characterised at ambient temperature, pH 8.0 over a narrow spectral 
width (SW = 1,000 Hz), in order to enhance resolution. Figure 2.17 
shows the spectrum obtained from urogen I. This is clearly composed 
of a double doublet centred on 117.74 ppm ( 2 J ( 13C- 13C) = 4Hz, 
31 ( 13C-C) = 2 Hz) arising from. C-3, C-8, C-13 and C-18, and an 
identical pattern centred on 126.06 ppm arising from C-1, C-6, C-ll 
and C-16. Incidentally, that the 
13
C atoms on the acetate side of 
the pyrroles should give rise to the doublets at 126.06 ppm is by no 
means obvious, and in fact the clue to this assignment came from the 
spectrum of uro'gen III. 
The spectrum of uro 1 gen III (see Figure 2.18) is not so easy to 
interpret, and only assignments to broad families of peaks can be 
made. We would expect C-3 and C-17 to show two clear doublets 
126•1 	 1260 	 117.8 	 111.1 
125 	 120 	 116 






FIGURE 2.17. 75.5 MHz 13 C NMR spectrum of [3,5-13C]-PBG-derived uro'gen III, SW = 1,000 Hz, pH 8.0, 25°C. 
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( 2 1 (' 3C- 13C) = 4 Hz), one at 117.03 ppm ( 2 J observed) and the other 
in the family of peaks centred at 117.37 ppm, probably at 117.34 ppm 
( 2 J observed). For C-3 and C-8, we would expect two doublet of 
doublets ( 
2 
 J ( 13C- 13C) = 4 Hz, 3J ( 13C- 13C.) = 2 Hz) which occur at 
117.39 ppm (not completely resolved) and at 117.56 ppm (not completely 
resolved). In the case of the other family of peaks arising from 
the acetate side of the pyrroles,. C-6 and C-li would be expected to 
give rise to two doublet of doublets ( 
2 
 J ( 13C- 13C) = 4 Hz, 
3J (' 3C-C) = 2 Hz), which occur centred at 125.90 ppm (not 
resolved) and 125.81 ppm (not resolved). For C-1 and C-19 we would 
expect a unique environment giving rise to a known two-bond coupling 
( 2 J ( 13C- 13C) = 4 Hz), and an unknown two-bond coupling. Thus we 
find.an unresolved doublet of doublets at 125.52 ppm and a more 
revolved double doublet at 125.33 ppm. 
With the substrate and two possible products characterised, the 
best possible NMR conditions were investigated. Uro'gen I in pyro-
phosphate-D2 0 buffer (2.0 cm3 , pH 8.0) in a 10 mm NMR tube was 
studied at 10°C with 0.8 W (12 H) continuous decoupling. A matrix 
was constructed varying pulse width and acquisition time against 
signal-to-noise over a fixed accumulation time of 4.5 minutes. In 
this way the optimum pulse width and recycle time were selected. 
Initially, deaminase (272 U) in pyrophosphate-D 20 buffer (pH 
8.5) was studied in the NMR spectrometer for 9 minutes, and no 
extraneous peaks occurred in the areas of interest. [3,5 -13C] - PBG 
(5 mg) in pyrophosphate buffer was added to the enziie, incubated 
at 37°C for 4 minutes before adjusting to pH 12 with NaOH and cooling 
to 0-5°C. A clearly resolved spectrum of HMB was obtained and is 






FIGURE 2.19. 75.5 MHz 13C NMR spectrum of [3,5-13C]-PBG-derived HMB, ph 12, 4°C. 
E:I 
and the tentative assignments are given in Table 2.5.. Also evident 
in the spectrum is the presence of uro'gen I at 117.54 and 125.98 ppm, 
and also residual [3,5.3C]-PBG, with C-3 coinciding with C-18 of HMB 
at 121.42 ppm and C-5 occurring at 129.16 ppm. This latter chemical 
shift for C-5of PBG is. clear from the earlier work (Section 2.6) 
on the pH titration of [ 3 ,5-13C] - PBG. 
TABLE 2.5. The 13 C NMR assignment (tentative) of 
[3,5-13C] - PBG .- derived HMB. 











C-i 127.28 	(d, 	
2 
( 13C- 13C) 	= 4 Hz) 
alndirectly referenced to p-dioxane, 6 = 66.5 ppm. 
This sample of HMB was readjusted back to pH 8.0 with HC1 after 
the addition of cosynthetase (30U) with rapidmixing, and spectra 
accumulated at 4.5 minute intervals over 3 hours and at Ca. 4°C. 
The full time-course is shown in Figure 2.20. Here we can see the 
loss of HMB and also residual PBG., and concomitant formation of 
uro'gen III. However inspection of thefull spectral width 
reveals no new sp 3-carbon bearing intermediates or indeed any sp 2 
intermediates (see Figure 2.21). In the expansion of the first hour 
of the reaction (Figure 2.21), no detectable intermediates are 
revealed. Note that the low-intensity peak which occurs at 21 ppm 
is also present in the non-enzymic blank (Figure 2.23) and probably 
represents resonances from the deaminase present. 
In order to test the possibility that some intermediates might 
be present in vanishingly small quantities, a non-enzymic control 
was performed. HMB derived from [3,5-13C]-PBG was analysed by 
NMR at pH 8.0, 5°C (s:ee Figure 2.22) and its spectrum is not 
significantly different from that obtained at pH 12. This was 
allowed to cyclise chemically as a non-enzymic control (see Figure 
2.23). Careful comparison of the series of spectra from the 
cosynthetase-mediated reaction with the spectra for the cosynthetase-
free reaction does not reveal any detectable transient intermediates 
unde.r these NMR conditions. 
Although both the 'H and 13C NMR techniques employed in the 
prosecution of the research outlined above did not reveal any of 
the putative intermediates in the mechanistic Scheme 11, they did 
allow a thorough study of HMB and uro'gens I and III. These studies 
therefore laid the foundations for much more detailed studies on 
the enzyme deaminase, where knowledge of all the NMR detectable 
intermediates and products was absolutely essential. 




FIGURE 2.20. 75.5 MHz 13C NMR spectra of full time-course of [3,5-13C]-PBG-derived HMB with 













FIGURE 2.21. 75.5 MHz 
13
C NMR spectra of [3,5-13C]-PBG-derived 11MB with cosynthetase, pH 8.0, 4°C. 
P. 
100 	 50 	 20 ppm 
FIGURE 2.22. 75.5 MHz 13 C NMR spectrum of [3,5-13C]-PBG-derived  FIMB, pH 8.0, 5°C. 








FIGURE 2.23. 75.5 MHz 13 C NMR spectra of [3,5-13C]-PBG-derived HMB cyclising chemically (non-enzymic 
control), pH 8.0, 5°C. 	 610 
CHAPTER 3 
ISOLATION AND NMR STUDIES OF ['3C]-PBG-DEAMINASE  COVALENT COMPLEXES 
3.1 Introduction 
Both this chapter and the next are confined to a detailed study 
of the second question mentioned in Section 2.1, namely how is the 
linear tetrapyrrole bound and assembled on the surface of deaminase? 
Following the work by Anderson and Desnick 126 and Jordan and co-
workers, 140 " 41 the possibility of binding 13C-labelled PBG to 
deaminase and examining the covalent complex by 13C NMR seemed very 
attractive. Such a complex might furnish vital information about 
the nature of the active site of deaminase and the way in which the 
tetrapyrrole is bound, presumably through a suitably nucleophilic 
I0 
group X as shown in Scheme .. 
In the work to be described in this chapter, five major attempts 
have been made using [2,11-13C]-PBG, [2,11- 13 C, 2 H 3 ]-PBG and [3,5- 13C] 
PBG, and large batches of purified deaminase. ' rior to the generation 
of these complexes, detailed studies had to be performed in order 
to establish a reliable protocol for their production. 
3.2 Preliminary Studies (with Dr. G. Burton) 
For the preliminary studies of the enzmie-substrate complex of 
deaminase and PBG,deaminase was partially purified from R. spheroids 
by the methods outlined in Section 3.3. This deaminase was analysed 
by flat-bed gel electrophoresis, and conditions optimised for the 
preparation of the complexes bearing one, two or three PBG molecules. 
For such experiments a "High Performance Mixing Device" (HPMD) was 
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constructed, and this was used to mix defined stoicheiometries of 
PBG and deaminase. 
Using [3,5-14C]-PBG, prepared by the action of ALA dehydratase 
on [4-14C]-ALA,. a series of experiments were conducted in which the 
stoicheiometry of E14CJ-PBG  and deaminase was varied, and the mixing 
performed under a variety of conditions. As with Jordan's experi-
ments, four bands could be obtained by gel-electrophoresis on 7.5% 
polyacrylamide. gels when stained either with Coomassie Blue, incubated 
with PBG and visualised by UV, or when subjected to autoradiography. 
These bands corresponded to native enzyme and three enzyme-substrate 
complexes. No band. corresponding to bound tetrapyrrole was detected, 
as Jordan found with the bacterial enzyme. The mobilities of the 
four bands were determined and for the native enzyme, "mono-PBG", 
"di-PBG" and "tri-PBG", the mobility/% of tracking dye = 57, 62, 64 
and 66%, respectively. This compares favourably with Jordan's 
reported141 values of 56, 59, 65 and 70% for the same bands, taking 
into account differences in gel-operating pH. Varying the stoi-
cheiometry of enzyme and substrate provided the means to optimise 
the yields, mainly for the complexes bearing one and two substrate 
molecules. The method for calculating the amount of enzyme made use 
of Jordan and Shemin's 9 reported specific activity of 128 U mg 
for homogeneous deaminase from R. spheroides. Using the M r 36 OOO 
for bacterial deaminase, we can calculate the moles of enzyme from 
its activity assuming that if the enzyme were completely pure it 
would have a specific activity of 128 U mg. 
The data shown in Table 3.1 are typical values obtained from 
cutting the bands corresponding to complexes bearing one., two and 
three 1 14CJ-PBG  units, dissolving the bands in 30% H 2 02 and assaying 
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TABLE 3.1. The effect of [14C]-PBG deaminase stoicheiometrieson 
the resultant enzyme-substrate complexes. 
Exptal. 
Stoich. 	Band 	
L % Total 	% Distribution 	d 	Exptal. 
	
E:S Ratioa  E:S Ra ti ou BOUfldC Radioactivity % Moles C Ofl d OflS e 
1.76:1 - 	 1:1 9.3 38.5 56.7 Mixing device 
1:2 53.2 39.2 
at 4°C. 
1:3 8.3 4.1 
1:1.26 1:1 29.1 21.1 37.2 Sequential 
1:2 55.7 49.1 
mix at 4°C. 
1:3 23.2 13.6 
1:1.88 1:1 25.0 28.0 46.1 HPMD mix 
1:2 52.4 43.2 at 4°C. 
1:3 19.5 10.7 
1:1.88 1:1 26.0 22.8 40.7 HPMD mix 
1:2 55.8 50.0 at 37°C. 
1:3 15.6 9.3 
1:1.88 1:1 30.0 17.7 33.8 Sequential 
1:2 55.9 53.3 mix at 4°C. 
1:3 20.3 12.9 
1:1.88 1:1 32.0 17.5 33.4 Sequential 
1:2 55.4 52.9 mix at 37°C. 
1:3 21.4 13.6 
1:2.63 1:1 23.9 17.4 32.1 Sequential 
1:2 55.9 51.5 
mix at 4°C. 
1:3 26.7 16.4 
acalculated using sp. act. of deaminase = 128 U/mg, M 	36,000, and 
Ehrlich's determination of ['C]-PBG. (A 553 	1.0 =J' 49.5 nmol PBG) 
bAssuming that the bands assigned correspond to the complexes Enz(PBG) 
where n = 1, 2, 3. 
CAssayed by radioactive counting. 
dNor1ised using assumption in (b). 
eprocedure either employed HPMD or sequential addition with mixing, and 
then stored at 4°C, orsubsequent 37°C incubation for 5 minutes. 
fAn earlier, less-efficient prototype of the HPMD was used here. 
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the radioactivity by liquid scintillation counting. The error in 
the values presented is significant, since cutting bands from a gel. 
in which several bands are located close together results in cross-
contamination and. errors. in counting. However, there are general 
trends from which certain conclusions can be drawn. Since the 
volumes of enzyme and substrate employed in. these experiments were 
very small (ca. 30 jiL) using the HPMD did not significantly enhance 
the yield over sequential mixing. Furthermore, the temperature of 
mixing did not affect either the yield of bound sub.strate or indeed 
the proportions of the three complexes. 
The results from these experiments suggested that it would be 
difficult to generate the "mono-PBG complex without a significant 
amount of ".di-PBG complex. While increasing the enzyme:substrate 
ratio favours the production of the mono-PBG" complex, the overall 
amount of substrate bound is lowered. Since the amount of bound 
substrate was critical for the success of any NMR experiment, this 
needed to be maximised, while trying to minimise the amount of 
"di-PBG" complex. In scaling up the mixing to a preparative scale, 
it is evident that the veloc.ity of the reaction needs to be lowered 
in order to minimise the formation of product. Thus on a preparative 
scale, mixing in the I-IPMD at 4 0 Cseemed to be the best procedure. 
The optimum enzyme-substrate ratio for preparative procedures was 
determined using the results of Table 3.1 as a guideline, while 
acknowledging that the dynamics of mixing on that scale are somewhat 
different.. The preparative techniques are described in Section 3.4 
The proteolytic digestion of the complexes was also investigated, 
and here it was found that while c-chymotrypsin only resulted in 
partial digestion, pronase was extremely effective. Pronase is an 
unusually non-specific proteolytic enzyme which is particularly use-
ful for generating small oligopeptides. 187 These effects were 
assessed using analytical gel-electrophoresis. 
3.3 Isolation and Purification of PBG Deaminase 
For most of the preparations of covalent complexes described in 
this chapter, the deaminase employed was purified from R. spheroides 
to a purity of Ca. 15% by protein mass.. Further purification of the 
resultant complex afforded samples of highly purified protein (>60% 
by protein mass and gel-electrophoresis) which were used for much of 
the experiments described in Chapter 4. The reasoning behind this 
approach for the purification of the enzyme was as follows. It has 
been reported 9 that the highly pure enzyme is inherently unstable, 
whereas formation of the covalen.t complex confers stability on the 
protein. It therefore seemed sensible to generate the complex while 
the enzyme was partially pure, and then highly purify the complex. 
The general procedure adopted for the purification of deaminase 
is shown in Figure 3.1, which includes the steps necessary to obtain 
enzyme of homogeneous purity. This procedure is a development of 
the methods of Jordan and Shemin, 9 and Davies and Neuberger. 71 
In a typical preparation, 3kg of wet cells (from 500 L of cell 
suspension) were processed in eight batches to yield Ca. 6000 U of 
deaminase. Thus wet cells (375 g) were suspended in phosphate buffer 
and sonicated.. After low-speed centrifugation to remove the cell 
debris, the supernatant was heat-treated in small batches and then 
subjected to high-speed cen.trifugation. The speed of centrifugation 
is critical at this point in determining the ultimate purity of the 
enzyme, forces below 100,000 g being less satisfactory. 
Sonication of Rhodopseudomonas spheroi&s. 
Centrifugation at 35,000 g. 
Heat-treatment for 15 minutes at 60°C. 
Centrifugation at 150,000 g. 
Ammonium sulphate precipitation (40-55%). 
Centrifugation at 16,000 g. 
Dialysis. 
Chromatography on DEAE-Sephacel. 
Concentration on PM-10 Ultrafilter. 
Gel-filtration on G-100 Sephadex. 
Concentration on PM-10 Ultrafilter. 
Heat-treatment for 15 minutes at 60°C. 
Second gel-filtration onG-100 Sephadex. 
Concentration on PM-lO Ultrafilter. 
Preparative polyacrylamide gel-electrophoresis. 
Concentration on PM-lU Ultrafilter. 
Second preparative gel-electrophoresis. 
Concentration of PM-lU Ultrafilter. 
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FIGURE 3.1. Isolation and purification of PBG deaminase. 
Crude deaminase was then separated from the high-speed super-
natant by fractional ammonium sulphate precipitation, and obtained 
as a pellet by centrifugation. This was redissolved in Tris buffer 
and dialysed against two changes of Tris buffer. The dialysate was 
then applied to a freshly equilibrated DEAE-Sephacel column (see 
Figure 3.2), and eluted with a salt gradient of 0.05 M KC1 to 0.7 M 
KC1 in Tris buffer.. DEAE-Sephacel is a coirmercially available brand 
of cellulose which is formed into beads and this removes the problems 
produced by fines which are invariably present in ordinary cellulose. 
Furthermore, the beaded configuration withstands considerably higher 
pressures when the column is packed, allowing a denser packing which 
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This cycle was then •repeated with another batch of cells and 
the pooled enzyme from both batches concentrated and applied to a 
freshly equilibrated G-lOO Sephadex column (see Figure 3.3). In 
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FIGURE 3.3. First purification of deaminase on G-lOO Sephadex. 
this way the other six batches of cells were processed to furnish in 
total four samples of enzyme after gel-filtration and concentration. 
This enzyme activity was then pooled, heat-treated at 60°C for 15 
minutes and again applied to a freshly equilibrated G-100 Sephadex 
column (see Figure 3.4). This step helps to remove a yellow protein 
which contaminates the deaminase. The two heat-treatment steps served 
to eliminate the presence of cosynthetase. The pooled enzyme specific 
activity was typically 12-30 U mg 	(6-12,000 U) at this stage. The 
further purification steps mentioned in Figure 3.1 will be described 
in the next section. Routinely the enzyme activity was assayed by 

















FIGURE 3.4. Second purification of deaminase on G-100 Sephadex. 
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3.4 Preparation and Purification of the Covalent Complexes 
Any NMR experiment designed to study an enzyme-substrate complex 
must take into account a number of factors which will influence its 
eventual outcome. The amount of substrate which can be successfully 
bound is one such factor. Since deaminase is a monomer of Mr = 36,000 
and a typical preparation yields 6000 U, or 47 mg (1.3 .imol), which 
could theoretically bind 375 ig of 13C-enriched PBG. This means that 
the NMR detectable concentration of enriched PBG is equivalent to 
37.5 mg at natural abundance (natural abundance of 13C = 1.1%). Thus 
the substrate, even if we succeed to bind it with a 100% yield, will 
be present at similar NMR detectable concentrations as the natural 
abundance protein background. Binding more than one substrate mole-
cule is unlikely to increase the chances of detecting the signals 
from the substrate, since the labelled resonances are likely to 
exhibit different chemical shifts. The results of Table 3.1 clearly 
show that 100% yields are exceedingly difficult to attain, and that 
the highest yields are achieved when the substrate-to-enzyme ratio 
is kept high. Accordingly, initial preparations of complex employed 
an enzyme:substrate ratio of 1 to 3, and were mixed using the HPMD 
at 4°C, eluting at Ca. 60 cm 3 hr. Minor variations on these 
conditions were made in each preparation, in an attempt to optimise 
the yield of "mono-PBG" complex. 
In a typical preparation, deaminase (13 viM, 6000 U) and [ 13CJ-
PBG (13 M) and 5 moles %. [14C]-PBG were mixed at 4°C using the HPMD, 
and the resultant solution concentrated by ultrafiltration to a 
volume of ca. 2 cm 3 . This was then applied to a preparative poly-
acrylamide gel (7.5%) and subjected to electrophoresis at pH 8.0 
102 
eluting with Tris/Barbital buffer for the upper electrode, and Tris 
buffer for the lower electrode and sample chamber. Figure 3.5 shows 
a typical elution profile, detecting protein concentration, enzyme 
activity and radioactivity. The radioactivity provides an accurate 
method for assessing the amount of PBG bound, since prior to mixing 
with deaminase we know the dpm per Pmol['3C]-PBG, and thus in the 
labelled protein the dpm will, give the amount of bound PBG. The 
pooled complex was concentrated by ultrafiltration down to Ca. 
0.45 cm 3 for NMR experiments in a 5 mm tube. The complex thus 
obtained was usually Ca. 70% pure and mainly (>90%) corresponded to 
"mono-PBG complex (by analytical gel-electrophoresis), bearing 
approximately 192 iig PBG (51% yield). The dramatic increase in 
yield of bound PBG over the analytical experiments presumably 
reflects more effective mixing when using large volumes of enzyme 
and substrate. 
3.5 13C NMR Studies of [2,11- 13C]-PBG-Deaminase Covalent Complexes 
The first 13C NMR investigation of the enzyme-substrate complex 
employed [2,11-13C1-PBG, in which the chemical shift of C-li would 
be highly diagnostic of the nature of binding of the substrate. 
Accordingly, impure complex which had been subjected only to G-50 
gel-filtration to remove excess substrate and product was examined. 
In this caseonly 50 jig of [13C]-PBG was bound to deaminase (ca. 
3000 U) and the protein resonance occluded any obvious 13C-enriched 
sites. After further purification by preparative gel-electrophoresis, 
the 13C NMR spectrum showed a very small peak at 124.4 ppm (see 









































FIGURE 3.5. Purification of PBG-deaminase covalent complex 
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FIGURE 3.6. 75.5 MHz 13C NMR spectrum of [2,11-C]-PBG-deaminase 
covalent complex, pH 8.0, 12.5°C. 
pure deaminase, also isolated from the preparative electrophoresis 
(see Figure 3.7). Careful examination of the aliphatic region 
failed to uncover any significantly enriched peaks. Subtraction 
techniques also failed to reveal any peaks in that region, due to 




FIGURE 3.7. 75.5 MHz 13C NMR spectrum of electrophoretically pure 
deaminase, pH 8.0, 12.5°C. 
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The complex was then incubated with .pronase in the NMR tube, 
using the Carr-Purcell-Meiboom-Gill spin-echo pulse sequence, which 
optimises narrow lines in the presence of broad ones. After 24 
hours, a forest of peaks were observed (see Figure 3.8), correspond-
ing to free oligopeptides. Selected resonances can be assigned to 
certain amino acid residues using Table 1.2. None, however,, could 
be easily assigned to 13C-enriched PBG. When the digested complex 
13 was analysed by 	C NMR using a conventional pulse-sequence, and 
compared to pure deaminase treated in an identical manner, no 
distinguishable differences are obvious (see Figure 3.9). Thus no 
conclusions could be drawn from these spectra, which is in stark. 
contrast to Battersby and co-workers, 188 '' 89 who recently published 
work along very similar lines in which he obtained a family of peaks 
at 42-43 ppm, which he assigned to X-CH 2 -pyrrole, and also one at 
24.5 ppm, which he assigned to pyrrole-CH 2 -pyrrole.. These resulted 
from oligopeptides. from a pronase incubation with the [11- 13C]-PBG-
deaminase complex. His conclusions are that such results point to 
the nature of the X group in Scheme 9 being the E-NH 2 of lysine. It 
should be noted, however,. that Figure 3.9 ciearly.shows. a. family of 
peaks at 41-43 ppm in both the 13C-enriched complex and the pure 
enzyme. These can be assigned to the a-carbon of glycine, the 
s-carbon of lysine, the s-carbon of leucine, and the 5-carbon of 
arginine, the resonances of which (see Table 1.2) all fall in this 
region. We chose not to draw conclusions, therefore, from observa-
tion of such peaks. 
Since the foregoing results were somewhat discouraging, another 
3 kg R. spheroides was processed to furnish 6000. U of deaminase. 
This was mixed as usual with [2,11 -13C] - PBG + 5% [3,5-14C]-PBG in 
FIGURE 3.8. 75.5 '•1Hz 13 C NMR spectra of [2,11-13C]-PBG-deaminase complex + pronase 













FIGURE 3.9. 75.5 MHz 13 C NMR spectra of [2,11- 13C]-PBG-deaminase complex (I) 
and pure deaniinase (ii) treated with pronase, pH 8.0, 12.5°C. 
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our HPMD, and the complex immediately concentrated and subjected to 
preparative gel-electrophoresis. The radioactive protein, correspond-
ing to the complex bearing 192 pg 1 13C1 - PBG, again shown to be 
"
1 mono-PBG" complex by analytical gel-electrophoresis, was concentrated 
and examined, by 13 C NMR. As before, electrophoretically pure 
deaminase was examined for comparison purposes (see Figure 3.10 (i)). 
As can be seen from Figure 3.10 (ii), a small extra peak is visible 
at 123.93 ppm, and again no clear differences in the aliphatic region. 
When the pure enzyme spectrum was subtracted from the enzyme-substrate 
spectrum, the spectrum obtained (see Figure 3.10 (iii)) showed 
clearly the peakat 123.93 ppm, and additionally a peak of similar 
linewidth at 22.15 ppm. These shifts are consistent with enzyme-
bound uro'gen I, which from Section 2.7 exhibits resonances at 124.1 
and 21.8 ppm. They would also be consistent with enzyme-bound di-
or.tri-pyrrole. If the latter were true, then we would expect 
resonances to occur at ca. 112 ppm.(see Table 2.4) for the terminal 
pyrrolic carbon, and at an unknown shift for the methylene directly 
attached to the enzyme. Figure 3.10 (iii) shows a very low intensity 
peak at 114.2 ppm, and then two other broad peaks at 44.9 ppm and 
31.6 ppm. The poor signal-to-noise does not allow any conclusions 
to be drawn from these resonances. 
In order to obtain a better subtraction, the electrophoretically 
pure deaminase available from this preparation was examined by 
NMR, and then mixed with [2,11-13C]-PBG, concentrated directly and 
examined by 13C NMR. The two spectra obtained are shown in Figure 
3.11 (i), (ii). A broad peak at 124.15 ppm is present in the 
enriched complex which is not present in the pure.enzyme, but 
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FIGURE 3.10. 75.5 MHz 	C NMR spectra of [2,11- 13C]-PBG--deaminase complex (ii), pure deaminase (1), 
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FIGURE 3.11. 75.5 MHz 13 C NMR spectra of [2,11 -13C] - PBG- deaminase complex (ii), pure deaminase (I), 
and the subtracted [(ii) - (1)] spectrum (iii), pH 8.0, 11.0°C. 
shown in Figure 3.11 (iii). A broad peak centred at Ca. 124.7 ppm 
is clearly visible, accompanied by sharp peaks at 21.5 and 25.0 ppm, 
and three broad peaks at 44.4, 36.9 and 31.9 ppm. These latter peaks 
could be assigned to residual glycine residues at 44.4 ppm, isoleucine 
residues at 36.9 ppm and.either lysine or residual barbital buffer 
at 31.9 ppm. 
The main batch of complex was subjected' to tryptic digestion and 
the resultant oligopeptides fractionated on G-50 Sephadex (see 
Figure 3.12). The radioactive peptides (fractions 21-32) correspond-







14 	 22 	 30 	 38 
Fractions 
FIGURE 3.12. Purification of trypsin-treated [2,11 -13C1 -PBG-
deaminase complex by gel-filtration on G-50 Sephadex. 
112 
In this technique, the oligopeptides are electrophoresed on paper in 
one dimension and then chromatographed in the descending mode in the 
second dimension. The peptides were detected using non-destructive 
fluorescamine, and the map obtained is shown in Figure 3.13. The 
peptides marked 1, 5 and 6 were eluted off with 0.1 M NH 3 and 
lyophilised.. The larger molecules from gel-filtration (fractions 







FIGURE 3.13. Peptide map of tryptic peptides from 
[2,11- 13C]-PBG-deaminase complex. 
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were obtained which were examined by 13 C NMR, 'H NMR, IJV spectroscopy 
and mass spectroscopy. For the purposes of further discussion the 
peptides 1-7 were obtained as follows: 
Peptide  ex map. 
Peptide  Fractions 21-32 from gel-filtration. 
Peptide  Fractions 33-41 from gel-filtration. 
Peptide  Fractions 13-20 fromgel-filtration. 
Peptide  ex map. 
Peptide  ex map. 
Peptide  Fractions 13-20 from gel-filtration 
after incubation with pronase. 
The 13C NMR investigations were difficult with all but two of the 
peptides (2 and 3) due to prohibitively low quantities (10-50 iig). 
Figure 3.14 (i) and (ii) show.the spectra obtained for peptides 2 
and 3. Interpretation of these spectra is extremely difficult, 
although it is obvious that the substrate is not easily detectable. 
The 'H NMR spectra displayed resonances much too broad to interpret 
with any confidence. However, UV spectroscopy revealed that peptide 
6 possessed a Amax 	395 nm, as didpeptide 1 to a much lesser 
extent. This corresponds to peptide-bound porphyrin. 
The use of fast-atom bombardment mass spectroscopy (FAB-MS) has 
recently attracted some attention 191 ' 192 in the sequencing of oligo-
peptides and proteolytically digested proteins. Since it would also 
be highly diagnostic for unusual substrate or product molecules 
attached to the peptide chain, this method was also employed as a 
means to study the peptides 1, 5 and 6. The results from these 
endeavours are presented in Chapter 5. 
150 	 100 	 50 	 0 
32 
ppm 
FIGURE 3.14. 75.5 MHz 13 C NMR spectra of peptide 2 (i) and peptide 3 (ii). 
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Evidently the 13C-substrate., being protonated at the sites of 
enrichment, might be expected193 to possess linewidths of the order 
of 100-200 Hz, which given the expected intensity of substrate rela-
tive to protein background would be very difficult to detect. 
Furthermore, the previous studies hinted at the presence of broad 
resonances hidden in the protein background, suggesting that the 
problem could be solved with more effective subtraction procedures. 
To achieve this, it was decided to split a large batch of enzyme 
(9000 U) into two part s, incubating one part with 13C-substrate, and 
the other with natural abundance substrate. Direct concentration 
would then furnish two identical samples which could then be examined 
in a 10 mm NMR tube. 
The two complexes thus obtained were initially subjected to a 
systematic investigation of various parameters, in order to optimise 
conditions for the subtraction. The 
Ti' 
 of selected protein reso-
nances were measured, in order to optimise the flip angle andpulse 
interval. Furthermore, the effect of pH, temperature, ionic 
strength and protein concentrations were investigated. Of these 
parameters, it was found that temperature had the most dramatic 
effect, with accumulations at 25°C being the optimum. When the 
complex was subtracted from the 13C-enriched complex at pH 8.0 and 
7.0 run under optimum NMR conditions, the spectra shown in Figure 
3.15 were obtained. In the subtracted spectrum at pH 7.0, there is 
a broad resonance centred at 130 ppm which probably corresponds to 
protein arising from slight inaccuracies in the subtraction. The 
other peak at 2.7 ppm probably has similar origins. The signal-to-
noise in the subtracted spectra at pH 8.0 prohibit any specific 
assignments. It should be pointed out at this stage that unless 
MM 
FIGURE 3.15. 75.5 MHz 	C NMR spectra of [2C]-PBG-deaminase complex subtracted 
' 3 from {2,11-C]-PBG-deaminase complex, different pFPs, 11°C. 	 Cn 
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the substrate was present with excellent signal-to-noise, it is 
exceedingly difficult to obtain accurate subtractions, since minor 
variations in temperature., pH •or ionic strength can seriously impair 
the accuracy of this technique. 
Accordingly, it was felt that mild acid denaturation of both 
complexes might yield more information as to the binding of the 
substrate. Figure 3.16 shows the effect of acid denaturation on 
both complexes. While the lines sharpen up considerably, there 
still remains little difference between the two complexes. There 
is an extra peak at 30.0 ppm, but no such corresponding peak in the 
aromatic region. It was therefore concluded that further attempts 
to detect 13C-enriched PBG attached to deaminase, must focus on 
alternative ways to reduce linewidth and increase sensitivity. 
3.6 13C NMR Studies of [2,11-13C,2H3]-PBG-Deaminase  Covalent Complex 
The foregoing results pointed very strongly to unusually large 
linewidths for the enzyme-bound substrate. Any other peaks detected, 
seemed to arise from uro'gen I either bound or associated with the 
enzyme. Thus any attempts which might assist in decreasing line-
width would increase the chances of detecting the substrate. One 
method for achieving this is to increase the temperature, but from 
the previous section, this did not render the linewidth sufficiently 
narrow to make detection easy. Accordingly, electrophoretically pure 
deaminase was mixed as usual in our HPMD with [2,11 -13C, 2H3] - PBG, 
which was prepared by methods covered in Chapter 4. Here the aim 
was to remove 13C-'H dipolar relaxation, thereby rendering the carbon 
more like a quaternary carbon having a linewidth some 2-3 times 
flff 
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FIGURE 3.16. 75.5 MHz 13 C NMR spectra of mild acid-denaturated (pH 2) [ 13C] -complex (1) 





narrower. Scalar quadrupolar coupling only amounts to Ca. 45Hz for 
a methylene, as mentioned in Section 1.3, so in theory the gains are 
significant. Furthermore, the experiment can be performed with no 
decoupling, thereby reducing the protein background due to coupling 
and thus broadening, and also loss of NOE. 
Thern freshly generated complex was subjected to preparative gel-
electrophoresis to remove any uro'gen I which might be associating 
with the protein, and after concentration, examined in a 5 mm tube 
at 125.8 MHz.. Despite the increased sensitivity of the 11.75 T NMR 
instrument, accumulations for long periods of time were necessary 
in order to achieve acceptable signal-to-noise. Figure 3.17 shows 
the initial spectrum obtained. Here peaks in the region of interest 
occur at 123.70, 110.89, 92.39 and 88.23 ppm. In •the early part of 
the data accumulation for Figure. 3.17 (i), the signals at 92.39 and 
88.23 ppm were not visible, suggesting that they are formed slowly. 
These can be explained as the product of oxidation of uro'gen I 
which is present in the sample. The 13C chemical shifts of 
uroporphyrin I from such 13C-labelled PBG are 76 and 98 ppm, which 
are very similar. The resonance at 123.70 ppm further corroborates 
this theory, leaving the signal at 110.9 ppm attributable to bound 
substrate. Unfortunately, however, no such corresponding signal is 
visible in the aliphatic region. Comparison with a sample of [ 12 C]-
complex did not reveal any unique aliphatic resonances (see Figure 
3.17 (ii)). 
The conclusions to be drawn from these experiments are conflict-
ing and complex. On the one hand, analytical gel-electrophoresis 
strongly suggests the presence of a "mono-PBG" bound to deaminase, 
and we are confident that our 'mono-PBG" is the same used by Jordan 
RE 
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FIGURE 3.17. 1 H-coupled 125.8 MHz 13  C NMR spectrum of {2,11 -13C, 2 H3] - PBG- deaminase 
complex (i) and [12C]-PBG-deaminase complex (ii), pH 8.0, 25°C. CD 
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in his experiments) 88 However, the NMR results suggest the presence 
of enzyme-bound uro'gen I. The origins ofthis urogen I may simply 
be residual product very strongly associating with the protein, or 
perhaps even more likely, is the disproportionation of the complex 
at that temperature and concentration. At the point at which bound 
tetrapyrrole forms, then uro'gen I formation can be expected. More 
studies on this will be presented in the next chapter. 
3.7 
13
C NMR Studies of [3,5-13C]-PBG-Deaminase Covalent Complex 
An alternative method for circumventing the problems of line-
width associated with protonated carbons is to make use of substrate 
with quaternary labelled carbons. This is true for [3,5 -13C] - PBG, 
for which the enzyme-bound species might be expected to exhibit 
linewidths of the order of 50-100 Hz. Furthermore, the substrate 
resonances should fall in a window region in which no protein 
resonances occur. Finally, another nice feature of this substrate, 
is that it can be used to test Battersby's tentative assertion 189 
that the group X in Scheme 9 is the c-NH 2 of lysine. This is based 
on the earlier observation (see Section 2.6) that the chemical shift 
of C-5 is sensitive to the PKa  of the amino group. Thus, titration 
of the enzyme-bound species should testthe validity of Battersby's 
assertions, even if the attachment of substrate is made via a 
secondary amine. 
For the preparation of the [3,5-13CJ-PBG-deaminase complex, the 
mixing of [3,5-13C]-PBG and deaminase (8000 U, 20 U mg) was 
performed in the presence of 25 mM lysine. Here the idea was to 
provide a large excess of a small charged molecule which might form 
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an ion-pair with any uro'gen I •produced, without.nucleophilically 
trapping any tetrapyrrole as is the case with ammonia. After gel-
electrophoresis, the purified complex, bearing 450 ig PBG, was 




FIGURE 3.18. 	75.5 MHz 13C NMR spectrum of [3,5 -13C]- PBG- deaminase 
complex, pH 7.6, 3.7°C. 
spectrum accumulated without decoupling but with full NOE. The 
same sample was then examined over a narrow sprectral width, as was 
a sample of [12C]-PBG-deaminase complex (see Figure 3.19). The two 
shaded peaks at 119.87 and 121.45 ppm are assignable to bound 
substrate. When both samples were re-run at 21 .6°C the spectra showed 
peaks at 120.00 and 121.90 ppm (see Figure 3.20). If we follow the 
fate of these two resonances with pH (see Figure 3.21), it can be 
seen that the resonance at 120.00 ppm shifts almost negligibly before 
it becomes too broad to identify, at pH 10.0. Interestingly, the 
peak at 121.90 ppm remains relatively sharp and easily assignable to 
C-3 of PBG.. The pH was not adjusted further than pH 10.2 for fear 
of denaturing the enzyme. When the solution was readjusted to pH 8.0 
and re-analysed, the spectrum obtaTined (Figure 3.20) was very similar 
nu 
FIGURE 3.19. 75.5 MHz 13C NMR spectra of [3,5-13C]-PBG-deaminase complex (1) and 
[ 12 C] - complex (ii), pH 7.6, 3.7°C, over a narrow spectral width. 
ffffl 
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FIGURE 3.20. 75.5 MHz 13 C NMR spectra of [3,5- 13C]-PBG-deaminase complex (1) 












FIGURE 3.21. 75.5 MHz 13 C NMR spectra at [3,5- 13C]-PBG-deaminase 
complex and [12C]-complex, various pH's, 21.6°C. 
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to that obtained before the titration, although most of the reso-
nances were somewhat broader. This latter effect is probably as a 
result of the high final ionic strength. 
This complex was then treated with unlabelled PBG (774 -tg). 
The spectrum obtained is shown in Figure 3.22 (i). When the uro'gen 
I region was resolution enhanced, the spectrum showed a double 
doublet centred 'at 117.6 ppm ( 2J ( 13C- 1 H) = 53 Hz, 31 ( 13C- 1 H) = 
8.5 Hz) and a doublet centred at 126.0 ppm ( 2 1 .( 13C-'H) = 46 Hz). 
Since the data was accumulated without 'H-decoupling, the double 
doublet at 117.6 ppm arises from 13C- 1 H coupling at C-3, C-8, C-13 
and C-18 from the propionate side-chain methylenes, the first 
methylene giving rise to two-bond coupling and the second methylene 
giving rise to three-bond coupling. Similarly, the doublet at 
126.0 ppm arises from two-bond coupling to the meso protons. 
Incidentally, this coupled spectrum confirms the assignments made 






Figure 3.22. 75.5 MHz 
13 
 C NMR spectra of E3,5-13C] - PBG- deaminase 
treated with unlabelled PBG, pH 8.0, 21.7°C, (i). 
Resolution enhanced, (ii). 
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CKAPTER 4 
NMR STUDIES OF [ 3H] - PBG - DEPMINASE COVALENT COMPLEXES 
4.1 Introduction 
The problems encountered in the work described in the previous 
chapter, in the attempt to study the 13C-enriched PBG-deaminase 
covalent complexes, had at their roots two basic causes: (i) the 
linewidths of the covalently attached substrate must be prohibitively 
large by 13C NMR, and (ii) the protein resonances seriously hamper 
substrate detection for most 13C-labelling patterns which would 
furnish useful information. 
We therefore set about examining other possible NMR nuclei which 
have a low natural abundance and a high sensitivity, and which might 
furnish the information sought. One such nucleus is tritium. 
4.2 The Use of 
3  H NMR in the Study of Enzyme-Substrate Complexes 
If we consider the data given in Table 1.1, it is clear that 
use in biol qgiçl 	It hasa natural 
abundance of <10_16,  and an NMR sensitivity at full enrichment some 
20% greater than 1 H. Indeed, it is the most sensitive NMR nucleus 
S 
known. Thisadvantage if. offset by its radioactivity, but then of 
all the radionuclides tritium is the least harmful. It is a "soft" 
s-emitter (0.018 MeV) and has a half-life of 12.3 years. While 
requiring special handling precautions, the mean range in air 
travelled by the s-particles is 4.5 mm, and at most levels employed 
for 3  H NMR these are stopped by the dead layers of skin, or the 
glass walls of the apparatus being used. 
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As far as NMR instrumentation is concerned, the use of 3H NMR 
requires certain additional items in order to equip an ordinary FT 
instrument adequately. The first of these is a probe suitably 
adapted to tune the main coil up to the 3H NMR frequency and have a 
subsidiary decoupler coil that can be tuned to the 'H NMR frequency. 
Also the instrument needs to be equipped with a pulse amplifier and 
pre-amplifier tuned for the 3H NMR frequency, and high-quality 
filters for both the 3H channel and the 1 H-decoupler channel 
capable of selectively filtering either 3H or 1 H frequencies where 
appropriate. This is particularly important because the NMR 
frequencies are so close together that breakthrough of one channel 
into the other can be a serious problem. 
The first reported 3H NMR spectrum was recorded by Tiers 
et al. 194  on a tritiated ethyl benzene sample of very high radio-
activity (10 Ci) at 42.5 MHz. For tritiated water, a satisfactory 
one-scan spectrum was obtained at a level of 1 Ci cm 3 (0.038%). 195 
The advent of FT NMR has reduced this limit to 0.5-5 mCi per site 
of enrichment. A survey of 26 monotritiated substrates showed the 
relationship 
= 
to be valid to a first approximation. 196 
A number of referencing procedures have been devised which avoid 
the use of an internal tritiated standard. 196 ' 197 ' 200 One way is to 
obtain the 1 H MMR spectrum of the sample containing a standard (TMS 
or TSP), and the absolute resonance frequency of the standard is then 
multiplied by T'H = 1.0666, to provide a ghost reference frequency 
for the 3H spectrum. In another technique, which is employed through-
out the workdescribed in this chapter s the 1 H NMR spectrum of the 
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sample containing a standard is obtained, and the 'H resonances 
referenced in the normal way. The 3H NMR spectrum is thenobtained, 
and using 6 H = 6T5 a sample resonance which is remote from the stand-
ard and bears both 3 H and 1 H is used as a reference. The validity 
of these techniques was confirmed using synthetic monotritiated 
s. 197 m 
A secondary isotopic shift of 0.021 ppm exists when going from 
CH2T to CHT2 . 196 The coupling constant 1 1 ( 13C- 3H) would be 
expected to be given by 
1 1 ( 13C-H) = 1.0666 'J (' 3C- 1 H) 
in which the constant (1.0666) again reflects the differences in y 
between the two nuclei 	 Deviations of ±0.2 Hz have been 
found, except for chloroform for which.a -1.52 Hz discrepancy 
exists. 198 These deviations are not due to differences in the 
accuracy of coupling constant measurements, since the linewidths of 
NMR signals are comparably narrow to those of 1 H signals. 
When broad-band 'H-decoupling is employed, a 3H-{ 1 H} NOE would 
be predicted, and after some controversy, 199 ' 200 the existence and 
value of this NOE has been demonstrated. 201 In •theory the maximum 
NOE is 47% 	
H12T 
 which is quite small when compared to 
13 
 C for 
example, in which the maximum 13C-{ 1 H} NOE is 199%. Since there are 
usually no significant differential NOE's in a particular sample, 
the errors in integrating the intensities of 1 H-decoupled 3H signals 
are generally similar to 1 H NMR (±2-5%). 
While a number of applications of 3H NMR exist for small 
molecules of biological interest, 202208 only one example of the 
study of a biological macromolecule has been reported, 209 in which 
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the interaction of [6-3H]benzo[a]pyrene  and yeast cytochrome P-450 
was examined, and a very poor quality 3 H spectrum obtained. Thus 
the work described here represents the first application of 3H NMR 
to the study ofan enzyme-substrate complex. With the appropriate 
equipment installed by Dr. P. E. Fagerness, we were able to plan a 
series of 3 H NMR experiments designed to solvethe problems posed 
above by 3C NMR. As an initial requirement, it was necessary to 
be able to synthesise [3H]-ALJ\  of unusually high specific activity 
in order to yield [3H]-PBG  which when bound to deaminase would be 
sufficiently tritiated (i.e. 0.5-5 mCi per site) to allow detection 
by 3H NMR with moderate ease. For this purpose, preliminary studies 
focused on the synthesis of [2H]-PBG  as a means of evaluating the 
synthetic methodology. 
4.3 Synthesis of [2H]-ALA and [2 H] -PBG 
Following a report21° that the protons at C-5 of ALA are 
exchangeable at pH 8, a detailed study of the kinetics of deutera-
tion at C-5 and C-3 was conducted using 1 H NMR. The kinetic profile 
obtained is shown in Figure 4.1. From this it is clear that >90% 
deuteration at C-5 can be achieved with only 15% deuteration at C-3. 
Since commercially available t3HJ-ALA,  which is of low specific 
activity, is invariably 60% tritiated at C-5 and 40% at C-3, this 
method appeared to provide the means for a significant improvement. 
As a test, ALA (1 g) was dissolved in D 
2 
 0 (50 cm3 ) and adjusted 
to pH 8.0 with solid anhydrous sodium carbonate. It was then 
incubated in a sealed vessel for exactly 225 minutes before adjust- 
ing the pH to 1.5 with 20% DC1/D2 0. The mixture was then lyophilised, 
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Deuteration of ALA 
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FIGURE 4.1. The deuteration of ALA. 
and on recrystallisation the pure [5-2H]-ALA  (495 mg, 49% yield) was 
found to have 90% 2H at C-5 and 15% at C-3 by 1 H and H NMR and 
FAB-MS. 
Attempts to generate [2H]PBG  from this sample of ALA using; 
ALA dehydratase initially failed for a number of reasons. It was 
mainly due to the incubation being performed for 2 hours at pH 8.0. 
At this pH and over this time period, the extent of exchange of 
deuterium out of the [2H]-ALA  is significant. If the amount of 
enzyme had been increased dramatically and the pH adjusted nearer 
to 7, then the exchange could be minimised. 
Accordingly, the activity of partially purified ALA dehydratase 
from R. spheroides I was examined at various pH values in the standard 
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FIGURE 4.2. Dehydratase activity versus pH. 
retains 44% of its activity at pH 8.0. Thus when the incubation was 
conducted at pH 7.0 with a large excess of enzyme, the deuterium 
incorporation was satisfactory as shown in Table 4.1, although the 
isolated chemical yield was only 29%, which perhaps reflects an 
isotope effect on the enzyme activity. Interestingly, the incorpora-
tion of deuterium into C-2 was greater than quantitative, probably 
due to the exchangeability of this proton with the D 20 in which the 
sample was dissolved for the 1 H NMR determinations. Furthermore, 
the incorporation at C-ll was some 70% lower than expected, suggest-
ing that the deuterium had been lost from C-5 of ALA prior to PBG 
formation. 
Having established anexperimental protocol applicable to the 
synthesis of [3H]-PBG,  conditions were sought which would be 
technically simpler. The first criterion here was the tritiated 







TABLE4.1 Deuterium incorporation of [2,11-2H]-PBG  from [5_2H]_ALA.a 
% overall 
% D 	 % D 	 incorporation 
	
Substrate 	(experimental) 	(theoretical) 	(ALA - PBG) 
ALA C-3 	 19 	 - 	 - 
C-5 	 82 	 - 	 - 
PBG C-2 	 56 	 41 	 137 
C-il 	 22 	 82 	 27 
C-6 	 23 	 19 	 100 
aData calculated from integrals of 300 MHz 1 H NMR spectra normalised 
to resonances not subject to deuteration, i.e. C-2 of ALA and C-9 
of PBG. 
relatively high dilution, since at pH 8.0 over the course of 2.75 
hours, appreciable decomposition of ALA takes place. 177 Negotiations 
with commercially available custom tritiation services revealed that 
while 100% T2 0 was available, the maximum quantity which could be 
handled was 100 Ci, which has a volume of 31 iiL. Furthermore, 
adjustment to pH 8.0 must be performed with avolatile base, if 
problems of removing the labile tritium were not to be encountered. 
A series of experiments were performed dissolving ALAHC1 
(150 mg) in D 
2 
 0 (309 .iL) and titrating to pH 8.0 with triethylamine. 
When the necessary amount of triethylamine was established, the 
experiment was conducted on the same scale as planned for the radio-
chemical exchange, one in D 
2 
 0 and one in H 
2 
 0 aiming for 10% deutera-
tion. Incubation was carried out for exactly 10 minutes (calculated 
using Figure 4.1) before adjustment with 0.1 M HC1 and lyophilisa- 
1 tion. Analysis of the 300 MHz H NMR spectra, integrating the 
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methylené at C-5 relative to the one at C-2, revealed that Ca. 15% 
deuteration had been achieved. 
4.4 Synthesis of [3H]-ALA  and [ 3HJ - PBG 
In order to gain some knowledge of the isotope-effect in 
substituting tritium for deuterium and to test the methods worked 
out above, a sample of[13C]-ALA  was sent for custom tritiation by 
New England Nuclear (Boston, Mass., U.S.A.). The sample of [ 13C, 3H]-
PBG subsequently obtained was used in one of the experiments 
described in Section 3.5, and as well as being radioactive and thus 
providing an internal means of detecting the complexes produced, 
the sample provided a ready method for testing the lability of 
tritium at all the various stages of complex purification. 
Therefore [5 -13C] -ALA (15 mg, 90 imol) was sent to New England 
Nuclear, who performed the custom tritiation as follows. The ALA 
was dissolved in 100 Ci 100% T 2 
 0 and triethylamine added with 
stirring. This was continued for exactly 10 minutes before adding 
excess 0.1 M HC1, and removing the labile tritium by cycles of 
lyophilisation and further addition of 0.1 M HC1. The crude [ 3H] - 
ALA was shipped directly in 0.1 M HC1, and converted to PBG as soon 
as possible after its arrival. 
For the incubation with ALA dehydratase, theenzyme (1500 U 
assayed at pH 7.0) was preincubated at 37°C in phosphate buffer, 
MgC1 2 and cysteine. The [ 3H] - ALA solution (286 mCi, 3.2 Ci mmol) 
was adjusted to pH 7.0 with NaOH and added to the enzyme. After 
incubating for exactly 3.5 minutes, the reaction was stopped with 
CuSO4 and the [ 3H, 13 C] - PBG purified by the procedures outlined in 
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Chapter 2'. This yielded pue 1 3H, 13C1 - PBG (3.6 rng, 4.7 mCi, 
3.5 Ci rnmol) in 28% chemical yield, as was found in the case with 
deuterium. If the [3H]-ALA  sample had not significantly decomposed, 
then the PBG produced should have a specific activity of 4.0 Ci mmol, 
which implies a 13% loss of tritium on PBG formation. 
One third of this sample (14.6 mCi) was analysed by 'H and 3H 
NMR, and the spectra obtained are shown in Figure 4.3. The 
spectrum (Figure 4.3 (i)) clearly shows the 90% 13C-enrichment at 
C-2 ( 1 J ( 1 H- 3C) = 183.5 Hz) and C-li ( 1 1 ( 1 H- 13C) = 144.2 Hz), and 
some 3H- 1 H coupling at C-6. When the 1 H-decoupled 3H NMR spectrum 
was recorded, it again showed (Figure 4.3 (ii)) the 13C- 3H coupling 




7 	 6 	 5 	 4 	 3 	 Zpprn 
FIGURE 4.3. (i) 300 MHz 1 H NMR spectrum of [2,6,11- 3H5 ], [2,11- 13C]-
PBG•HOAc (1.2 mg, 14.6 mCi). 
320 MHz 1 H-decoupled 3H NMR spectrum of sample (i), 
2 hours after solvation. 
320 MHz 1 H-coupled 3H NMR spectrum of sample (1), 
24 hours later. 
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Note that from the relationship given in Section 4.2 we would have 
expected the latter coupling constants to have been 195.7.and 153.8 
Hz, which is fairly good agreement. Additionally, the integrals 
gave a quantitative measure of the 3H distribution, which was 46% 
at C-2, 35% at C-li and 19% at C-6. When the 1 H-coupled 3H NMR 
spectrum was recorded, considerable exchange of 3H from C-2 had 
taken place, giving rise to the HOT resonance at 4.85 ppm. The reso-
nance at 4.14 ppm (C-li) clearly shows 3H- 1 H coupling ( 1 J ( 3H- 1 H) = 
15.2 Hz). 
When this sample of PBG (10.3 mCi, 852 jig) was used to generate 
a [13C]-complex,  which was later denatured for more detailed 13C NMR 
studies (see Section 3.7), it was found that 1.57 mCi (15.2% bound) 
was bound to deaminase (4500 U, 1 jimol). This low incorporation may 
well reflect appreciable loss of tritium at C-2 of P3G. These 
results therefore pointed to. the necessity for PBG with a high 
specific activity as is theoretically possible. Furthermore, the 
incorporation of 3H into ALA was 64% less than the theoretical 
incorporation (791 mCi, 8.85 Ci mmol), implying a kT/kD = 0.36. 
From this a better estimate of the time necessary to ensure complete 
tritiation was possible. 
The first time ALA (15 mg) was tritiated at a high level, the 
procedure was exactly as with the 113C]-ALA,  except that the exchange 
was allowed to incubate for 360 minutes. This is twice the time 
necessary for deuterium, with an extra 30 minutes, which is not 
quite as long as the time predicted from the kT/kD  obtained above 
(i.e. 460 minutes) owing to the inconvenience for New England Nuclear. 
After removal of the labile tritium, the product was dissolved in 
0.1 M HC1 and shipped in dry-ice. The crude ALA (3.122 Ci, 
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34.8 Ci mmol) was incubatedwith ALA dehydratase exactly as before. 
This yielded impure [3H]-PBG  which, after a second purification on 
Dowex 2 acetate, furnished [3H]-.PBG  (250 tg,. 144 mCi, 165.9 Ci mmo1) 
found to be relatively pure by 3H NMR (see Figure 4.4). This 
dramatic increase in specific activity reflectsthe fact that the 
starting ALA was far from pure. This arises from exposing ALA to 
somewhat extreme conditions. Storage of ALA at pH 8.0 for 6 hours 
probably resulted in significant chemical decomposition, producing 
the sorts of impurities identified by Franck et al. 77 Furthermore, 
exposure of ALA to 100 Ci for the same period of time gives rise to 
considerable autoradiolysis. 
- 	2•59 
HO2C - HCOH 
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FIGURE 4.4. (i) 300 MHz 'H NMR spectrum of unlabelled PBG (for 
comparison. 
(ii) 320 MHz 'H-decoupled 3H NMR spectrum of 
[2,6,11-3H5]-PBG. 
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The 'H-decoupled 3H NMR spectrum of pure [ 3H] - PBG (Figure 4.4 
(ii)) shows some interesting features. Firstly the resonance due 
to the propionate me'thylene would be expected to exhibit a singlet, 
but in fact shows an.unsymmetrical doublet. This is due to the 
main signal arising from a I-C-H methylene (at 2.59 ppm) and 
additionally the lower, intensity signal arising from a I-C-I 
methylene (at 2.56 ppm, 0.03 ppm, 9.4 Hz upfield from -ICH). This 
assignment was confirmed when the. 1 H-coupled spectrum revealed that 
the isotope-shifted species was largely unaltered by geminal I H-
coup 	Another, feature of the spectrum is the intensity o,f the 
signal from the C-ll methyl ene at 4.16 ppm, reflecting a lower 
incorporation of tritium into that position. This is consistent 
with the deuterium results already mentioned, and suggested two 
possible causes. Firstly, the mechanism by which PBG is formed 
from ALA is usually thought (see.Section 1.4.2) not to involve the 
aminomethyl side-chain. However, it is conceivable that the enzyme 
stereospecifically removes a tritium from that position. Secondly, 
ALA transaminase, the enzyme responsible for ALA biosynthesis in 
plants (see Section 1.4.1), is known 56 ' 6° to co-chromatograph to 
some extent with ALA dehydratase. It seems likely that this enzyme 
is similar to ALA synthetase, both of which are pyridoxal phosphate 
dependent, and the latter enzyme is known 21 ' to stereospecifically 
exchange the pro-R hydrogen at C-5 of ALA. Thus treatment of ALA 
dehydratase with lysine should remove the pyridoxal phosphate, and 
selectively inactivate the transaminase. In order to assess the 
effect of lysine. on ALA dehydratase activity, some highly purified 
enzyme was assayed in the presence of lysine and found to be 
virtually unaffected. 
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In another preparation of 13HJ-PBG,  the effect of lysine on the 
incorporation of tritium into C-li of PBG was examined. ALA dehydra-
tase was partially purified to the stage outlined in Chapter 2, and 
then adjusted to 25 mM in lysine and further purified by gel-
filtration on G-100 Sephadex. When this was used to synthesise 
1 
[H] -PBG from["H] -ALA (2.438 Ci., 27.3 Ci mmol'), the product .e--t-
14Re (264 pg, 122 mCi, 132 Ci mmoY ) exhibited only ca. 20% more 
3H at C-li over the previous preparation, when assayed by integra-
tion of the 3H NMR spectrum. 
4.5 3H NMR Studies of [2,6,11 - 3-j] - PBG- Deaminase Covalent Complexes 
On the first occasion that [3H]-PBG-deaminase  covalent complex 
was generated, partially purified deaminase (6500 U, 1.6 times 
excess) was used, and the resultant complex purified by gel-electro-
phoresis. The pure complex, as usual mainly "mono-PBG", was 
concentrated and examined by 3H NMR at 10.8°C. In the early 
accumulations, there was a hint of a signal at Ca. 6.3 ± 0.2 ppm 
rapidly exchanging, or reacting away. However, the predominant peak 
was tritiated water (HOT), presumably arising from exchange of the 
residual aromatic tritium. After approximately 20,000 scans, two 
peaks were visible, one at 2.4 ± 0.2 ppm corresponding to the 
propionate side-chain, and one at 3.5 ± 0.2 ppm corresponding to 
the tritium at C-li (see Figure 4.5 (i)). Longer accumulations are 
shown in Figures 4.5 (ii) and (iii), with the aromatic resonance 
barely visible. 
The same sample was examined with a longer recycle time, and 
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FIGURE 4.5. 320 MHz 3H NMR spectra of t3H]-PBG-deaminase  complexes 
(i) with NS = 22,604; (ii) NS = 34,313; (iii) NS = 
43,200, at 10.8°C and pH 8.0. 
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FIGURE 4.6. 320 MHz NMR spectra of [3H]-PBG-deaminase  complex at 
(i) 10.8°C and (ii) 30°C, and pH 8.0. 
the complex appeared at 2.6 and 3.6 ppm, and in both cases the line-
widths were approximately 150 Hz. When this sample was re-equilibrated 
to ca. 30°C, the linewidths improved to 75 Hz (see Figure 4.6 (ii)). 
Apart from considerations of linewidth being indicative of our 
detection of an enzyme-bound species, T 1 measurements, which were 
of the order of 0.08 s, seemed to be highly suggestive also. The 
sample was therefore split into two parts and one half treated with 
unlabelled PBG in the NMR. No reaction seemed to take place and 
after two further additions of PBG, only 20% of the expected porphyrin 
formation had taken place when assayed spectrophotometrically. When 
the protein was assayed for enzyme activity, however, it showed full 
activity, suggesting a concentration effect. This accords with 
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Battersby's finding' 89 that deaminase is inhibited at high enzyme 
concentrations such as we encounter in the NMR tube. 
As a result of these findings, a portion of the PBG-treated 
protein was diluted four times, incubated for 10 minutes at 37°C 
and re-examined by NMR (see Figure 4.7 (ii)). When compared with 
the protein prior to treatment with PBG (Figure 4.7 (i)) the lines 
became narrower at 2.6 ppm •(propionate side-chains of uro'gen I) 
and 3.6 ppm (methylene bridgeheads of uro'gen I). Note that no 
significant chemical shift differences could be detected, suggesting 
that the species originally observed might be enzyme-bound uro'gen I, 
or some oligopyrrole gradually forming uro'gen I. When an oxidising 
agent such as iodine was added to the PBG-treated complex, an extra 
peak appeared at 4.3 ppm with concomitant loss of the resonance at 
3.6 ppm (see Figure 4.7 (iii)). This corresponds to the propionate 
side-chain of uroporphyrin I. When a portion of the complex which 
had not been treated with PBG was examined (Figure 4.8 (i)), 
characteristic resonances of uroporphyrin I at 4.3 ppm (propionate 
side-chains) and 10.1 ppm (meso-positions - exchangeable) appeared. 
Interestingly, while the porphyrin peaks occurred at the expense of 
the peak at 3.6 ppm, the peak at 2.6 ppm remained. Furthermore, 
re-examination of PBG-treated complex which had not been exposed to 
iodine revealed the same pattern of resonances (see Figure 4.8 (iii)). 
Treatment of the PBG and 1 2 -treated complex with hydroxylamine 
hydrochloride failed to displace the resonance at 2.6 ppm. Finally, 
treatment of the untreated complex (as in Figure 4.8 (i)) was 
examined in 8 M urea, in addition to the porphyrin resonances at 
10.2 and 4.4 ppm, the resonance at 2.6 ppm was unaffected, and a 
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FIGURE 4.7. 320 MHz NMR spectra of [3H]-PBG-deaminase complex (i); 
with added PBG (ii); with added PBG and 12  (iii) at 
30°C, pH 8.0. 
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FIGURE 4.8. 320 MH± 3H NMR spectra of [ 3H] - PBG- deaminase covalent 
complex after prolonged storage (i) and compared to 
complex with added PBG after prolonged storage (ii), 
at 30°C, pH 8.0. 
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FIGURE 4.9. 320 MHz 3H NMR spectrum of [ 3H]- PBG -
deaminase in 8 M urea at 30°C, pH 8,0. 
The interpretation of these results is not straightforward. 
The indications are that the bound species detected was uro'gen I 
and not a monopyrrole as firstthought. This is corroborated by 
the detection of porphyrin in the peptides from tryptic digestion 
of the complex (see Chapter 3). The fact that the complex without 
the presence of either PBG or 12  slowly oxidises to give porphyrin 
further corroborates this theory. However, the fact that analytical 
gel-electrophoresis initially showed a band well-characterised as 
the "mono-PBG" complex and then after prolonged storage at 30°C 
showed a new band corresponding more closely to a tetrapyrrole 
suggests that the mono-PBG" complex gradually disproportionates 
to the bound tetrapyrrole. This tetrapyrrole would appear to 
cyclise either still covalently attached to the enzyme, or ionically 
146 
associated with it presumably through the propionate. carboxylate of 
ring A, and the resultant uro'gen I gradually oxidises to Ø'9phyrin. 
The disappearance of the peak at 3.6 ppm without concomitant loss 
of the peak at 2.6 ppm, and the ' 1 extra" peak at 5.8 ppm after treat-
ment of the complex with urea both remain mysteries to date. 
When a repeat of this experiment was planned, certain features 
of all the previous complex preparations described in this chapter 
and the preceding one became apparent. The 13 C NMR results described 
in Chapter 3 suggested that while the substrate signals were 
necessarily of extreme linewidth, disproportionation of the complex 
to uro'gen I at >25°C took place readily, and the resultant uro'gen 
I was much more detectable by 13C NMR. Furthermore, this dispro-
portionation seemed to be promoted by the oxidative procedure of 
preparative gel-electrophoresis. Thus it was clear that a repeat 
experiment needed to test the disproportionation by analysing the 
"mbno-PBG" complex with time at >25°C, and all the NMR work performed 
at Ca. 4°C. The complex should also not be exposed to electro-
phoresis, but instead electrophoretically pure deaminase used to 
generate the complex in - the presence of 25 mM lysine, to prefer-
entially form an ion-pair between the lysine and the uro'gen I that 
is produced, rapidly followed by gel-filtration. 
Thus electrophoretically pure deaminase(ca. 4000 U) was mixed 
with [2,6,11-3H5]-PBG (122 mCi, 27.3 Ci mmol) and 25 mM lysine in 
the HPMD, immediately concentrated, and applied to a freshly 
equilibrated G-50 Sephadex column. The complex which eluted off 
cm., 
was concentrated to Ca. 0.50 £.1, and examined by H NMR at 5.5°C. 
A portion of the complex was also examined at 14°C and 23°C (see 
Figure 4.10 (i)-(iii)). When the spectrum was recorded at 5.5°C, 
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FIGURE 4.10. 320 MHz 3 H NMR spectra of [ 3H] - PBG- deaminase 
complex at (i) 5.5°C, (ii) 14°C and (iii) 
23°C, and pH 8.0. 
resonances occur at 6.18 ppm (pyrrole-I)-, 3.28 ± 0.1 ppm (pyrrole-
CT2-X-Enz) and 2.48 ± 1 ppm (pyrrole-CT 2 -CH2 CO2 H). Here it is 
interesting to note that the aromatic resonance of PBG which normally 
occurs at 6.69 ppm shifts to 6.17 ppm on binding to the enzyme. On 
warming to 14°C, the resonance at 3.28 ppm starts to disappear, and 
a new peak is just visible at 2.75 ppm. At 23°C, the aromatic reso-
nance at 6.17 ppm disappears, and the remaining resonances occur at 
3.58 ± 0.05 ppm (20-mesoof uro'gen I + pyrrole-CHT-X-Enz), 2.75 ± 
0.05 ppm (Enz-pyrro1e-C]CH2 CO2 H) and 2.48 ± 0.05 ppm (uro'gen I 
propionate side-chain). The latter two signals are considerably 
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sharper than those obtained at 5.5°C. Also these results can be 
considered as evidence for the disproportionation of the u mono_PBGU 
complex todi-, tn- and tetra-pyrroles and subsequently uro'gen I 
at this temperature (23°C) and protein concentration (ca. 1.6 mM). 
Presumably the signals at 3.58 and 2.75 ppm arise from an oligo-
pyrrole en route from bound monopyrrole to uro'gen I. The assign-
ment of the resonances to uro'gen I were confirmed when a sample of 
enzymatically prepared uro'gen I was examined at 23°C (see Figure 
4.12). 
To demonstrate the catalytic competence of the complex, 
unlabelled PBG (950 iig) was added to the portion which had been 
equilibrated at 23°C, and the formation of uro'gen I studied with 
time. Uro'gen I showed characteristic resonances at 3.58 ppm (meso 
positions) and 2.5 ppm (propionate side-chain), exactly as found in 
NMR studies (see Section 2.2). When this was repeated with the 
portion which had been stored at 3.5°C, the substrate is clearly 
connected to uro'gen I (see Figure 4.11) which when warmed to 23°C 
(see Figure 4.12) exhibited the characteristic resonances found in 
the 
I  H NMR studies. Interestingly, however, at 3.5°C the uro'gen I 
resonances occur at 2.15 and 3.28 ppm, which shift by 0.3 ppm on 
warming to 23°C. At 3.5°C the uro'gen I is probably still attached 
or associated with protein, coming free at 23°C. That the shift is 
not due to temperature is confirmed by consideration of the 
1  H NMR 
data for uro'gen I (see Section 2.2) at 4°C. 
A noteworthy feature of the spectra in Figure 4410 is the lack 
of accumulation of any obvious intermediates such as HMB (55). It 
seems likely that at this high protein concentration (ca. 1.6 mM), 
intermediates such as HMB, which probably represent the nucleophilic 
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FIGURE 4.11. 320 MHz 3H NMR spectra of [3H]-PBG-deaminase complex 
+ unlabelled PBG (950 iimg) at 3.5°C, pH 8.0. 
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FIGURE 4.12. 320 MHz 
3 
H NMR spectra of [ 3H] - PBG- deaminase 
complex + unlabelled PBGat 3.5°C (i) and 
after warming to 23°C (ii), pH 8.0. 
trapping of an exomethylene species (60) with water, never have an 
opportunity to accumulate. Rather, the highly reactive exomethylene 
species cyclises directly to uro'gen I. In fact, a transient low-
intensity peak appears at 4.76 ppm (Figure 4.11), a chemical shift 
which is consistent with an exomethylene species. This is perhaps 
more obvious in Figure 4.13. As mentioned in Section 2.2, model 
systems exhibit a 1 H-resonance at 4.86 ppm.' 75 
The unusually large linewidths (ca. 150-300 Hz) of the spectra 
in Figure 4.10 (i) reflect an environment in which the active site 
of the enzyme is probably buried within the protein. Furthermore, 
the implications for 13C NMR explain completely the comparative 
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lack of success with that nucleus, since there the linewidths would - 
be substantially greater due to larger T 2 values for the [13C]-complex. 









The propionate side-chain linewidth also suggests that it is either 
covalently attached or ionically associated with the protein. This 
is consistent with the reports on the inhibitory effects of PBG 
analogues (see Section 1.4.3), and also the electrophoretic mobilities 
of the complexes. Jordan 14 ' interpreted the increase in the mobility 
between the "mono-PBG" complex band and the di-PBG!' complex band as 
evidence for the neutralisation of a negatively charged enzyme group 
(after loss of -NH 3 ), thus providing only a net increase of one 
negative charge. However, the single net negative charge is much 
more likely to arise from involvement of one of the pyrrole carboxyl- 
+ 
ates in binding as well as elimination of -NH 3 . The chemical shift 
of the methylene (C-li) directly attached to the enzyme allows some 
tentative conclusions to be drawn, and these will be presented in 
the next chapter. 
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CHAPTER 5 
BIOSYNTHESIS OF PORPHYRINS: 
CONCLUSIONS AND OUTLOOK 
5.1 The Mechanism of Deaminase 
The results presented in the previous chapters clearly show that 
PBG deaminase initially binds one PBG unit, which subsequently 
condenses with further PBG units to genera.te ultimately uro'gen I. 
With the bacterial enzyme, the binding of these PBG units results 
in three stable covalent enzyme-substrate complexes. At high con-
centrations and temperatures >25°C, these can gradually dispropor-
ti.onate with time, 
EES -s- ES - ES - ES ' 	l 	2 	3 	4 
in an equilibrium process which lies far to the right under those 
conditions, and the bound tetrapyrrole gradually forms. This would 
appear to be inherently unstable and forms uro'gen I via HMB. 
The nature of the groups of deaminase involved in the binding 
of the substrate is difficult to determine in the absence of more 
detailed information about the protein. Most conventional techniques 
for the study of binding sites involve the isolation and purification 
of peptide-bound substrate, but these fail here because the hydrolytic 
conditions employed result in the polymerisation of the substrate. 
While proteolytic enzymes can and have been used to obtain oligo-
peptide fragments, the analysis of these fragments has proved to be 
extremely difficult, especially since they cannot be further 
hydrolysed to their constituent amino acids without destroying the 
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substrate. Unfortunately, to date the analysis of the fragments 
described in Chapter 3 using FAB-MS is not complete due to technical 
problems. Ther.e are, however, preliminary indications that porphyrin 
is present in some of the fragments. Thus without crystalline 
protein, which could be used for a detailed X-ray crystallographic 
investigation, NMR provides a. method par excellence for the study of 
the mechanism of the enzyme. 
NMR failed to detect enzyme-bound PBG with any confidence, 
and only detected uro'gen I attached or associated with the protein. 
3H NMR, however,, provided the means to detect the enzyme-substrate 
complex and furnished.a chemical shift of 3.3 ± 0.1 ppm for the 
methyl ene at C-ll of PBG directly attached to the protein. Since 
PBG can be regarded as a Mannich base, it seems reasonable to expect 
it to alkylate a group on the enzyme that is probably nucleophilic. 
Mechanistically it is unlikely to alkylate a histidine or any other 
aromatic amino acid residue, since it would be extremely difficult 
to liberate the pyrrole methylene after tetrapyrrole formation had 
taken place. Similarly, an amide linkage can be ruled out on the 
basis of its highstability. Much more likely is the involvement 
of a nucleophilic group on the enzyme, such as the oxygen of serine, 
the nitrogen of lysine or the sulphur of cysteine. Let us consider 
models of each of these in turn as a means to rationalise the 
observedenzyme-substrate chemical shift of 3.3 ± 0.1 ppm A very 
good model for the serine-0-PBG is the chemical shift of the 
methylene of HMB (55), which from Section 2.2 exhibits a resonance 
at 4.4 ppm. Going from a primary alcohol to an ether linkage 
usually results in a Ca. 0.2 ppm upfield shift. We can therefore 
definitely rule out serine oxygen. 
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For nitrogen,.a number of good models exist. PBG itself dis-
plays a resonance at 4.2 ppm for the C-li methylene, and from the 
work described in Section 2.2, only shifts 0.05 ppm upfield on 
deprotonation. Aminomethylbilane (40) displays a resonance at 
3.92 ppm at pH 12,115  which implies a chemical shift of 3.97 ppm 
at pH 8.0. The dipyrrole derivative of PBG exhibits a resonance 
at 4.05 ppm. 212 Thus, contrary to recent conclusions,' 89 the 
c-NH2 of lysine can be ruled out unequivocally. 
For sulphur, model compounds were prepared in this laboratory 
by Dr. N. E. Mackenzie, 213 and the 'H NMR data is shown in Table 5.1. 





I 	II 	(94) 
'-CO2Me - 
a s- CO2Me 
4.94 ± 0.05 
4.10 ± 0.05 
Me AMe 
tz \ * 	(96) 
14Br 
4.23 ± 0.05 
Me AMa 
MI \ 	(2) 	 3.39 ± 0.1 (calculated) 
H S. 
aDa ta  taken from Ref. 213. 
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The final chemical shift for the model thioether (97) was calculated 
from (94) - (96) to be 3.39 ±0.1 ppm, which is in close agreement 
with the experimentally observed value of 3.30 ± 0.1 ppm. 
On the basis of this 3H NMR evidence, combined with the observa-
tion that deaminase is strongly inhibited by suiphydryl reagents, 
an effect which can be reversed by dialysis against thiol reagents 
(see Section 1.4.3), there is compelling evidence in favour of 
sulphur for the X group to which the substrate binds, in the form 
of a cysteine thiol. Although an attempt was made to titrate the 
enzyme thiol groups using 2,2'-dipyridyldisulphide, none were 
detected,and it seems likely that if the active thiol were buried 
in the active site of the enzyme, it would not readily titrate. 
Thus the chemical shift obtained from 
3 
 H NMR strongly suggests 
that the nature of the enzymic group to which the substrate binds 
is a cysteine thiol. There is a caveat, however, that some unknown 
or unusual group could be involved, or that the electronic environ- 
ment of the active site radically perturbs the bound substrate. The 
former possibility is unlikely, since from the amino acid analysis 
of human deaminase (Table 1.4), there are no unusual amino acids, 
and there is no evidence of a cofactor requirement for the enzyme. 
The isolation and purification of deaminase described in 
Chapter 3 furnished 'protein Ca. 70% pure. Therefore, a portion of 
[ 13 C] - complex which had been incubated with unlabelled PBG was 
further purified by gel-electrophoresis to provide samples of ultra-
pure (>95% pure) deaminase and "mono-PBG" complex. These were sent 
for amino acid analysis and protein sequencing, but unfortunately 
the results were not complete at the time of writing. 
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Kinetic studies conducted by Williams et al.,using purified 
deaminase from Euglena gracilis 77 and rat spleen 214 have established 
some interesting features of the deaminase-catalysed reaction. The 
pH dependence of Vmax  was investigated, and for enzyme from both 
sources a classic bell-shaped curve was obtained, indicating that 
two ionisable groups with pK values of 6.1 and 8.9 (Euglena) or 7.4 
and 8.8 (rat spleen) are important for catalysis. These represent 
ionisations in the enzyme-substrate (ES) complexes, but without 
knowledge of the nature of the rate-limiting step in the overall 
process, or the possibility of equivalent ionisations throughout the 
series of partial reactions, it is not possible to attribute these 
pK values to individual reaction steps. 
The dependence of Km  with pH was also studied, and found to 
decrease with decreasing pH. This was interpreted as the absence 
of the pK in the free enzyme or substrate corresponding to the pK 
of 6.1 in the Euglena enzyme. Thus if the effect is due to ionisa-
tion of the substrate part of the ES complex, then the substrate 
complex must be raised from 3.7 or 
495176  for the carboxyl functions 
to 6.1. If, however, the pK reflects ionisation of the enzyme 
portion of the ES complex, then the absence of a pK in the measured 
pH range (pH 6-8.7) may be due to the group having a pK <5.0 in the 
free enzyme or to the group being burir(ed in the protein and made 
accessible to the solvent by substrate-induced conformational 
changes. It was also found that the dependence of Vmax/Km  with pH 
showed a single ionisation (pH 8.2) reflecting ionisations in the 
free enzyme or its three pyrrolic forms. 
These results can be further rationalised in the light of the 
foregoing NMR investigations, which have established that binding 
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of the firs.t PBG unit takes place through both the C-li methylene and 
the C-8 carboxylate (propionate side-chain). The dependence of Vmax 
on pH could reflect ionisations in any of. the ES complexes, but 
taking into consideration the dependence of Km  upon pH, it seems 
likely that the pK of 6.1 arises from.a highly perturbed value for 
the propionate carboxyl of P8G. This unusual value could be explained 
if the carboxylate function formed an ionic bond with a suitably 
basic enzyme group, such as the c-NH 2 of a lysine residue, the 
guanidino group of an arginine, or the imidazole of a histidine. 
The other ionisation, as borne out by the dependence of Vmax/Km  with 
pH, probably reflects lonisations in the enzyme portion of the ES 
which is only slightly perturbed (0.7 pH units) by the presence of 
substrate. If this were true, then the free enzyme pK is closer to 
typical values for a sulphydryl group (pK 8.3-8.6) than for an 
ammonium (c-NH2 ) group (pK 9.4_10.6).215 
Thus a mechanism for deaminase can be proposed based on all the 
evidence acquired. to date, as depicted in Scheme 20. The first PBG 
unit alkylates a free thiol group with the elimination of one mole 
equivalent of ammonia, and the propionate forms an ion pair with a 
lysine or arginine residue, 216 and subsequent condensations with PBG 
result in the bound tetrapyrrole. At this point the first step in 
the release of the tetrapyrrole is the regeneration of the free 
thiol and the formation of an exomethylene double bond. This highly 
reactive species could be intercepted by endogenous water, or any 
other suitable nucleophile, as has been shown by numerous trapping 
experiments. 71 ' 108 ' 188 Either the exomethylene species or its trapped 
version (HMB) are presumably released into the medium by breaking the 
propionate ionic bond, for further chemical cyclisation to uro'gen I. 
IH,O 






SCHEME 20. Proposed mechanism for PBG deaminase. 
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5.2 The Mechanism of Cosynthetase 
The results from the experiments in Chapter 2 do not really 
allow any further conclusions to be drawn as to the mechanism of 
cosynthetase. However, recent studies by Battersby et 
taken together with the studies on deaminase summarised in the 
previous section, point strongly to the conclusion that HMB (55) 
is not the true substrate for cosynthetase. 
Battersby covalently bound tetrapyrrole from [1-3H]-HMB to 
deaminase from E. gracilis,. and treated the complex with cosynthetase. 
Here it was found that 72% of the bound tetrapyrrole was released 
and converted to uro'gen III. This contrasts with the 16%. of tetra-
pyrrole released by incubation of the complex at pH 8.0 and 37°C, 
and >96% released when the complex was incubated with excess PBG. 
The experiments described in Chapter 4 established that at high 
deaminase concentrations, the species released from the enzyme is 
the very reactive exomethylene pyrrolenine (60). This can be inter-
cepted by water at low protein concentrations, or indeed by co-
synthetase if it is present. It has been often suggested 75 ' 78 ' 79 
that deaminase and cosynthetase act in a multienzyme complex, and 
yet it has been shown 124 that when HMB is the substrate, cosynthetase 
can act completely independently from deaminase. Perhaps an explana-
tion for these disparate viewpoints is that the exomethylene species 
is stabilised locally by deaminase, and if cosynthetase loosely 
associates with deaminase, then the exomethylene species immediately 
binds to cosyrithetase for the subsequent ring-inversion step. It is 
only in the absence of cosynthetase, and at low deaminase concentra-
tions that 1-1MB ever has an opportunity to accumulate. The true 







Unfortunately, none of the studies presented in this thesis shed 
any light on the intriguing ring-inversion mechanism. While the 
Mathewson and Corwin mechanism involving the 'spiro intermediate 
seems a likely candidate (see Scheme 7), alternative mechanisms still 
continue to be put forward, in the absence of any experimental results. 
Battersby and co-workers 128 recently proposed the involvement of 





URO'GEN X + 
SCHEME 21. Battersby's mechanism for uro'gen III formation (1982). 
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This is essentially a variation on the mechanisms put forward by 
Rimington,. Johnson and Russe11 217219 for dipyrrole involvement, 
and an analogous scheme put forward by K. S. Ho. 22° However, until 
further studies are conducted on cosynthetase, such mechanisms must 
remain yet more idle speculation. 
5.3 Outlook 
5.3.1 Deaminase 
From the studies outlined for deaminase, the way forward to 
the investigation of the finer details of the mechanism of the 
enzyme are clear. While the intermediacy of the exomethylene 
pyrrolenine species is strongly suggested by what we believe to be 
its direct observation, and also from the numerous trapping experi-
ments which have been performed, •there are two approaches which 
would establish this unequivocally. 
The 3H JVMR Approach 
The resonance from tritiated water (HOT) casts some doubt on 
the reality of the resonance assigned to the exomethylene species, 
owing to the latter's transience and the magnitude of the HOT line 
partially obliterating the resonance of interest. Thus if the 
activity of deaminase was examined, in a cryosol vent such as DMSO-
water, and it were possible to remove the tritiated water completely 
from [3H]-PBG  by repeated cycles of treatment with water and 
lyophilisation, then there might be a good chance of detecting the 
exomethylene species directly and more convincingly. The method 
would involve cooling the [3H]-PBG-deaminase  enzyme-substrate complex 
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to Ca. -10°C in the NMR, and treating it with unlabelled PBG. The 
exomethylene species would then have more time to accumulate and 
would not be obliterated by the HOT resonance. 
The Chiral PBG Approach 
If it were possible to follow the stereochemical fate of the 
methylene directly attached to the enzyme, from PBG through to 
uro'gen I, the intermediacy of an exomethylene species might be more 
rigorously tested. For this experiment, large quantities of chiral 
[11 -2 1-11] - PBG would be necessary and furthermore a means, hiterto 
unclear, to determine the stereochemistry of the resultant HMB and 
uro'gen I, possibly using CD methods by comparison with synthetic 
material of known stereochemistry. To date, chiral PBG has been 
prepared only in tracer amounts55 and in very poor yields from 
chiral glycine using ALA synthetase. However, with a highly 
efficient synthesis of [5-2H]-ALA  now established (see Section 4.3) 
there are alternative, much more effective means for producing 
milligram quantities of chiral PBG. ALA synthetase is known to 
stereospecifically exchange the protons at C-5 of ALA, 211 and thus 
incubation of [5-2H]-ALA  with this enzyme, and subsequent incubation 
with ALA dehydratase under the conditions established in Chapter 4, 
would furnish large amounts of chiral [11S -2 H] - PBG. An even easier 
alternative would be to incubate. [5- 2 H] -ALA with partially purified 
ALA transaminase from R. spheroides and then complete the synthesis 
of PBG with ALA dehydratase. This approach would be easier because 
apart from the transaminase having a reportedly higher turnover 
than ALA synthetase, 221 the purification of ALA dehydratase from 
R. spheroides contains fractions largely distinct from dehydratase 
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activity that exhibit transaminase activity. Thus two enzymes for 
the price of one is a distinct advantage. Furthermore, the other 
enantiomer could be prepared by performing the incubation with 
unlabelled ALA in a 90% D 
2 
 0 medium. 
The stereochemical course of chiral PBG through to HMB and 
uro'gen III is shown in Scheme 22. The possible involvement of a 
carbonium ion could then be ruled out, and if racemisation took 
place, the intermediacy of the exomethylene species would be 
clearly indicated. Note that either inversion or retention of 
configuration could still arise from the exomethylene species being 
held stereospecifically in the cleft of the enzyme. 
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SCHEME 22. The stereochemistry of HMB formation. 
Further aspects of the precise mechanism of deaminase will 
become clearer when the sequencing of the protein is complete, 
hopefully shortly. Additionally, if the gene that codes for 
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deaminase synthesis could be identified and cloned back into 
R. spheroides, then 80-90% of the bacterial protein mass could be 
deaminase. Using affinity chromatography with immobilised mono-
clonal antibodies222 for deaminase, the crude homogenate from the 
cloned R. spheroides could be purified, to give deaminase of >95% 
purity in one step. With abundant quantities of pure enzyme, the 
X-ray and solid-state NMR structures could be determined, both with 
and without the substrate. This will ultimately lead to a deeper 
understanding of the detailed mechanism for the enzyme. 
5.3.2 Cosynthetase 
Cosynthetase is a difficult protein to purify in very large 
quantities, and for NMR investigations to be of any assistance, 
abundant quantities must be available. Thus the molecular biological 
techniques outlined for deaminase could also be employed for ca-
synthetase, and then the ring inversion step studied in much greater 
detail. For this, cryoenzymological techniques would be necessary, 
and the enzyme would need initially to be studied in suitable cryo-
solvents such as DMSO-water. With the most suitable conditions 
established, a number of approaches would need to be tried. 
NMR spectroscopy, using [3,5-13C]-PBG-derived  HMB as a 
substrate, might provide the means to detect the Spiro intermediate 
if it is involved, but here again the sp 3 carbon would probably be 
occluded by the protein background, and possess an extreme linewidth 
at low temperatures (ca. -10°C to -30°C). 3H NMR might again furnish 
valuable information, especially if a mechanism such as the methylene-
tetrahydrofolate one proposed by Battersby were involved. 
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An alternative to cryoenzymological NMR, which so often suffers 
from problems of. linewidth, would be the use of a "poor substrate 
for cosynthetase, such as the D-ring inverted HMB prepared by 
Battersby et al. 9° suitably enriched with 13 C, or perhaps a bilane 
blocked at the free pyrrolic end with a fluorine for example, where 
19 F NMR could be employed to study the bound tetrapyrrole and the 
initial stages of ring inversion. 
The study of porphyrin biosynthesis over the last decade has 
been characterised by a lack of detailed knowledge and understanding 
of the enzymes involved, particularly those responsible for the 
assembly of the porphyrin macrocycle. The reasons for this are 
due to the comparatively small quantities of the proteins which are 
available from the conventional sources, and the absence of non-
invasive techniques for investigating these complex enzyme-reaction 
mechanisms. However, with the advent of cloning techniques, the 
- 	potential for producingsufficient quantities of both deaminase 
and cosynthetase for NMR investigations is greatly increased. The 
manifest virtues of NMR will then be fully exploited in an attempt 





GENERAL EXPERIMENTAL PROCEDURES 
Reagents and solvents employed throughout this work were of the 
highest grade obtainable. Water was doubly-deionised and distilled 
in glass. Analytical and preparative thin-layer chromatography were 
carried out on E. Merck GE 254 silica gel glass-backed plates (0.25, 
0.5, 1.0 or 2.0 mm), Brinkmann Machery-Nagel (D[iren) silica gel 
plates, Machery-Nagel neutral alumina plates, or Machery-Nagel DC 
Fertigplatten cellulose plates (0.1 mm). The solvent systems 
employed were as follows: 
Solvent I: 	12:3:5 n-butanol:glacial acetic acid:water. 
Solvent II: 	80:16:4 benzene:ethyl acetate:methanol. 
Solvent III: 1:9 methanol :chloroform. 
Column chromatography was carried out on E. Merck Kieselgel 60 
Art. 9385 (230-400 mesh) silica gel or E. Merck neutral alumina 90 
Activity I Art. 1077 (70-230 mesh) or Brinkmann Avicel microcrystalline 
cellulose (38 pm particle size). 
---H1-gh-performance -1iquid-chromatography—(HPLC)- was -perfoed on 
a Waters Liquid Chromatograph equipped with a Model 6000A solvent 
delivery system, a Model U6K Universal injector and a Model 440 UV 
detector operated at 405 nm, or alternatively, a Spectra Physics 
SP1800 Liquid Chromatograph equipped with an 5P8440 UV/vis variable 
wavelength detector operated at 405 nm, and an SP4100 computing 
integrator. The columns employed were two p-Porasil (300 x 3.9 mm 
I.D., 10 pm particle size) connected in series. The columns were 
pre-equilibrated for several hours (usually overnight) with 
n-heptane:glacial acetic acid:acetone:water (600:300:200:1), and 
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operated using n-heptane:glacial acetic acid:acetone (6:3:2) with a 
flow-rate of 0.5cm 3 min 	at a pressure of Ca. '400 p.s.i. This is 
94 
essentially the technique of Nordlöv et al., 	used for the analysis 
of uroporphyrin isomer ratios in ca. 60 minutes per sample. 
Melting points were determined using a Kofler-type hot-stage 
microscope apparatus (Reichert, Austria) and are uncorrected. 
Infrared absorption..spectra (IR) were recorded as thin films or 
Nujol mulls using NaCl plates,o.r in KBr discs using a Perkin-Elmer 
Model 297 IR spectrophotometer. Abbreviations used to express peak 
intensities are s - sharp, w - weak. 
Ultraviolet/visible absorption spectra (UV) were recorded on 
a Varian DMS-90 spectrophotometer (Edinburgh), Hitachi Model 100-60, 
Pye-Unicam SP1800, or Varian Cary 210 spectrophotometers (Texas). 
For routine determinations, 1 cm pathlength matched quartz cuvettes 
were used, and for small volumes, 1 cm pathlength quartz micro 
cuvettes (600 pL capacity) were used. All determinations were 
carriedout at room temperature, except where specified. Absorption' 
maxima (Amax)  are reported in nanometers, and absorbances are 
---reported atspec-ific- waveiengths -(-A where x is the -wavelengthin 
nanometers). 
Determinations of p1-I were made using an Orion Research digital 
pH meter, Model 601A, with either a standard Orion 10 mm combination 
electrode, a Beckmann 5 mm combination electrode (for radioactive 
determinations), or an Ingold 3 mm combination electrode (for 5 mm 
NMR tubes). Electrodes were standardised in the usual manner with 
standard buffers from MCB Inc. (E. Merck, U.S.A.) at pH 4.00 and 
pH 7.00. Corrections for measurements in 020  have not been made, 
since the permeability of a deuterated sample through the glass 
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membrane of the electrode is usually as low as the permeability of 
a deuterated substrate say, into an enzyme active site. Generally 
these effects are equal , and there is no gain from making the 
corrections. 
The buffers employed throughout this work were as follows. 
Potassium phosphate (K Phos) buffer was made up as 0.1 M KH2PO4 
(monobasic) and adjusted to pH 7.6 with solid KOH. Iris Cl buffer 
was made up as 0.1 M Tris (ex Sigma, Trizma reagent grade) and 
adjusted to pH 8.0 with concentrated HC1. Pyrophosphate buffer was 
made up as 0.1 M Na2 P 2 0 7 and adjusted, to pH 8.0 with NaOH. Deuterated 
buffers were prepared in an identical manner using anhydrous salts 
and D2 0. 
Accurate volumes were dispensed using Gilson Pipetman automatic 
pipettes. Models P-5000 (up to 5 cm 3 ), P-bOO (up to 1 cm 3 ), P-200 
(up to 0.2. cm 3 ) and P-20 (up to 0.02 cm 3 ) pipettes were used in this 
work, and periodic calibration (using water and an accurate balance) 
ensured their accuracy. 
Weighing was routinely performed ona Mettler Model H10T balance, 
- - ---------and- accu-ra-te--ma-sses (to- 0-.-1--mg)-were-ob-tai.ned -  using. a- Cahn--rat-io------- ---
el ectrobal ance. 
Bacteria cells were harvested using a New Brunswick Model GLE 
continuous centrifuge. Sonication of cells was performed using a - 
Heat Systems-Ultrasonics Model W200R Sonicator. Centrifugation at 
low speeds was carried out using a Dupont.Sorvall RC-5B refrigerated 
centrifuge, using either the SS-34, the GSA or the GS-3 rotors. 
High-speed centrifugation was. performed using a Beckman L3-50 Ultra- 
centrifuge equipped with a diffusion pump and refrigeration, using 
either a Type 35 rotor, or latterly a 45 Ti rotor. Centrifugation 
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of small samples at low speeds (<5000 rpm) was performed witha 
Sorvall GLC-1 Benchtop centrifuge. 
All enzyme manipulations were carried out at 4°C in a cold room. 
Gel-filtration was carried out on either G-lO, G-25, G-50 or G-lOO 
Sephadex, purchased from Pharmacia Fine Chemicals, Piscataway, N.Y., 
U.S.A., or Sigma, St. Louis,M0, U.S.A. DEAE-cellulose and Dowex 2 
(Cli were obtained fromSigma, and DEAE-Sephacel from Pharmacia. 
These were treated before use, as described in the appropriate 
sections. Columns were pumped using an LKB 2132 Microperpex 
peristaltic pump under the control of either an LKB Ultrorac 2000 
fraction collector or an LKB Superrac 2211 fraction collector. 
Proteins were detected using either LKB Uvicord S 2138 or Uvicord 
8301 UV detectors at fixed wavelengths of 280 nm. Concentration of 
protein samples was performed using Amicon stirred ultrafiltration 
cells (Model.8400, 350 cm 3 ; Model 8050, 50 cm 3 and Model M-3, 3 cm 3 ), 
using PM-10 Ultrafilters and operating at 75 p.s.i. of nitrogen 
pressure. 
Analytical gel-electrophoresis was carried out using 7.5% 
- - 	p_o]yacryLanji degejs. 
gel-former apparatus (see Chapter 8 for details of gel preparation) 
and electrophoresis performed on an LKB Multiphor horizontal electro-
phoresis apparatus and an LKB Model 2103 power supply. The buffers 
and voltages employed are indicated where appropriate. Preparative 
gel-electrophoresis was performed using a Buchier Poly-prep 2000 
preparative vertical column apparatus, using the buffers and voltages. 
indicated. 
Analytical and preparative paper chromatography were performed 
on a Savant Model FP-22A ethylene glycol/water-cooled flat-bed 
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apparatus, using the buffers and voltages indicated. Whatman No. 1 
or 3 MM paper was used, depending on the scale of the separation. 
Determinations of radioactivity were made with a Packard PL 
Prias Tri-carb liquid scintillation counter interfaced with a Texas 
Instruments Silent 700 data terminal. Samples were counted in a 
liquid scintillation cocktail of 5-x cm 3 of Aquasol (New England 
Nuclear) and x cm 3 of sample, where x < 0.5 cm 3 .. To correct the 
counts (cpm) to the actual number of disintegrations per minute (dpm), 
efficiency curves were constructed in the usual fashion, employing 
both the external standards and channels ratio methods. 
Lyophilisation was carried out on a Virtis Freeze-mobile 24 
freeze-dryer, and for radioactive samples a special freeze-dryer was 
constructed. This consisted of a vacuum pump and two large dry 
ice-acetone traps connected in series with wide-bore rubber tubing, 
all dedicated to the use of radioactive samples and located in a 
well-ventilated fume cupboard. 
Mass spectroscopic determinations were made using a Kratos MS-50 
instrument operated by Dr. D. Russell (Texas). All determinations 
reported here were-niade-in- the -fa-sta-tom bomba-rdment (FAB-)- mode-,-and---------
any special techniques are reported where appropriate. 
Routine 1 H and 3C NMR spectra were obtainedusing a variety of 
instruments: Varian EM-360, Varian FT-80, 	HA-lOO, Varian XL-lOO 
(all in Edinburgh) and Varian 1-60, Varian EM-390 (Texas). The 
spectra are reported in the following-manner: Chemical shift 
relative to tetramethylsilane (TMS), (multiplicity, coupling constants 
in Hz, integrated intensity, assignment). Abbreviations used are 
those commonly employed: s - singlet; d - doublet; t - triplet; 
q - quartet; m - multiplet; br - broad; c - complex. For 
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spectra recorded 'in deuterium oxide, sodium 3-(trimethylsilyl)-
3,3,2,2-tetradeuteropropionate (TSP) was chosen as an internal 
reference. For 3C spectra recorded in D 20, p-dioxane (6 C = 66.5 
ppm) was used. 
High-field FT NMR studies were carried out using a Bruker WM-300 
wide-bore (Edinburgh) or a Bruker WM-300 wide-bore and a Bruker 
AM-500' (Texas.). All these instruments were equipped with a Bruker 
Aspect 2000 computer. The WM-300 instrument operated at 7.0497 1 
and the AM-500 at 11.7470 T. Both instruments used deuterium for 
locking the field, and in the case of precious biological samples 
where the presence of an internal reference compound was not advisable, 
and an external reference capillary impaired already poor homogeneity,. 
the procedure of indirect referencing was employed. In this method, 
the NMR spectrum of a sample containing internal reference compound,.. 
is obtained at the identical temperature, pH and ionic strength to 
the biological sample, using deuterium oxide for the lock signal. 
The biological sample is subsequently examined using the referencing 
parameters of the reference sample. 
Temperatures -in the-h-igh-field- instruments were mai-n.tai-ned- wi-th 
a Bruker VT-bOO variable temperature control unit, using cooled 
gaseous nitrogen. This nitrogen was cooled either by boil-off from 
a 220 L stainless steel liquid nitrogen dewar which was transferred 
to the probe by way of dewared low-temperature transfer lines, or by 
passing dry nitrogen (obtained by boil-off from a remote liquid 
nitrogen dewar) through a coiled copper tube immersed in an insulated 
bath containing isopropanol and stirred using an air-driven aluminium 
motor and paddle assembly. The isopropanol bath was cooled using a 
Neslab Cryocool CC-8011 immersion cooling element. The temperature 
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of the bath was monitored using a digital thermocouple, and in general 
at -50°C the probe could be maintained at Ca. 2°C, measured using the 
Bruker Cu-Cu/Ni digital thermocouple which was built into the VT-bOO. 
The sample temperature was then monitored in situ in the magnet or 
just outside. using a Luxtron fluorop.tic thermometer, which employes 
a fibre-optic temperature probe. Fine adjustments of the temperature 
were made using the heating element mounted in the probe with a 
feedback loop to the VT-bOO control unit. 
For biological samples, the superconducting magnet was shimmed 
for each sample, and the probe tuned to 50 S1 for each sample, using 
a sweep-generator(Wavetek Model 1002), a signal generator (Wavetek 
Model 3002), an RF bridge (Texscan RCB-3), and a Tektronix 7854 
oscilloscope. For 3H NMR, a Bruker pulse generator, pre-amplifier, 
and 3H and 1 H filters were used. It was also necessary to use an 
extra filter in the 
3H channel toensure minimal breakthrough of 
the 1 H-decoupber channel into the 3H channel. A Bruker 1 H probe 
was suitably adapted for 	work by Dr. P. E. Eagerness, and the 
probe tuned to 50 c for both 3Hand 1 H on the decoupber channel (at 
-least -twice), -for-each -sample. -The -probe -also--had- its thermocouple-
port blocked below the RE coils, to ensure safety in the event of 
radioactive sample leakage. In the absence of any feedback 
mechanism, temperature control was nonitored in a non-radioactive 





7.1 Hydrolysis of PBG Lactam 
PBG lactam (70, ex Dr. M. Kajiwara) was recrystallised from 
dilute ammonia, by careful addition of glacial acetic acid. This 
lactam (41 mg) was dissolved in 2 M KOH (0.6 cm3 ) and left sealed 
under N2 in the dark for 70-75 •hours. 
To this, sufficientglacial HOAc was added to adjust the pH to 
4.5, and the mixture cooled to -10°C for 1½ hours. The PBG mono-
hydrate which separated was collected, washed with ice-cold water, 
and cold acetone (39 mg, 82% yield). 
7.2 Synthesis of [5- 13C] -ALA 
The procedure outlined below represents a typical synthesis, 
according to the route in Scheme 18. 
Preparation of diethyl foniiylsuccinate.(82) 
This preparation was found to be somewhat sensitive to scale, 
too large a scale sacrificing yields considerably. 
Sodium hydride (6.3 g, 0.13 mol of 50% dispersion in oil washed 
with dry pentane) was suspended in 1 ,2-dimethoxyethane (40 cm 3 , 
freshly distilled ex CaH2 ) under nitrogen and at -10°C to -5°C with 
stirring. To this, diethyl succinate (14.4 cm 3 , 0.08 mol freshly 
distilled ex CaH2 ) was added slowly over about 10 minutes, maintain-
ing the temperature below 0°C. When the addition was complete, the 
mixture was allowed to warm gradually to room temperature (ca. 20 
minutes) in order to allow formation of the diethyl succinate anion. 
1 76. 
The mixture was then cooled to Ca. -20°C while ethyl formate 
(10.5 cm3 , 0.16 mol freshly distilled ex CaH2 ) was added dropwse 
over one hour, maintaining the temperature below -10°C. When the 
addition was complete, the mixture was allowed to warm gradually to 
room temperature and left stirring overnight. 
Water (ca. 100 cm3 ) was added to the yellow-orange mixture, and 
extracted with ether (3 times). The aqueous layer was then acidified 
to pH 3 with 2 M HCl, and re-extracted with ether (3 times). The 
latter ether extracts were combined, dried (MgSO 4 ) and the solvent 
removed in vacuo to give crude product as a yellow oil (on average 
14.2 g, 88% yield). 
Preparation of ethyl 4-oxobutyrate (83) 
Half of the crude product from the previous step (e.g. , 7.1 g, 
0.04 mol) was placed in a Carius tube with sodium acetate (0.078 g, 
0.95 mmol) and wa.ter (15 cm 3 ). Care was taken to cool the tube to 
-78°C before sealing. It was then heated for 2 hours at 150°C, and 
again cooled thoroughly to -78°C before carefully opening. The 
mixture was decanted out and solid NaCl and water (ca. 10 cm3 ) were 
added. The aqueous medium was then extracted with ether (3 times), 
and the extracts combined, dried (MgSO 4 ) and the solvent removed 
in vacuo. 
This whole procedure was performed in duplicate with the other 
half of the diethyl formylsuccinate, to yield crude product (ca. 
12.94 g). This.was fractionally distilled in vacuo through a 
vigreux column, collecting the fraction distilling at 75°C and 
0.1 mm Hg, which was found to be pure product (5.4 g, 59%) by 'H 
NMR: 	6 
H 
 (CDC1 3 + This) =9.95 (s, 1 H), 4.22 (q, 2 H), 2.75 (m, 4 H), 
1.37 (t, 3 H). 
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Preparation of ethyl 4-acetoxy-4-[ 1 3C-cyano] -butyrate (84) 
• Ethyl 4-oxobutyrate (83, 4.5 g, 0.035 mol) was added dropwise 
to a solution of sodium metabisulphite (3.29 g, 0.017 mol) in water 
(23 cm3 ) at 0°C with stirring, and the mixture left stirring at 4°C 
overnight. It was then cooled again to 0°C and Na 13CN (1.77 g, 
0.035 mol) in water (10 cm3 ) was added dropwise, and the mixture 
stirred at 0°C for a further hour. The solution was then saturated 
with NaCl, and extracted with toluene (3 times). The organic layers 
were combined, dried (MgSO4 ) and the solvent removed in vacuo, to 
afford crude cyanohydrin (4.2 g). 
This was dissolved in pyridine (45 cm 3 , freshly distilled ex 
CaH2 ) and stirred at room temperature while acetic anhydride (4.13 
cm3 , 0.044 mol) was added. Stirring was maintained for 20 hours 
before 6drops of water were added, and the solvent removed in vacuo. 
The residue was partitioned between 3 M HC1 and ether, and the organic 
layer washed consecutively with water, saturated NaHCO 3 , brine and, 
then dried (MgSO 4 ). The solvent was removed in vacuo to give crude 
product (ca. 4.7 g, 67% yield). 	13C NMR: 	6 = 117.1 (s). 
Preparation of 5-hydroxy-[6 -13C] - 2 - piperidone (86) 
Crude ethyl 4-acetoxy-4 - [ 3 C- cyano] - butyrate (84, 4.7 g, 0.024 
mol) and 5% palladium on carbon (4.7 g) in ethanol (140 cm 3 ) and conc. 
HC1 (9.4 cm 3 ) was hydrogenated at 20°C and 1 atm. until no further 
uptake of hydrogen (ca. 730 cm 3 ). The solution was filtered through 
celite, the solvent removed in vacuo, and the residue dissolved in 
anhydrous ethanol. This was treated with HC1 gas until 18 g had 
been absorbed, and then left at room temperature for 60 hours, after 
which the solvent was removed in vacuo, and then treated with fresh 
ethanol and re-evaporated, twice. The semi-crystalline residue (85) 
was dried at. room temperature overnight (P 205 ,. vacuum desiccator). 
The residue was dissolved in anhydrous ethanol, and to this 
stirred solution, sodium hydride (1.13 g, 0.045 mol, 50% dispersion 
in oil) was added in one portion. The mixture was stirred at 20°C 
for 20 minutes and after neutralisation with glacial acetic acid, 
was filtered, washing the solid with ethanol. Evaporation of the 
combined ethanol wastes and chromatography of the residue in a 
polarity gradient of 1:9 MeOH/CHC1 3 - pure methanol ° on alumina 
(150 g) afforded pure product (0.9 g) after removal of the solvent 
in vacuo. 1 H NMR: 6H  (D2 0) = 4.22 (m, 1 H), 3.51 and 3.25 (each 
ddd, 1 H), 2.72-2.24 (m,.2 H) and 2.18-1.15 (m, 2 H); SC ( 02 0 ) = 
48.4 (C-6); IR: 
umax 
 (Nujol) = 3210, 3120 (s) and 1635 cm* R f 
(Solvent III) = 0.45 (alumina). 
Preparation of [5- 13C]-5-aminolaevulinic acid hydrochloride (45) 
This reaction was found to be rather sensitive to scale, and 
accordingly has usually been performed on a small scale. Thus the 
foregoing 5 - hydroxy - [6 -13C] - 2 - piperidone (86) wasdivided into two 
portions. 
5-hydroxy - [6-3C] - 2 - piperidone (0.45 g, 0.004 mol) was dissolved 
in dimethyl sulphoxide (6 cm 3 , freshly distilled ex CaH 2 ) and tn-
fluoroacetic acid (0.16 cm 3 ) added. This was left for about 5 
minutes under N 2 before dicyclohexylcarbodiimide (2.43 g, 0.012 mol) 
was added in one portion. Dicyclohexylurea immediately precipitated 
out and the mixture went a light red/orange colour. This was stirred 
under N 2 at room temperature for 18 hours before a few drops of water 
and then ethyl acetate (ca. 50 cm 3 ) were added. The ethyl acetate 
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layer was separated, dried (MgSO 4 ) and the solvent removed in vacuo. 
At this stage the second portion of starting material similarly 
processed afforded product which was combined with the first. 
The combined residue (87, containing DMSQ) was treated with 
water (47 cm 3 ) and conc. HC1 (84 cm 3 ) and refluxed for 4 hours. 
The solvent was then removed in vacuo, further water added and the 
mixture heated with a minimum of activated charcoal. Evaporation 
in vacuo again yielded a residue from which the DMSO was finally 
removed using a high-vacuum rotary evaporator. The resultant oil 
was redissolved in a small amount of water and applied to a column 
of Amberlite IR-120 (H) ion-exchange resin (bed volume Ca. 150 cm3 ), 
and eluted with 0.01 M HC1. After elution with Ca. 300 cm 3 0.01 M 
HC1, the product was eluted with 1 M HC1 (ca. 600 cm 3 ). The solvent 
was removed by lyophilisation and the residue crystallised from 
ethanol-ether. Cool ing to -20°C was necessary to ensure crystall i-
sation. The product was obtained as cream-coloured crystals 
(0.819 g, 63% yield). 1 H NMR: 6 (020) = 4.20 (d, J = 143 Hz, 2 H, 
COCH2 N), 2.98 (2 H, t, CH 2 CH2 ), 2.79 (2 H, t, CH 2 CH2 ). 13C NMR: 
(020) = 48.3 (s, C-5). R f (Solvent I) = 0.3 (silica, sprayed 
with ninhydrin; 2% w/v in acetone + 1 cm 3 HOAc). 
7.3 Synthesis of [4 -13C] -ALA 
The procedure described follows the route shown in Scheme 19. 
Preparation of N-hydroxymethylphthalimide (88) 
Phthalimide (10 g) was heated in a Carius tube at 100°C for 2 
hours with formaldehyde (6.3 cm 3 , 40% w/v) and water (18.7 cm3). 
to 
The tube was carefully shaken every half an hour to ensure that all 
the phthalimide dissolved. 
On cooling (to -78°C) the sample was removed and white crystalline 
product appeared. The solvent was removed, by evaporation in vacuo, 
and the product recrystallised from 1:1 toluene/EtOH, giving white 
crystals.of pure product (9.6 .g, 80% yield, mp 147-9°C [lit. 178 
146-8°C]). 
Preparation of N-chloromethylphthal.imide 
MOKbi 
N-hydrox)hthalimide (88, 9.6 g, 0.054 mol) was suspended in 
thionyl chloride (ca. 50 cm3 , freshly distilled) and stirred for 
2 hours at room temperature. The.mixture was then refluxed for 30 
minutes, after which the excess thionyl chloride was removed by 
evaporation in vacuo. Complete removal was achieved by azeotroping 
with dry toluene (twice). The crystalline residue was recrystallised 
from toluene to afford off-white crystals (9.5 g, 90% yield, mp 
134-6°C [lit. 178 132-4 0 C]). 
Preparation of [1 -13C] - phthalylacetonitrile (89) 
N-chloromethylphthalimide (3.9 g, 0.02 mol) was dissolved in 
hot p-dioxane (15 cm3 ) and this poured into a solution of K 13CN 
(1.32 g, 0.02 mol) in anhydrous MeOH (ca. 30 cm3 ). The mixture was 
allowed to stir overnight at room temperature, filtered to remove 
KC1 (washing the solid with additional warm dioxane), and the 
solvent removed by evaporation in vacuo, giving crude product (5.6 g 
crude). 	 , 
Preparation of [1- 3C]- phthaly1g1ycine 
[1 -13C] -phthalylacetonitrile (5.6 g crude) was refluxed with 
3:1 acetic acid/conc. HC1 (60 cm 3 ) for one hour, and then evaporated 
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in vacuo.. The residue was dissolved in water, and evaporated in 
vacuo two times. The crystall me, product was suspended in ice-water 
(ca.. 20 cm3 ) and collected, washed with more ice-water, and dried, 
yielding crude product (Ca. 4 g). 
Preparation of [1-13C]-phthalyl'glycyl  chloride (90) 
Crude. [l-'3C]-phthalylglycine (ca. 4 g) was suspended in thionyl 
chloride (ca. 25 cm3 ) and heated at 40-50°C for 2 hours, and then 
refluxed.to dissolve all the solid (ca. 20 minutes). The excess 
SOd 2 was removed by evaporation in vacuo, complete removal being 
achieved by azeotroping with toluene (twice), yielding slightly 
yellow crystalline product (3.3 g, 73% from K 13CN, mp 83-4°C [lit.' 78 
84-85 ° C]). 
Preparation of 1 -diazo-3-phthal imido - [2 -1 3C] - propanone (!.L) 
[1 -13C] - phthalylglycyl chloride (3.3 g, 0.015 mol) in anhydrous 
ether (ca. 100 cm3 ) was added dropwise to 0.5 M alcohol-free diazo-
methane in anhydrous ether (98 cm 3 , 0.05 mol) maintaining the 
temperature at -10°C throughout the addition. Almost immediately a 
flocculent precipitate separated, and the mixture was stored at -20°C 
overnight. Evaporation of the solventin vczcuo yielded crude product 
as a yellow solid. 
Preparation of 1-bromo - 3- phthalimido - [ 2-13C] - propanone (92) 
Crude 1-diazo-3-phthalimido - [2 -13C] - propanone was suspended in 
glacial acetic acid (ca. 60 cm3 ) and 48% HBr (5.0 cm 3 ) added slowly. 
The solid dissolved with the evolution of N 2 . Stirring was continued 
for 3 hours after which the solvent was removed in vacuo, the 
remaining HBr being eliminated by successive additions and evapora-
tions of water. The residue was suspended in toluene, filtered, and 
HO 
evaporated to give crystalline product (2.7 g, 64% from 
phthalylglycyl chloride). 
Preparation of [4-C]-5-aminolae.vulinic acid hydrochloride (76) 
Sodium (0.69 g, 0.03 mol) was suspended in anhydrous ether 
under N 2 and di-tert-butylmalonate (7.0 cm 3 , 0.03 mol) was added 
dropwise with stirring. This was left overnight, after which a 
white precipitate of a sodium derivative of di-tert-butylmalonate 
formed. This was collected and rapidly suspended in DMF (ca. 50 cm3 , 
freshly distilled ex CaH2 ), and added to a stirring solution of 
1-bromo-3-phthalimido-[2- 13C] - propanone (92, 2.7 g, 0.015 mol) in 
DMF. The mixture was stirred for 24 hours at room temperature, 
after which the solvent was removed with a high-vacuum rotary 
evaporator. The reddish semi-crystalline residue (93) was dissolved 
in dioxane (ca. 50 cm3 ), saturated with HC1 gas at 0°C, and kept at 
room temperature overnight. After removal of the solvent in vacuo, 
the residue was dissolved in 6 M KC1 (ca. 60 cm 3 ) and refluxed for 
Ca. 5 hours. 
The solvent was removed by lyophilisation, and the residue re-
dissolved in water and applied to a column (bed volume Ca. 150 cm3 ) 
of Amberlite IR-120 (H f ), eluting with 0.05 M HCl (600 cm 3 ). The 
product was eluted with 1 M HC1 (ca. 600 cm 3 ), and the solvent 
removed by lyophilisation. The residue from this was crystallised 
from ethanol-ether, cooling to -20°C overnight. The product was 
obtained as cream-coloured crystals (1.411 g, 57% yield). 13C NMR: 
(D2 0) = 203.9, (s, C-4). Rf (Solvent I) = 0.3 (silica, sprayed 
with ninhydrin, 2% w/v in acetone + 1 cm 3 HOAc). 
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7.4 Synthesis of [ 2H]-ALA 
Preparation of 90% 0 at C-.5 
ALA hydrochloride (ex Sigma, 1.0 g, 0.006 mol.) was dissolved in 
D 
2 
 0 (50 cm3 , 97.98%, ec Cambridge Isotopes, MA, U.S.A.) and the pH 
adjusted with anhydrous Na 2CO3 to 8.1 (uncorrected) initially. The 
solution was left at room temperature sealed in the dark, and approxi-
mately every half an hour the pH readjusted to 8.0, for a total of 
165 minutes. By this time the mixture had become yellow, and the pH 
was adjusted to 1.5 with 20% DC1 in 020  (100%, ex Aldrich), and the 
mixture lyophilised. The residue was suspended in absolute ethanol, 
filtered to remove NaCl, and the solvent removed by evaporation in 
vacuo. The product was then crystallised from ethanol-ether to yield 
a light brown solid (0.495 g, 49% yield). 1 H NMR: 	5H 
 (D2 0) = 4.20 
(s, residual 1 H at C-5), 2.98 (2 H, br, CH 2 CH2 ), 2.79 (2 H, t, 
CH2 CH2 ). 2 H NMR: 	6 D 
 (H20) = 4.2 (s i 2 H, C-5), 2.98 (<2 H, br, 
CCH2 ). 	Rf (Solvent I) = 0.3 (silica). m/e: MH 170.5 (Dcl salt). 
Preparation of 10% 0 at C-5 (Pilot study for [3H]-ALA  synthesis) 
ALA hydroch1ide (15 mg) was dissolved in 020  (99%, 31 iL) and 
triethylamine (24.48 iL, distilled ex KOH) was added. The mixture 
was shaken and allowed to stand in the dark.for exactly 10 minutes 
before adding 0.1 M HC1(ca. 5 cm 3 ) and lyophilising. 
This was dissolved in 020  (99%, 0.5 cm 3 ) for analysis by 1 H NMR: 
H (020) = 4.20 (s, 85% of resonance at 2.79 ppm), 2.98 (2 H, sl. br, 
t, CH2 cH2 ), 2.79 (2 H,.t, CH2 cH2 ). Rf (Solvent I) = 0.3 (silica). 
Preparation of [5 -1. 3C, 2 H] -ALA 
[5 -13c] -ALA hydrochloride (15 mg, see Section 7.2) was dissolved 
in 020  0 .03 cm 3 ) and triethylamine (24.48.pL, distilled ex KOH) was 
added. The mixture was shaken and allowed to stand in the dark for 
exactly 165 minutes before adjusting to pH 1.5 with 40% DC1 in 100% 
020 (Aldrich). Lyophilisation yielded crude product which was used 
directly for PBG synthesis. 
7.5 Synthesis of [ 3H] - ALA 
Preparation of [ 13C, 3H]-ALA (custom preparation by New England Nuclear) 
[5 -13C] -ALA hydrochloride (15 mg, see Section 7.2) was dissolved 
in 100% T 
2 
 0 (100 Ci, 24.48 iL) at room temperature in subdued light. 
Triethylamine (24.48 iL, freshly distilled ex KOH) was added, and the 
mixture stirred gently for exactly 10 minutes before adding excess 
0.1 M HC1 (5 cm 3 ), and immediately lyophilising (in subdued light). 
All labile tritium was then removed by cycles of addition of 
0.1 M HC1 and lyophilisation. The crude product (286 mCi, Ca. 3.2 
Ci mmol). was dissolved in 0.1 M I-lCl (10 cm 3 ) and shipped directly. 
It was used for PBG synthesis immediately upon arrival. 
Preparation of [3,4 -3H4] -ALA 
ALA hydrochloride (15 mg) was treated exactly as above except 
that stirring was continued for 360 minutes prior to the addition of 
excess 0.1 M HC1. The crude product (3,122 mCi, 34.8 Ci mmol) was 
dissolved in 0.1 M HC1 (5 cm 3 ) and shipped directly, packed in dry 
ice. 
7.6 Synthesis of [13C]-, [14C]-1 [2H]- and [ 3H] - PBG 
Preparation of [ 13C]- and [ 14C] - PBG 
This preparation was also used for making unlabelled PBG. 
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A solution of MgC1 2 (12.2 mg) and L-cysteine free base (36.3 mg) 
in buffer (19 cm 3 , 0.1 M KH2 PO4/0.l M NaHCO 3 adjustedto pH 8.0 with 
KOH) was degassed by bub )l.ing N 2 through it for 15 minutes. Partially 
purified ALA dehydratase (10 cm 3 , 205.5 U, see Chapter 8) was added 
and the solution pre-incubatedat 37°C for Ca. 5 minutes. 
[ 13 C] -ALA hydrochloride (50 mg) dissolved in the same buffer 
(1.0 cm3 ) was added, the pH adjusted to 7.9, N 2 blown over the surface 
of the solution, and the mixture incubated in a sealed vessel in the 
dark at 37°C for 90. minutes. The reaction was monitored by removing 
an aliquot at the start of the incubation, and assaying 10 iL samples 
every 10 minutes by addition to 3 cm3 of modified Ehrlich's reagent 
(see Chapter 8). At. the end of the reaction CuSO 4 solution (1.3 cm 3 , 
25 % w/v) was added, and the mixture was cooled prior to centrifuga-
tion at 35,000 g (10 minutes). The supernatant was decanted off and 
lyophilised overnight. 
The crude PBG was then dissolved in water (18 cm3 ), adjusted to 
pH 6.0 with HOAc, and applied to a column of Dowex 2 acetate ion-
exchange resin (bed volume 35 cm 3 , 7 x 2.5 cm). The Dowex 2 acetate 
was prepared by washing commercial resin (in the chloride form) in a 
sintered funnel with 1 M NaOH until no more chloride (assayed with 
1% w/v AgNO3 solution) eluted (about 3 L.for 150 cm 3 resin). It was 
then washed to neutrality with distilled water, and then with 1 Ni 
HOAc (ca. 100 cm3 ), and again with 1-200 cm3 distilled water. 
After the crude PBG solution was adsorbed onto the resin, the 
washings from the flask were also applied to the column, and then 
the column washed with water (75 cm 3 ),. eluting at 40 cm3 hr 	and 
collecting 25 cm 3 fractions. The column was then allowed to go just 
dry and then topped to 1 cm with part of 25 cm 3 of 1 M HOAc. When 
this was adsorbed, the rest of the iM HOAc was applied, collecting 
5 cm 3 fractions. After the 25 cm 3 1 M HOAc was adsorbed, elution 
was continued with 0.2 M HOAc. Fractions 8-12 contained pure PBG 
which was obtained as a fluffy white solid after lyophilisation 
(34 mg, 79%). 	H NMR (D20 buffer, pH 8.0): 	S1. (PBG) = 6.69 (s, 1 H, 
C-2), 4.16 (s, 2 H, C-li), 3.41 (s, 2 H,C-9), 2.67 (t, J = 7.8 Hz, 
2 H, C-6), 2.41 (t, .J = 7.8 Hz, 2 H, C-7). 
H ([2,11-13C]-PBG) = 6.69 (d, 1 J( 1 H- 13C) = 183.5 Hz, 1 H, C-2), 
4.16 (d, 'J ( 1 H- 13C) = 144.2 Hz, 2 H, C-li), 3.41 (s, 2 H, C-9), 
2.67 (br, m, 2 H, C-6), 2.41 (t, 2 H, C-7). 
H ([3,5-13C]-PBG) = 6.69 (t, 2 1 ( 1 H- 13C) = 6.8 Hz, 1 H, C-2), 4.16 
(d, 2 J ( 1 H- 13C) = 4.8 Hz, 2 H, C11), 3.41 (s, 2 H, C-9), 2.67 (q, 
2 ('H- 13C) = 6.8 Hz, 2 H, C-6), 2.41 (q, 	j ( 1 H- 13C) = 3.3 Hz, 2 H, 
C-7). 
NMR data are reported in Chapters 4 and 9. 
Preparation of [ 2 H] - PBG 
Partially purified dehydratase (225 U assayed at pH 7.0) 
dissolved in phosphate buffer (8.1 cm 3 , 0.1 M KPhos pH 7.0 + 5 mM 
5-mercaptoethanol) containing MgC1 2 (3.25 mg) and L-cysteine 
(9.68 mg) was pre-incubated at 37°C for 5 minutes. [2H]-ALA (10 mg) 
dissolved in the same buffer (1.0 cm 3 ) was added and the mixture 
incubated at 37°C for exactly 10 minutes, before adding CuSO 4 
solution (430 LIL, 25% w/v). After centrifugation at 35,000 g (10 
minutes) the supernatant obtained was adjusted to pH 6.0 and applied 
to a Dowex 2 acetate column (12 cm 3 bed volume, 1.2 x 16 cm). Elution 
was carried out initially with distilled water, collecting 3 x 8.6 cm3 
fractions. 1 M HOAc (8.57 cm 3 ) was then applied to the column, 
collecting 1 . 7 cm 3 fractions, before continuing with 0.2 M HOAc. 
Fractions 10-16 contained PBG whichafter lyophilisation yielded 
pure product (2mg, 23% yield). 1 H NMR exactly as unlabelled PBG 
except integrals different according to the extent of deuteration 
in the ALA (see Chapter 4). 
Preparationof [2,11- 13C, 2 H]-PBG 
Partially purifieddehydratase (1160 U assayed at pH 7.0) 
dissolved in buffer (25 cm 3 , 0.05 M KPhos., 99% D 20, pH 7.0) contain-
ing MgC1 2 (8.13 mg) and L-cysteine (24.2 mg) was pre-incubated at 
37°C for 5 minutes. [ 3C, 2 H] - ALA (crude preparation described 
above) dissolved in the same.buffer (2.0 cm3 , adjustedto pH 7.2) 
was added., and incubation continued for exactly 4 minutes at 37°C. 
The reaction was stopped with CuSO 4 solution (0.8 cm 3 , 25% w/v) and 
after centrifugation (35,000 g, 10 minutes), the supernatant was 
adjusted to pH 6.0. Further precipitation took place, so another 
centrifugation was necessary, before applying to a Dowex 2 acetate 
column as in the previous preparation. The PBG solution (in 
fractions 9-15) was lyophilised, affording pure product (3.25 mg, 
25% yield). 	1 H NMR: 	6 (020) = 6.69 (br, s, <1 H, C-2), 4.16 (br, 
s, <2 H, C-li), 3.41 (s, 2 H, C-9), 2.67 (br, m, <2 H, C-6), 2.41 
(t, 2 H, C-7). 
NMR: 	6C (020) = 116.1 (s, C-2) and 34.4 (t, C-il). 
Preparation of [ 13C, 3H] - PBG 
Partially purified dehydratase (1512 U, assayed at pH 7.0) 
dissolved in buffer (13.3 cm 3 , 0.1 fri KPhos, pH 7.0) containing 
MgC1 2 (8.13 mg) and.L-cysteine (24.2 mg) was pre-incubated at 37°C 
for 5 minutes. [13C,3H]-ALA (286 mCi, ca. 3.2 Ci mmo1) dissolved 
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in 0.1 M HC1 (10 cm3 ) was adjusted to..pH 7.0 with 3.0 M NaOH, 
measuring the pH directly using a dedicated radioactive pH electrode, 
and rapidly added to the enzyme. The mixture was incubated at 37°C 
for exactly 3.5 minutes prior to the addition of CuSO4 solution 
(0.8 cm3 , 25% w/v). After centrifugation (35,000 g, 10 minutes) 
the supernatant was decanted off and adjusted to pH 6.0 Since there 
was further precipitation, another centrifugation step was necessary, 
and the supernatant applied toa Dowex 2 acetate column, eluting as 
in the previous preparation. The product eluted off in fractions 
11-16, and lyophilisation on a tritium freeze-dryer yielded pure 
PBG acetate (3.63 mg, 28% yield, 43.76 mCi, 3.5 Ci ninol). 3H NMR: 
6T (D
2 0) = 6.69 (d, 1 J ( 3H-13C.) = 195.3 Hz, 1 H, C-2), 4.16 (d, 
1 J (H- 13C) = 152.1 Hz, 2 H, C-il), 3.41 (br, m, 2 H, C-9). 	1 H NMR: 
H (D
2 0) = 6.69 (d, 1 J ( 1 H-13 C) = 183.5 Hz, 1 H, C-2), 4.16 (d, 
l 	
( 1 H- 13C) = 144.2 Hz, 2 H, C-il), 3.41 (s, 2 H, C-9), 2.67 (br, m, 
2 H, C-6), 2.41 (t, 2 H, C-7). 
NMR: 	6 (D20) = 116.1 (s, C-2) and 34.4 (s, C-li). 
Preparation of [ 3H] - PBG 
Partially purified dehydratase (1220 U, assayed at pH 7.0) 
dissolved in buffer (19.9 cm 3 , 0.1 M KPhos, pH 7.0) was pre-incubated 
for 5 minutes at 37°C. 	[ 3H] -ALA (3,122 mCi, 34.8 Ci niiiol) dissolved 
in 0.1 M HC1 (5 cm 3 ) was transferred carefully from two vials using 
a Pasteur pipette into a 10 cm 3 vial containing a small magnetic 
stirrer-bar, MgCl 2 (8.13 mg) and L-cysteine (24.2 mg). The pH was 
adjusted to pH 7.0, measuring the pH directly, and rapidly added to 
the enzyme. Incubation at 37°C was carried out for 4.0 minutes in 
a stoppered flask, whereupon CuSO 4 solution (0.8 cm 3 , 25% w/v) was 
no 
added. After centrifugation (35,000 g, 10 minutes), the supernatant 
was adjusted to pH 6.0, and applied to a Dowex 2 acetate column and 
eluted as in the.previous. preparations. The product eluted in 
fractions 8-13, and after lyophilisation on a tritium freeze-dryer, 
yielded impure [3H]-PBG. Since 3H NMR revealed impurities, the 
sample was applied to another Dowex•2 acetate column (bed volume 
5 cm3 , 6 x 1.2 cm), washed with distilled water (3 x 5 cm 3 ) and 
then 1 M HOAc (3.57 cm 3 ), collecting 0.7 cm 3 fractions. Elution 
was continued at 40 cm3 hr 	with 0.2 M HOAc and pure PBG eluted 
in fractions 12-17. Lyophilisation afforded pure product (250 .'g, 
1.9% yield from unlabelled ALA, 144 mCi, 165.9 Ci niiiol). 3H NMR: 
T (D
20) = 6.69 (s, 1 H, C-2), 4.16 (s, 1-2 H, C-li), 2.59 (s, 2 H, 
C-6 -CHT) and 2.56 (s, 2 H, C-6 -CT 2 ). 1 H NMR: 	H 
 (D20) = 6.69 
(br, s, <1 H, C-2), 4.16. (br, s, <2 H, C-il), 3.41 (s, 2 H, C-9), 
2.67 (br, m, <2 H, C-6), 2.41 (t, 2 H, C-7). 
7.7 Preparation of Porphyrins for HPLC Analysis 
The end products from enzymic experiments with deaminase and 
cosynthetase were generally diluted with buffer (ca. 30 cm 3 , 0.01 M 
KPhos, pH 7.5) and oxidised with iodine solution (250 iL, 0.2 N 12 
in 0.2 N KI). The mixture was then lyophilised, and stirred in 5% 
conc. H2 SO4/anhydrous MeOH (75 cm 3 ) for 48 hours. Water (ca. 50 cm3 ) 
was then added and the pH brought to neutrality (solid NaHCO 3 ). 
Extraction with CHC1 3 (2 times), and evaporation of the solvent in 
vacuo yielded crude uroporphyrin I/Ill. This was analysed by TLC 
(Solvent II) on silica, and generally it was necessary to chromatograph 
the crude product on a preparative silica plate (2 mm), eluting with 
Solvent II. Extraction of the silica with CHC1 3 and evaporation of 
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8.1 Growth of Rhodopseudomonas spheroides (by S. Miller, K. Mackenzie 
and C. McCullar) 
Rhodopseudornonas spheroides as lyophilised cultures (ATCC 17023) 
were revived in the medium (10 cm3 ) outlined in Table 8.1, which is 
essentially Lascelles' Medium S. 223 The medium was previously auto-
claved in a steriliser at 121°C for. 25 minutes at 15 p.s.i. The 
revived cells were grown anaerobically at ca. 30°C under illumination 
from electric lights, passedthrough glass jars filled with water for 
cooling, for 3-4 days or until a healthy-looking culture was obtained. 
They were then aseptically transferred to agar slants (20 cm3 , 
15.0 gL 	agar) and grown in anaerobic jars in the light for 4-5 days. 
The cultures were used to inoculate 1 L conical flasks containing the 
above medium (4 slants per flask, flasks completely. filled), and the 
flasks plugged with cotton wool , aluminium foil and sealed with 
Parafilm. They were grown. semi-anaerobically in the light for 3 
days, before being aseptically transferred to a 6 L flask containing 
the same medium (one 1 L flask per 6 L flask, flasks completely 
filled). These were grown semi-anaerobically in the light turning 
the flasks one-quarter turn every day, until cells looked green-
brown (usually 5 days). It should be noted that the growth times 
were assessed according to the appearance of the bacteria. 
Cells were then harvested using a continuous centrifuge (usually 
10 gL 	wet cells), and the cells stored at -20°C until use. 
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All subsequent manipulations with the cells and enzymes isolated 
from them were performed at.4°C in a cold room, except where stated 
otherwi Se. 









(NH 4 ) 2HPO4 




















aAdded separately after adjusting to Ca. pH 7 with NaOH 
(ca. 1.6 g). Final medium adjusted to pH 6.8-7.0 with 
NaOH. 
bDi sso l ved in water prior to addition. 
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8.2 Isolation and Purification of ALA Dehydratase 
Assazi 
Dehydratase activity was assayed in the following manner. 
Buffer (1.0 cm 3 , 0.1 M KPhos/0.l Ni NaHCO 3 adjusted to pH 8.0 with 
KOH), MgC1 2 (0.5 cm 3 ,, 0.01 M), L-cysteine (0.25 cm 3 , 0.1 M freshly 
adjusted to pH 7.0 with KOH), water (0.725 cm 3 - x, where x = volume 
of enzyme solution) and the enzyme (10-50 iL) were preincubated for 
5 minutes at 37°C. ALAHCl (0.025 cm 3 , 0.2 M [33.6 mg cm 3 ] in 
water) was added, and the incubation continued at 37°C with gentle 
shaking for 10 minutes. CuSO 4 solution (0.1 cm3 , 25% w/v) is then 
added and the tubes allowed to cool. After centrifugation (ca. 
2000 g, 5 minutes), 1.5 cm 3 was carefully removed and reacted with 
1.5 cm 3 of modified Ehrlich's reagent181 (0.5 g p-dimethylamino-
benzaldehyde in glacial HOAc + 4 cm 3 70% HC104 and made up to 25 cm 3 
with. glacial HOAc). After exactly 15 minutes, A553 read, and activity 
calculated using 
A553 X 5200 
Activity/mol PBG produced hr 	cm3 	Vol NO X t (mins) 
This equation uses e = 57,700 mol L 1 cm 	for [PBG]. 18° 
Isolation and Purification 
In a typical preparation, R. spheroides (80-100 g wet cells) 
were suspended in buffer (300cm3 , 0.05 M KPhos pH 7.6) and sonicated 
in 100 cm 3 batches for a total time of 9 minutes in 3 minute bursts 
with 3 minutes between each burst for cooling. The cell suspension 
was sonicated in a cooling bath, cooled with circulating ethylene 
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glycol/water at -10°C. In this way the temperature of the cell 
suspension could be maintained below +10°C throughout the process.. 
The homogenate was then centrifuged (35,000 g, 12 minutes) to 
remove cell, debris, and the supernatant carefully decanted. This 
was then. centrifuged at >60,000 g (120 minutes), and the supernatant 
carefully decanted, taking precautions to avoid the dark-coloured 
syrupy pigmented protein near the bottom.of each centrifuge tube. 
The supernatant (ca. 150 cm3 ) was made 10 mM in -mercaptoethanol, 
and brought to 20% saturation with ammonium. sulphate (15.9 g) with 
stirring. This was allowed to stir for 30 minutes before centrifuga-
tion at 20,000 g (15 minutes). The pellet was discarded and the 
supernatant brought to 35% saturation with ammonium sulphate (13.2 g). 
After stirring for 30 minutes, the mixture was centrifuged at 20,000 g 
(15. minutes), and the pellet containing dehydratase retained. On 
occasions the supernatant was treated further with ammonium sulphate 
(19.8 g) to bring it to 55% saturation. After 30 minutes, centrifu-
gation (20,000 g, 15.minutes) yielded a pellet of crude deaminase-
cosynthetase which could be used in deaminase preparations (see 
Section 8.3). 
The pellet of dehydratase was dissolved in buffer (ca. 20 cm3 , 
0.01 M Tris Cl -  pH 8.0) and applied to a freshly equilibrated G-100 
Sephadex column (bed volume 1000 cm 3 , 31 X 6.5 cm). The G-lOO 
Sephadex was prepared by swelling out Ca. 58 g of dry beads (40-120 
ltm particle size) in buffer (2 L, 0.01 M Tris Cl -  pH 8.0) heated on 
a boiling water bath for 5 hours, stirring occasionally. The column 
was then packed carefully, and washed with buffer (2 L, 0.01 M Iris 
Cl pH 8.0 + 0.01 M KC1 + 5 mM -mercaptoethanol) with no greater 
than 20 cm head of pressure. 
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The G-100 Sephadex column was eluted with 0.01 M Tris Cl pH 
8.0, 0.01 M KC1, 5 mM -mercaptoethanol at 30 cm 3 hr, collecting 
10 cm3 fractions. Fractions 10-26 were found to contain the active 
enzyme (Ca. 770 U) which was pooled and concentrated on a PM-lU 
Ultrafilter in an Amicon concentrator to a volume of Ca. 30 cm 3 . 
The concentrate was applied to a freshly equilibrated DEAE-
cellulose column (bed volume Ca. 500 cm 3 , 14 X 6.5 cm). The DEAE-
cellulose was prepared by pouring the commercial powder (Ca. 50 g, 
0.88 meq g, medium mesh, ex Sigma) onto 1 M NaOH (1 L) in a 2 L 
beaker, and allowing to settle. The excess liquid was decanted off, 
and the remainder was washed with additional 1 M NaOH (1 L) in a 
sintered glass funnel, followed with distilled water to neutrality 
(Ca. 3 L). The resin was then washed with 1 M HC1 (1 L) and again 
with distilled water to neutrality (ca. 2 Q. Finally it was washed 
with buffer (400cm 3 , 0.1 M Tris Cl pH 8.0), resuspended in fresh 
buffer, and left to stand overnight. The column was then packed 
under ca. 2 p.s.i. of nitrogen pressure, and then equilibrated over 
two nights with (i) 0.01 M Tris Cl -  pH 8.0 buffer (1 L); and (ii) 
0.01 M Tris Cl pH 8.0 buffer + 5 mM -mercaptoethanol (2 L). 
The DEAE-cellulose column was eluted with a linear salt 
gradient of 0.05 M KC1 (500 cm 3 , in 0.01 M Tris Cl pH 8.0 + 5 mt1 
-mer.captoethanol) to 0.5 M KC1 (500 cm 3 , in 0.01 M Tris Cl - pH 8.0 + 
5 mM -mercaptoethanol) at 30 cm 3 hr, collecting 15 cm 3 fractions. 
Fractions 38-55 contained the bulk of the enzyme (410 U) which was 
pooled and concentrated on a PM-10 Ultrafilter to ca. 20 cm 3 for 
use in PBG syntheses. 
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8.3 Isolation and Purification of PBG Deaminase 
Assaij 
Deaminase activity was routinely assayed by consumption of 
P8G. 76 A stock solution of PBG (2 mg cm 3 dissolved in 0.1 M Tris 
Cl pH 8.0), which could be stored in a freezer for several months, 
was diluted (75 pL stock PBG + 925 pL 0.1 M Tris Cl pH 8.0) and 
0.1 cm3 of this added to 10 iiL deaminase which had been allowed to 
preincubate for 5 minutes at 37°C. Two non-enzymic blanks were 
also included, and incubation continued at 37°C for 10 minutes. 
The reaction was then stopped by addition of diluted Ehrlich's 
reagent (1:0.9 modified Ehrlich's reagent [see Section 8.2]:water). 
After exactly 15 minutes, A 553 read, and the activity calculated 
using the difference between the PBG blank and the enzyme: 
Activity/imol PBG consumed hr 	cm 3 = 
29.7 X (A553 (blank) - A 553 (enzyme) 
for 10 pL deaminase and 10 minute incubation. This equation uses 
= 60,606 mol L 	cm 	for [PBG], i.e. when A 553 = 1.0, [PBG] = 
49.5 nmol. 
The deaminase activity can also be assayed by production of uro-
porphyrin 1. 
76  The assay consitions are exactly the same except 
that the reaction was stopped by the addition of iodine (2 iiL, 0.2 N 
12 in 0.2 N KI) in buffer (0.1 cm 3 , KPhos pH 7.5), and making up to 
3 cm3 with buffer (0.1 M Tris Cl pH 8.0). After leaving for 30 
minutes, a few crystals of NaHSO 3 were added, and the A 395 read 
(e = 224,000 mol L 1 cm). Alternatively, the reaction was stopped 
3 by the addition of HC1 (2.5 cm, 5% w/v), leaving for 30 minutes, 
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and the A405 read (E:= 496,000 mol L 1 cm'). 1 U of activity is 
defined as forming 1 nmol uroporphyrin hr . 
Protein concentration was routinely assayed by the method of 
Warburg and Christian,224 ' 225 using the relationship 
[protein]/mg cm 3 = 1.55 A280 - 0.76 A260 . 
Isolation and Purification 
For this section the purification of a large batch of deaminase 
suitable for enzyme-substrate NMR investigations is described. 
R. spheroides (350-400 g) was suspended in buffer (700-800 cm 3 , 
0.05 M KPhos pH 7.6) and sonicated in 100 cm3 batches for a total 
time of 9 minutes in 3 minute bursts with 3 minutes between each 
burst for cooling. The temperature was maintained using a cooling 
bath with circulating ethylene glycol-water at -20°C. In this way 
the temperature of the cell suspension was kept below +10°C. 
The homogenate was then centrifuged at 35,000 g (12 minutes) 
and the supernatant carefully decanted. This was then heated to 
60°C for 15 minutes in 150 cm3 batches, before cooling in ice and 
centrifuging at 100-150,000 g (60 minutes). The supernatant (ca. 
810 cm3 ) from this was made 10 mM in -mercaptoethano1 (567 pL) and 
brought to 40% saturation with ammonium sulphate (183.06 g) with 
stirring. After 30 minutes, the mixture was centrifuged (20,000 g, 
15 minutes) and the pellet containing crude dehydratase retained 
for large-scale preparations. The supernatant was then brought to 
55% saturation in ammonium sulphate (72.09 g) and stirred for 30 
minutes. After centrifugation (20,000 g, 15 minutes) the pellet of 
deaminase was dissolved in 0.01 M Tris Cl -  pH 8.0 buffer (ca. 20 cm3) 
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and dialysed against two changes of buffer (2 L, 0.01 M Iris Cl -  pH 
8.0 + 5 mM -mercaptoethano1). 
The dialysate (ca. 50 cm3 ) was then applied to a freshly equili-
brated DEAE-Sephacel column (500 cm 3 bed volume, 14 X 6.5 cm). The 
DEAE-Sephacel was prepared in an exactly analogous manner to the 
DEAE-cellulose as described in Section 8.3. Elution was carried out 
with a linear salt gradient of 0.05 M KC1 (750 cm 3 , in 0.01 M Tris 
Cl -  pH 8.0 + 5 mM -mercaptoethanol) to 0.6 M KC1 (750 cm 3 , in 
0.01 M Tris Cl -  pH 8.0 + 5 mM -mercaptoethano1) at 30 cm hr, and 
collecting 15 cm 3 fractions. Typically fractions 61-73 contained 
active enzyme (ca. 1800 U), which was pooled and concentrated on a 
PM-10 Ultrafilter to ca. 30 cm 3 . 
At this stage the whole process was repeated with another batch 
of cells, and the pooled enzyme from DEAE-Sephacel chromatography 
was combined with the first batch, and further concentrated (PM-la) 
to ca. 30 cm3 . This pooled enzyme was applied to a freshly equili-
brated G-100 Sephadex column, and eluted with 0.01 M Tris CY pH 
8.0 + 5 mM -mercaptoethanol at 30 cm 3 hr, collecting 10 cm 3 
fractions. Generally fractions 45-60 contained active enzyme (ca. 
3200 U) which was pooled and concentrated (PM-la) to Ca. 15 cm 3 . 
Another six batches of cells were processed in pairs in an 
identical manner, furnishing after gel-filtration, four 15cm 3 
samples of the enzyme (total ca. 12,000 U) which were pooled and 
concentrated (PM-la) to ca. 20 cm 3 . This was then heated at 60°C 
for 15 minutes to ensure complete inactivation of any residual 
cosynthetase. No precipitation was observed, so the enzyme was 
rapidlycooled in ice, and applied to another freshly equilibrated 
G-lOO Sephadex column.. Elution was performed with 0.01 M Tris Cl 
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pH 8.0 + 5 mM -mercaptoethano1 at 30 cm3 hr, collecting 10 cm3 
fractions. Fractions 46-62 contained active enzyme and were pooled 
and concentrated (PM-b) to ca. 100 cm3 (total Ca. 8000 U, 20 U mg). 
8.4 Isolation and Purification of Uro'gen III Cosynthetase 
(by Dr. R. C. Davies) 
AssaLJ 
Cosynthetase (10 jiL, Ca. 1 U cm 3 ) and pure deaminase (25 .iL, 
10 U cm 3) were preincubated together at 37°C for 3 minutes. PBG 
solution (0.1 cm 3 , diluted PBG stock as in deaminase assay) was 
added, and the reaction stopped after exactly 1 minute by cooling 
to -78°C in dry-ice/acetone, and then stored in ice. Fresh benzo-
quinone solution (0.1 cm 3 , 1 mg cm 3 MeOH) was added as soon as 
possible, and the mixture left in the dark for 30 minutes. Then 
saturated NaHS0 3 (0.1 cm 3 ) was added at 0°C for 5 minutes before 
adding either buffer (3 cm 3 , 0.1 M Tris Cl pH 8.2) or HC1 (2.5 cm 3 , 
5% v/v). The Soret band was recorded over the range 450-350 nm. 
For a blank the Amax = 0, for deaminase Amax = 0.03 and for deaminase 
+ cosynthetase Amax 	0.17 at the most. The difference between the 
deaminase alone and deaminase + cosynthetase gave the activity 
calculated using c 395 (Tris buffer) = 224,000 mol L 1 cm 	or 
.(HC1) = 496,000 mol L 	cm. 1 U of activity is defined as forming 
1 nmol uroporphyrin hr, or 1 U forms 1 imol uroporphyrin hr. 98 
Isolation and Purification 
R. sphroides (200 g wet cells) were suspended in buffer (400 cm 3 , 
0.5 M KPhos pH 7.5) and sonicated as for deaminase. After centrifuga-
tion at 35,000 g (30 minutes) the supernatant was decanted off and 
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made 10 mM in -mercaptoethanol, and brought to 30% saturation with 
ammonium sulphate. The mixture was then allowed to stir for 30 
minutes, and centrifuged (20,000 g, 15 minutes) and the pellet 
discarded. The supernatant was brought to 55% saturation with 
amrnonium sulphate, stirred for 30 minutes, and centrifuged (20,000 g, 
15 minutes). The pellet was dissolved in a minimum volume of buffer 
(ca. 50 cm 3 , 0.01 M KPhos pH 7.5) and dialysed overnight against 
several changes of buffer (0.01 M KPhos pH 7.5 + 1. mM -mercapto-
ethanol). The dialysate was then centrifuged at 100-150,000 g for 
Ca. 5 hours, and the brown pellet discarded. 
The supernatant was applied to a freshly equilibrated hydroxy%-
apatite column (5 X10 cm) eluting with 0.01 M KPhos pH 6.8 + 1 mM 
-mercaptoethanol at 30 cm 3 hr, collecting 10 cm3 fractions. The 
deaminase present was retained, whereas the cosynthetase was not. 
The pooled cosynthetase activity was concentrated (PM-b) to 
ca. 30 cm 3 and applied to a freshly equilibrated DEAE-cellubose 
column (5.X 12 cm), eluting with a salt gradient of 0.05 M KC1 (300 
cm3 , in 0.01 M KPhos pH 7.5 + 2 mM -mercaptoethanol) to 0.4 M 
(300 cm3 , in 0.01 M KPhos pH 7.5 + 2 mM -mercaptoethanol) at 30 cm 3 
hr 	collecting 10 cm 3 fractions. The cosynthetase activity eluted 
just before deaminase. 
The active cosynthetase fractions were then pooled and concen-
trated (PM-b) to ca. 20 cm3 , and applied to a freshly equilibrated 
G-100 Sephadex column, eluting with 0.05 M KPhos pH 7.5 + 2 mM 
-mercaptoethano1. The active fractions (ca. 500 U) were then pooled 
and concentrated (PM-b) to Ca. 2 cm 3 . 
It should be noted that all columns were monitored for both 
deaminase activity and cosynthetase activity. 
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8.5 Preliminary Studies on PBG-Deaminase Complexes 
(with Dr. G. Burton) 
For the generation of PBG-deaminase complexes using defined 
stoicheiometries of PBG and deaminase, either our NPMD (see Section 
8.6) or sequential mixing was employed, and the resultant complexes 
analysed by gel-electrophoresis. The gels were cast using the LKB 
Multiphor system of. gel-former and glass with a rubber gasket, using 
the following solutions. 
Stock Acrylczmide 
Acrylamide (ex Sigma) 	 22.2 g 
N,N'-methylene-bis-acrylamide (ex. Sigma) 	0.6 g 
Water 	 to 100 cm3 
Filtered through a fine sinter to remove solid impurities, 
and stored at 4°C. 
Stock Buffer 
Glycine 	 75 g 
Sodium azide 	2.5 g 
Tris 	 Ca. 100 g (to pH 8.9) 
Water 	 to 5 L 
7.5% Analutical Poluacrulajnide GeL 
Stock buffer 	33.0 cm 3 
Stock acrylamide 	22.2 cm 3 
Water 	 7.5 cm3 
These were all mixed and vacuum-degassed for Ca. 5 
minutes before adding rapidly and simultaneously: 
Ammonium persulphate (ex Sigma) 	 3.2 cm 3 
(150 mg/10 cm 3 ) 
N,N,N' ,N'-tetramethylethylene diamine 
(TEMED) (ex Sigma.) 	 0.1 cm3 
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The mixture was then quickly poured into the template, left for 30 
minutes to polymerise and then the rubber gasket was removed. The 
gel was cooled to 4°C for Ca. 10 minutes and the former removed, 
yielding a gel (24 X 12 X 0.1 cm) with 9 pockets for samples of 
volume 14 jiL each. The gel was stored. at 4°C until use, with a 
maximum lifetime of 4 days. 
Electrophoresis was conducted using electrode buffer consisting 
of 1:1 stock buffer:water. The gel was pre-electrophoresed for Ca. 
30 minutes in the LKB Multiphor apparatus with cooling fluid at 4°C, 
at 50 mA (ca. 750 V). After the sample was applied with Bromophenol 
blue tracking dye (1 1.IL, 0.25% w/v in stock buffer), it was concen-
trated at 20 mA for 15 minutes. Electrophoresis was then carried 
out at 40 mA (ca. 700 V) for 4-5 hours. The running pH was ca. 9.5. 
After this time gels were usually developed for protein, stain-
ing for 30 minutes in a solution of Coomassie Brilliant Blue R-250 
(0.8 g), trichloroacetic acid (200 g) and water (400 cm 3 ). The gel 
was then left to destain overnight with destaining solution (600 cm 3 
water, 300 cm 3 ethanol and 100 cm 3 glacial acetic acid). Another 
change of destaining solution the next morning was usually necessary 
for complete destaining of the gel. 
The following solutions were employed for the investigations 
on substrate-enzyme ratios: 
Deaminase 	(100 U cm 3 , 0.01 M KPhos pH 7.6). 
PBG 	(66.7 nmol cm 3 , 0.1 M Tris Cl pH 8.0). 
[315 -14C] - PBG 	(60 pCi in 1.0 cm 3 0.1 M Tris 	Cl 
pH 8.0 and 0.1 cm 3 of this diluted 
to 1.614 cm 3 0.1 M Tris Cl pH 8.0, 
37.6 nmol cm3). 
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Experiment 1 
The above solutions of deaminase and PBG were mixed in equal 
volumes (30 iiL) to give ratios of 1:1, 1:2, 1:3, 1:4 and 1:6 
enzyme:substrate, and analysed by gel-electrophoresis together with 
partially pure deaminase.. This revealed a large number of bands 
corresponding to impurities when stained for protein, but also a 
strong band corresponding to deaminase (mobility/% of tracking 
dye = 57) and also an extra broad band. (mobi.l.ity/% of tracking 
dye. = 64) corresponding to the complex. This was confirmed when 
another gel-electrophoresis was performed using the same complex 
solutions. This time a strip of. the gel was removed for protein 
staining, and the remainder was incubated in 0.01 M Tris Cl -  pH 8.0 
(20 cm 3 ) containing PBG (640 big). After 45 minutes at room tempera-
ture in the dark, the solution was washed off and the gel treated 
with iodine in HC1 (0.2% w/v 12  in 1 M Nd). The bands of porphyrin 
were detected with !JV light, and only two for each lane were visible. 
These corresponded to native enzyme (mobility/% of tracking dye = 
55-7) and a broad band corresponding to complexes (mobility/% of 
tracking dye = 62-4). 
Experiment 2 
Using the HPMD, the above solutions of deaminase and [3,5- 14C]-
PBG were used to generate complexes with the enzyme:substrate ratios 
1:0.57, 1:1.69, 1:3.38, which were applied to a gel as in Experiment 
1. After electrophoresis, the gel was stained for protein, which 
showed three new bands. The gel was dried out using a vacuum gel-
dryer (Bio-Rad) and then subjected to autoradiography using Kodak 
X-ray film. The exposure was for 6 days at room temperature, and 
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three bands were detected, as with the protein stain (mobility/% 
tracker dye for native enzyme = 57%, "mono-PBG" = 62, hldi_PBGU = 64, 
"tri-PBG = 66). Some bands were cut out and dried (vacuum 
desiccator) and treated with 0.5 cm3 30% H 2 0 2 
 at 80°C until com-
pletely dissolved. (ca. 90 minutes). Then Aquasol (43 cm3 ) was 
added and the bands assayed by liquid scintillation counting. 
These results form part of Table 3.1 
Experiments 3 and 4 
[ 14C] - PBG and deaminase were used exactly as in Experiments 1 
and 2 to generate complexes either using the HPMD or sequential 
mixing at either 37°C or 4°C, and the band cut out and assayed as 
in Experiment 2. The results from these experiments form the major 
part of Table 3.1 
Experiment 5 
The proteolytic digestion of [14C]-complex  as generated in 
Experiment 4 was investigated using a-chymotrypsin (0.74 mg, ex 
Sigma, in 35 iL 0.1 M.Tris Cl - pH 8.0, 1 unit iiL). a-chymotrypsin 
(10 units) was incubated with [14C]-complex  (68 iL) and also deaminase 
(25 iL, 1.95 U) at 37°C for 45 minutes. Analysis by gel-electro-
phoresis revealed that only partial digestion had taken place, and 
most of the bands present in the native enzyme were present in the 
digested material. 
Experiment 6 
Proteolysis of the [14C]-complex  (60 L) and deaminase (40 pL 
of activity 70 U.cm 3 ) was attempted using Pronase E (5 pL, Type xiv 
Bacterial protease, 5.8 units mg 
1, 
 ex Sigma, 452 ig in 90.4 iL 0.1 M 
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Iris Cl -  pH 8.0, 29 units cm 3 , 5 ig 	incubating at 37°C for 
45 minutes. Gel-electrophoresis revealed that an equal distribution 
of counts occurred in the middle of the gel and in the upper part of 
the gel, implying that digestion had taken place satisfactorily and 
a series of [4C]-oligopeptides  occurred throughout the gel. 
8.6 Preparation and Purification of PBG-Deaminase Complexes 
The PBG-deaminase complexes generated for all this work required 
the construction of a mixing device. This is shown in Figure 8.1. 
Deaminase 
mber 
FIGURE 8.1. High Performance Mixing Device ('HPMD"). 
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The mixing chamber was constructed. out of a perspex cylinder (3.5 
dia X 2 cm) with standard HPLC fittings to three 22 gauge holes 
meeting at the centre where the mixing takes place. The enzyme and 
substrate, in identical volumes, were pumped into the mixing chamber 
by means of a dual-channel peristaltic pump (Gilson Minipuls 2) 
operating at a flow rate of Ca. 600 cm3 hr' . The complex eluting 
out of the mixing chamber was passed into a conical flask equipped 
with a magnetic stirrer. 
In a typical preparation, purified deaminase (8000 U, 20 U mg 
in 50 cm3 of 0.01 M Tris Cl pH 8.0 buffer) and labelled PBG (750 pg 
[13C]..PBG + 37.5 .ig [ 14 C] - PBG, 6789555 dpm imol 	13C PBG, in 51 cm 3 
of 0.01. M Tris Cl pH 8.0 + 5 mM EDTA +[25 mM lysine, optional]) 
were mixed in the HPMD, and the resultant complex immediately 
concentrated (PM-la) to Ca. 2 cm3 . 
While the complex was being generated and concentrated, the 
preparative gel-electrophoresis equipment was assembled. For this 
the following stock buffers were made: 
Stock Tris Buffer 





to pH 7.5 
Water 
	
to 2,400 cm 3 
Final pH 7.5 
Upper Electrode Buffer 
Barbital (ex Fisher Scientific) 	11.04 g 
Tris 	 2.0 g 
Water to 2 L 
Final pH 7.5 
Lower Electrode Buffer and Elution Buffer 
Stock Tris buffer:water 	 1:1 
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The gel was made using the following solutions: 
7 • 5% Preparative Poltiacri4-a'nide Gel 
Stock Tris buffer 	110 cm 3 
Stock acrylamide 	74 cm3 
(see Section 8.4) 
Water 	 29 cm3 
These were mixed and vacuum-degassed with stirring for 30 minutes 
prior to the rapid, simultaneous addition of: 
Ammonium persuiphate 	 7 cm3 
(150 mg cm 3 water) 
N,N,N' ,N'-tetramethylethylene diamine 	190 pL 
(TEMED) 
After quickly mixing, 210 cm 3 of the solution (10 X 4 cm gel) was 
poured into the preparative electrophoresis apparatus, equipped with 
a Buchier gel-supporting nylon screen and a gel-former, and distilled 
water quickly and carefully layered onto the surface of the gel with 
a 10 cm 3 plastic syringe and applicator tube. This ensured that the 
gel polymerised with a flat top surface without a meniscus. The gel 
was allowed to polymerise at room temperature for 30 minutes before 
the gel-former was removed, and the apparatus cooled to 4°C in the 
cold room. The apparatus was connected to a cooling bath circulating 
ethylene-glycol/water at 0°C. The upper and lower electrode buffers 
were pumped into the apparatus using peristaltic pumps eluting at 
60 cm3 hr; and the waste buffers collected in separate containers 
to avoid the risk of a short-circuit. Elution buffer was pumped out 
of the apparatus by a peristaltic pump eluting also at 60 cm 3 hr 
and through a UV detector to the fraction collector. 
After all the air-bubbles in al.l the various chambers had been 
completely eliminated, pre-electrophoresis was conducted at 65 mA 
(ca. 200 V) for 30 minutes. The sample (2 cm 3 ) was made 5% w/v in 
sucrose, and Bromophenol blue tracking dye (10 pL, 0.25% w/v in 
stock buffer) added.. Thiswas very carefully layered onto the surface 
of the gel using a 10 cm3 plastic syringe and applicator tube, having 
previously filled the applicator tube with water so as not to waste 
valuable complex.. Concentration of the sample was carried out at 
30 mA (<100 V) for ca. 15,minutes, and electrophoresis continued at 
50-65 mA (ca. 150 V). Initially the elution buffer was collected 
in bulk (150 cm3 ) but after about 6 hours the fraction collector 
was started, and electrophoresis was continued for approximately 
another 17 hours, collecting 10 cm 3 fractions. The running pH was 
Ca. 7.9. 
The fractions were assayed for radioactivity (liquid scintilla-
tion counting), protein (A 280 used as a rough guide, since barbital 
interferes at this wavelength) and enzyme activity. Typically 
fractions 38-45 contained complex which was concentrated (PM-b) 
down to ca. 0.4 cm 3 and washed/reconcentrated twice with 0.05 M 
20% D 2 
 0 pH 8.0 buffer. The final sample (0.4 cm 3 ) was assayed 
for radioactivity, the total dpm giving the amount [13C]-PBG bound 
in pmol or pg. This sample was then used in 5 mm NMR studies. 
Fractions 46-53 contained electrophoretically pure deaminase 
(>60% pure, ca. 80-120 U rng 1 ) which was also pooled, concentrated 
(PM-b) and washed (0.05 M P 
2 0 
 7 2- 20% D 
2 
 0 pH 8.0 buffer). This was 
used either as a blank in a 13C NMR experiment, or for the generation 
of ultrapure complex. In the latter case, the enzyme and substrate 
were mixed exactly as before in the mixing device, and after 
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concentration (PM-la, Ca. 30 cm3 ), applied to a freshly equilibrated 
G-50 Sephadex column (500. cm3 bed volume, 19 X 6.5 cm).. Elution was 
performed with 0.025 M P 20 72 pH 8.0 buffer + 5 mM -me,rcaptoethanol, 
collecting 10 cm 3 fractions. Fractions 18-28 were combined and 
concentrated. (PM-b) to Ca. 0.4 cm 3 , washing with 0.05 M P 20 72 20% 
D20 pH 8.0 buffer, for use in 5mm NMR experiments. 
8.7 Proteolyti c Digestion of E' 3C] - PBG- Deaminase and Purification 
of Oligopeptides 
After examination by 13C NMR, the [ 13C] - complex (+ 5% 
complex) was lyophilised to give 75 mg of protein. This was dis-
solved in NH 4HCO 3 buffer (7 cm 3 , 0.1 M) and the mixture placed in 
a test-tube and covered with nitrogen. After preincubation at 37°C 
for 10 minutes, trypsin (75 iiL, 0.76 mg or 1% w/w, ex Sigma, TPCK-
treated, 10 mg in 1 cm 3 of 10 pM HC1 containing 1.1 mg CaC1 2 ) was 
added, and the mixture incubated at 37°C for 1 hour before further 
trypsin stock (75 pL) was added. Incubation was continued for a 
further hour, and the mixture was lyophilised. This was redissolved 
in buffer (0.05 M NH 4HCO 3 ) and applied to a freshly equilibrated 
G-50 Sephadex column (1.8 X 140 cm). Elution was carried out with 
0.05 M NH4 HCO 3 buffer at 30 cm3 hr, collecting 3.5 cm3 fractions. 
Fractions 21-32 were combined and lyophilised (Peptide 2), as were 
fractions 33-41 (Peptide 3) and also fractions 13-20 (Peptide 4). 
The oligopeptides from fractions 21-32 were redissolved in 
electrode buffer (ca. 200 pL, 1:10:189 pyridine:HOAc:water, pH 3.5) 
and tracking dye (ca. 40 pL, 0.5 mg cm 3 DNP-lysine ex Sigma and 
0.2 mg cm 3 xylene cyanole FF ex Bio-Rad, both in water) and applied 
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to a spot 10 cm from one edge and 20 cm from the anode on Whatman's 
3 MM paper (46.X 57 cm) pre-wetted with electrode buffer. Flat-bed 
paper electrophoresis was then carried out in one dimension (100 mA, 
2.5 kV) for about 10 hours. The paper was then air-dried, and 
bisected in two, and thehaif bearing the peptides subjected to 
descending paper chromatography in the perpendicular dimension, 
using n-butanol:HOAc:water:pyridine 15:3:12:10 (by volume) in a pre-
equilibrated chromatography tank. Elution took Ca.. 10 hours, and 
after air-drying, the paper was sprayed with fluorescamine (10 mg 
ex Sigma in 100 cm3 dry acetone and 1 cm 3 of this diluted to 100 cm 3 
with dry acetone + 1 cm 3 dry pyridine). This is a non-destructive 
reagent which allowed detection of the oligopeptides when viewed 
under UV light (see Figure 3.15 for map). 
The peptides were cut out and cut into small pieces, eluting 
off the paper with 0.1 M NH 3 (aq).. After filtration, the peptide 
solutions were lyophilised and thus generated Peptides 1,5 and 6. 
Fractions 13-20 (Peptide 4) from G-50 Sephadex gel-filtration 
were lyophilised, yielding 24 mg of protein after removal of a small 
amount for further analysis. This was dissolved in buffer (5 cm 3 , 
0.1 M NH 4HCO3 ) and Pronase E solution (300 pL, 2 mg cm 3 , 2% w/w 
in the same buffer) was added. The mixture was incubated at 37°C 
for 24 hours before lyophilisation to yield Peptide 7. 
8.8 Purification of PBG Deaminase for Amino Acid Analysis and 
Protein Sequencing 
The [ 13C] - complex from Experiment 10 (see Chapter 9, p.  236) after 
incubation with unlabelled PBG, was subjected to a second preparative 
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gel-electrophoresis step and described in Section 8.6. This 
furnished samples of both pure enzyme and u mono _PBGII complex, 
shown to be >95% pure by analytical gel-electrophoresis. The 
pooled proteins were desalted by gel-filtration on G-lO Sephadex 
(bed volume 150 cni, 31 X 2.5 cm) eluting. with pure water at 
100 cm3 hr, and collecting 2 cm 3 fractions. Both the complex 
and subsequently the pure enzyme eluted in fractions 20-24. These 
were pooled and lyophilised to furnish pure complex (2.728 mg) and 




The procedures in this chapter cover the ways in which data 
presented in Part II was (a) acquired and (b) processed. Where 
this has already been adequately covered, the details have been 
omi tted. 
Abbreviations employed are as follows: DP = decoupler power, 
in Bruker notation 15 H = 0.4 W, 12 H = 0.8 W, 10 H = 1.4 W, 9 H = 
1.6 W, 6 H = 3.2 W, 3 H = 6.4 W; SI = size of data table; AQ = 
acquisition time; PW = pulse width, or "flip angle"; NS = number of 
scans; RD = relaxation delay; NZP = number of points removed from 
the start of an FID; LB = line broadening. All data were accumulated 
with a full spectral width (SW), except where stated otherwise. 
9.1 1 H NMR Studies 
Studies of PBG and Deaminase (with Dr. R. C. Davies) 
For the experiment shown in Figure 2.1, PBG, (2 mg) was dissolved 
in D 2 0 (99%, 0.1 cm 3 ) and the pH adjusted to Ca. 8.0 with a crystal 
of Na2CO 3 . This was then mixed with deaminase (0.4 cm 3 , 100 U, in 
0.05 M KPhos pH 7.6 buffer) in the NMR tube at 4°C and rapidly 
transferred to the NMR. Data was then accumulated at 300 MHz and 
4°C, with the low-power (6 L in Bruker notation) irradiation of the 
HOD line, and with SI = 16K, AQ = 1.64 s, PW = 90° and NS = 4.8. 
The FID's were accumulated using a kinetics microprogram, with the 
interval between FID's being 198.88 seconds (3 minutes, 19 seconds). 
The FID's were then subjected to Fourier transformation. The 
spectra shown in Figure 2.2 were generated in an identical manner. 
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Studies on PBG with pH 
The pH titration of PBG by 
1 H NMR represents a technical 
problem, sincethe spectrometer is locked onto the HOD line, which 
shifts with pH giving rise to changes in the field. Thus PBG (3 mg) 
was dissolved in buffer (0.1 Ni KPhos, 99% DO, pH 7.27) and 
referenced to a coaxial capillary insert of 1% (v/v) of TMS in 
CC1 4 . The chemical shifts are not corrected for magnetic suscepti-
bility differences. For a superconducting magnet, the internal 
chemical shift dint' 
 can be calculated from the observed chemical 
shift using 
d int = 6obs + 	(Xref - Xsample) 
where in this case the magnetic susceptibilities Xref = -0.691 X 106 
and xsample = -0.719 X 106, which gives rise to an effect of 0.117 
ppm. 
The pH was adjusted using a 0.5 cm3 syringe mounted in a holder, 
with a micrometer screw to force the plunger of the syringe in by 
fractional amounts. The syr.inge was connected to a teflon tube and 
in this way very small amounts of 0.2 M NaOD in 99% D 2 
 0 could be 
added, using the teflon tube as a stirrer. Below pH 7.2, 20% DC1 
in 100% D 2 
 0 was judiciously added using a Gilson Pipetman. The pH 
was measured directly using a 3 mm pH electrode. The pH measurements 
were not corrected for D 2 0. 
Data was accumulated with homonuclear irradiation of the HOD 
line, and with SI = 8K, AQ = 1.139 s, PW = 900, NS = 16. The FID's 
were exponentially multiplied with LB = 0.2 Hz before Fourier. trans-
formation (see Figure 2.3). 
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9.2 Complete 3C NMR Assignment of PBG 
Preliminary studies on [3,5 -13C] -PBGwere performed as follows. 
[3,5 -13C] - PBG (2 mg) was dissolved in 0.1 M P 20 72 , 10% D20  pH 8.0 
buffer and examined at 75.5 MHz and 25°C, with DP = 3 H gated 
decoupling, SI = 16K, AQ = 0.541 s., PW = 90°, NS = 1200, and FID 
was exponentially multiplied with LB = 2Hz prior to Fourier trans-
formation (see Figure 2.7). 
Selective irradiation experiments were made by moving the 
decouplerto the frequency corresponding to the 1 H resonances at 
C-6 and C-ll, at 6 
H 	
2.63 and 6 = 4.15. Data was acquired with 
OP = 3 H gated decoupling, SI = 16K, AQ = 0.541 s, PW = 45°, NS = 
4000. The FID's were zero-filled to 32K, exponentially multiplied 
with LB = 1 Hz and Fourier transformed (see Figure 2.8). 
The complete 13C NMR assignment of PBG' was performed at 125.8 
MHz and 25°C. Unlabelled PBG (20 mg) was dissolved in buffer 
(453.7 iL, 0.1 M P2072 , 99% D20, pH 8.0) to which 3.0 M NaOD in 
100% D 2 
 0 (46.3 iL) was added. Initially the 500 MHz H NMR spectrum 
was obtained and an absolute frequency list (expressed later in ppm) 
drawn up. The coupled 3C NMR spectrum was then obtained: 6 = 
21.7 (t of t, 1 1 ( 13C-'H) = 127.5 Hz, 2 1 ( 13C- 1 H) = 4.0 ± 0.5 Hz), 
32.8 (t, 
l 	( 13C- 1 H) = 126.5 Hz), 34.4 (t, 1 1 ( 13C-'H) = 144.0 Hz), 
38.2 (t of t, 
l 	( 13C- 1 H) = 126.8 Hz, 
2  (' 3C- 1 H) = 5.2 Hz), 117.4 
(c, m), 120.6 (c, m), 122.5 (c, m), 181.1 (t, 2 1 ( 13C- 1 H) = 6.8 Hz), 
183.0 (hi, 2 1 ( 13C-'H) = 4.8 Hz, j ( 13C- 1 H) = 4.0 Hz). 
Selective off-resonance 1 H-decoupling experiments were then 
performed, using a very low decoupler power 
Aliphatic Region 
Selective decoupling at 6 = 2.41 ppm. 
The triplet at 21.7 ppm collapsed to a singlet, and 
decreased for the triplet at 38.2 ppm. All others unaffected. 
Selective decoupling at 6 = 2.67 ppm. 
The triplet at 38.2 ppm collapsed to an unsymmetrical 
doublet, and J decreased for the triplet at 21.7 ppm. All others 
unaffected. 
Selective decoupling at 6 = 3.41 ppm. 
For the triplet at 32.8 ppm, 
1 J decreased. All others 
unaffected. 
Selective decoupling at 6
H
= 4.16 ppm. 
For the triplet at 34.4 ppm, 1 J decreased. All others 
unaffected. 
Selective decoupling at 6 = 6.69 ppm. 
No visible effect. 
Arcmatic Region 
Selective decoupling at 6 H = 2.41 ppm. 
Intensity of peak at 117.4 ppm enhanced, and peak at 
122.5 ppm sharpened. 
Selective decoupling at 6 H
= 2.67 ppm. 
Long-range coupling at 116.1 ppm lost to give a clean 
doublet. The resonance at 122.5 ppm sharpened (showed extra 
coupling). 
Selective decoupling at 6
H
= 3.41 ppm. 
Intensity of peak at 117.4 ppm enhanced, and peak at 
215 
216 
120.6 ppm showed some fine structure... Peak at 122.5 ppm sharpened 
considerably. 
Selective decoupling at 6 = 4.16 ppm. 
The resonance at 120.6 ppm sharpened to a quintet, and 
the peak at 117.4 ppm also sharpened. 
Selective decoupling, at 6 = 6.69 ppm. 
The resonance at 116.1.ppm split into a triplet with a 
central singlet representing, the decoupled line, and the outer 
parts of the triplet representing the residual coupling. The 
resonance at 120.6 ppm was slightly sharper but the others were 
unaffected. 
COOH Region 
Selective decoupling at '5H = 2.41 ppm. 
The resonance at. 183.0 ppm collapsed to a singlet. 
Selective decoupling at 6 = 2.67 ppm. 
The resonance at 183.0 ppm collapsed to a clean triplet. 
Selective decoupling at 	=3.41 ppm. 
The resonance at 181.1 ppm collapsed to a singlet. 
Selective decoupling at 6 = 4.16 ppm. 
No visible effect. 
Selective decoupling at 6 H
= 6.69 ppm. 
The resonance at 183.0 ppm lost its left-hand couplings. 
pH Titration of [3,5- 13C] -PBG. 
[3,5- 13C] - PBG (2.2 mg) was dissolved in buffer (0.45 cm 3 , 
0.05 M P2 0 72 , 50% D 2 0, pH 8.0) and 3.0 M NaOH (5.2 iL) and p-dioxane 
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(5.0iiL) added. The pH was measured directly using a 3mm pH 
electrode, and the pH adjusted with 1 M -alanine pH 10.26 buffer. 
Above pH 10.2, the pH was adjusted by judicious addition of 3.0 M 
NaOH. Data.wasaccumu.latedat 75.5 MHz and 23 °C with DP = 12 H, 
SI = 8K, AQ = 0.250 s, PW= 90 0 , NS = 2712. The FID's were zero- 
filled to 16K, exponentially multiplied with LB = 2 Hz, and Fourier 
transformed (see Figure 2.9). 
9.3 	NMR Studies of Uro'gen Biosynthesis with t2,11 -13C] - PBG 
(with Dr. R. C. Davies) 
For these experiments, 13C NMR investigations were conducted 
at 75.5 MHz, and the deamiriase and cosynthetase employed was pre-
pared by Dr. R. C. Davies. 
Experwientsi wth [2,11- 
13C]-PBG in aS mm Probe 
Experiment 1 
[2,11 -13C] - PBG (2 mg) in buffer (0.5 cm 3 , 0.05 M P20 72 , 20% 
D20, pH 8.35) was characterised by 13C NMR at 0°C: 6 	 34.4 (C-ll) 
and 116.1 (C-2). Deaminase (0.1 cm 3 , 176 U cm 3 ) in the same buffer 
was added and examined at 0°C. Data was accumulated with DP = 3 H 
gated decoupling, SI = 16K, AQ = 0.459 s, PW = 90°, NS = 2000. A 
spectrum of uro'gen I was obtained after exponential multiplication 
with LB = 3 Hz and Fourier transformation. HPLC analysis of 
products: 60% I, 40% III. 
Experiment 2 
[2,11- 13C] - PBG (2 mg) was dissolved in buffer (0.1 cm 3 , 0.05 M 
20% D20, pH 8.34) and mixed with deaminase (0.3 cm 3 , 176 U cm3) 
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in the same buffer and incubated under N 2 for 4 minutes at 37°C. 
The reaction was stopped by freezing (ice-salt), warmed to 0 ° C and 
cosynthetase (0.1 cm3 , 10 U) added with mixing. The sample was 
then examined at 1.5°C using a kinetics program to accumulate data 
every 15 minutes 11 seconds, with DP = 3 H gated decoupling, SI = 
16K, AQ = 0.459 s, PW = 90°, NS = 256. Poor spectra of bilane and 
uro'gen III obtained. HPLC analysis of products: 10% I, 90% III. 
Experiment 3 
[2,11 -13C] -PBG (2 mg) dissolved in buffer (0.1 cm 3 , 0.05 M 
P20 72 ,20% D20, pH 8.34) was added to deaminase (0.4 cm3 , 176 U cm 3 ) 
in the same buffer and incubated under N 2 for 6 minutes at 37°C. The 
reaction was stopped by freezing (ice-salt), warmed to 1.5°C, and 
the 13C NMR time-course taken with 15 minutes 11 seconds between 
accumulations. Data was acquired with DP = 3 H gated decoupling, SI = 
16K, •AQ = 0.459 s, PW = 90°, NS = 256 and the FID's were exponentially 
multiplied with LB = 5 Hz prior to Fourier transformation. HMB 
detected., but short-lived, all cyclising to uro'gen I in Ca. 30 
minutes (see Figure 2.12). HPLC analysis of products: 90% I, 10% 
III. 
Exoeriment 4 
[2,11 -13C] - PBG (2 mg) dissolved in buffer (0.1 cm 3 , 0.05 M 
20% D20, pH 8.34 adjusted to pH 8.7 with 3 M NaOH) was 
added to deaminase (0.4 cm 3 , 176 U cm 3 ). in the same buffer (pH 8.7), 
incubated under N 2 for 6 minutes before adjusting to pH 12 with 3 M 
NaOH and 13C NMR spectra recorded at 0°C. Data was accumulated for 
Ca. 4 hours with DP = 3 H gated, SI = 16K,AQ = 0.459 s, PW = 90°, 
NS = 4500. The FID was zero-filled to 32K, exponentially multiplied 
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with LB = 3 Hz prior to Fourier transformation. A satisfactory 
spectrum of HMB was obtained. 
Experiment 5 
The foregoing HMB solution was adjusted back to pH 8.7 (with 
3 M HCl) and to this cosynthetase. (0.1 cm 3 , 10 U in the same buffer, 
pH 8.7) and -mercaptoethanol (5 jiL) was added. Data was accumulated 
at 0°C in a kinetics time-course, with DP = 3 H gated, SI = 16K, 
AQ = 0.459 s, PW = 90, NS = 500. The FID's were summed, zero-filled 
to 32K and exponentially multiplied with LB = 3 Hz prior to Fourier 
transformation. No detectable intermediates. HPLC analysis of 
products: 43% I, 57% III. 
Experiment 6 
[2,11- 13C] - PBG (1.5 
90%, pH 8.0) and 
was accumulated with DP 
PW = 900, NS = 1000, and 
LB = 3 Hz prior to Fouri 
mg) was dissolved in buffer (0.5 cm 3 , 0.05 M 
adjusted to pH 12 (30 11L 3 M NaOH). Data 
12 H continuous, SI = 16K, AQ = 0.541 s, 
the FID was exponentially multiplied with 
r transformation. 
Experiment 7 
[2,11- 13C] - PBG (2 mg) was dissolved in degassed buffer (2.8 cm 3 , 
0.025 M KPhos pH 7.6) and deaminase (0.1 cm 3 , 10 U) and cosynthetase 
(0.1 cm3 , 10 U) in the same buffer was added and incubated at 37°C 
for 2 hours. The mixture was lyophilised and redissolved in 0.5 cm 3 
D 
2 
 0 (99%) and examined at 25°C with DP = 12 H continuous, SI = 16K, 
AQ = 0.541 s, PW = 30°, NS = 4000, and the FID was zero-filled to 
32K, exponentially multiplied with LB = 5 Hz and Fourier transformed 
to give, a satisfactory spectrum of uro'gen III (see Figure 2.13). 
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Experiments with [2,11- 13C]-PBG in a 10 nvn Probe 
Experiment 8 
[2,11- 13C]-PBG (2 mg) was dissolved in buffer (0.5 cm 3 , 0.05 M 
P20 72 , 99% D 20, pH 8.0) and diluted with degassed phosphate buffer 
(2,2 cm3 , 0.025 M KPhos pH 7.6), and incubated with deaminase 
(0.1 cm 3 , 26 U) in the same buffer at 37°C for 2 hours. The mixture 
was lyophilised, and the residue dissolved in D 2 
 0 (2.0 cm3 , 99%). 
This solution of uro'gen I was studied at 25°C varying DP and PW. 
Gated decoupling with DP = 15 H, 12 H, 9 H, 6 H and 3 H was used 
with PW = 90°, and then DI' = 12 H continuous with PW = 15°. Data 
was accumulated with Si = 16K, AQ = 0.541 s, NS = 500, and the FID's 
were exponentially multiplied with LB = 5 Hz, prior to Fourier trans-
formation (see Figure 2.11). HPLC analysis of products: 89% I, 
11% III. 
Experiment 9 
[2,11- 13C] - PBG (5 mg) dissolved in buffer (0.4 cm 3 , 0.05 M 
80% D2 0, pH 8.5 + 10 biL 3.0M NaOH) was incubated with 
deaminase (1.6 cm 3 , 400 U) in the same buffer for 3.5 minutes at 
37°C, before adding 3 M NaOH (25 iL) and cooling (ice-water). Data 
was accumulated at 4°C for 36 minutes with DI' = 12 H continuous, 
SI = 16K, AQ = 0.541 s, PW = 15°, NS = 5000. The FID was zero-
filled to 32K, exponentially multiplied with LB = 3 Hz and Fourier 
transformed. Satisfactory spectrum of HMB obtained (see Figure 2.14). 
Experiment 10 
To the foregoing solution of HMB, cosynthetase (0.2 cm3 , 20 U 
in 0.05 M KPhos pH 8.0 buffer) was added and 3 M HC1 (35 pL) added 
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with rapid mixing tobring the pH to 8.0 	The sample was rapidly 
transferred to the NMR, and. a time-course run over 2 hours, collect-
ing data every 4.5 minutes. Data was accumulated with DP = 12 H 
continuous, SI = 16K, AQ = 0.541 s, PW = 15 0 , NS = 500 and the FID's 
exponentially multiplied with LB = 3 Hz prior to Fourier transforma-
tion (see Figures 2.15, 2.16).. HPLC.analysis of products: 15% I, 
85% III. 
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13  NMR Studies of Uro'gen Biosynthesis with [3,5- 13C] - PBG 
(with Dr. R. C. Davies) 
For these experiments, 13C NMR investigations were conducted 
at 75.5 MHz, and the deaminase and cosynthetase employed was pre-
pared by Dr. R. C. Davies. 
Experiments with [3,5- 13C]-PBG in a 5 wn Probe 
Experiment 1 
[3,5 -13C] - PBG (1 mg) in buffer (0.25 cm3 , 0.1 M P 2 0 72 , 90% 
D 20, pH 8.0) was incubated with deaminase (0.05 cm3 , 10 U and 2.2 cm 3 
0.025 M KPhos pH 7.8) for 2 hours at 37°C under N 2 in the dark. This 
was lyophilised and the residue redissolved in N 2 -degassed buffer 
(0.5 cm 3 , 0.05 M P2 0 72 , 90% D 20, pH 8.0). Data was accumulated 
with DP = 12 H gated, SW = 1000 Hz, SI = 2K, AQ = 1.024 s, PW = 90°, 
NS = 27,500 and the FID was zero-filled to 16K prior to Fourier 
transformation. Fully resolved spectrum of uro'gen I (see Figure 
2.17). HPLC analysis of products: 96% I, 4% III. 
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Experiment 2 
[,5-13C] - PBG. (1 mg) in buffer (0.25 cm3 , 0.1 M P20 72
, 90% 
020, pH 8.0) was incubated with deaminase (0.05 cm3 , 10 U and 2.1 
cm3  0.025 M KPhos pH 7.8) and cosynthetase (0.1 cm 3 , 10 U) in the 
same. buffer for 2 hours at 37 °C under N2 in the dark. This was 
lyophilised and redissolved in N 2 -degassed buffer (0.5 cm 3 , 0.05 M 
P 2 0 72 , 90% D20, pH 8.0). Data was accumulated with OP = 12 H 
continuous, SW = 1000 Hz, SI = 2K, AQ = 1.024 s, PW = 90°, NS = 
34,250 and the FID was zero-filled to 16K, exponentially multiplied 
with LB = 1 Hz prior to Fourier transformation (see Figure 2.18). 
Partially resolved, spectrum of uro'gen III. HPLC analysis of 
products: 6% I, 94% III. 
Experiment 3 
[3,5- 13C] - PBG (2 mg) in buffer (0.1 cm 3 , 0.1 M P 20 72 , 90% D
20 1 
pH 8.0, washed into the tube with a further 0.05 cm 3 of the same 
buffer) was incubated with deaminase (0.4 cm 3 , 120 U) in the same 
buffer at 37°C under N 2  for 4 minutes. 3 NI NaOH (10 iiL) was added 
and the solution cooled. Data was accumulated at 3°C with DP = 12 H 
gated, SW = 1000 Hz, SI .= 2K, AQ = 1.024 s, PW = 90°, NS = 6000 and 
the FID was zero-filled to 16K, and exponentially multiplied with 
LB = 1 Hz prior to Fourier transformation. Poorly resolved spectrum 
of HMB obtained. HPLC analysis of products: 95% I, 5% III. 
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Expervnents with [3,5- c]-PBG in a 10 nvn Probe 
Experiment 4 
The sample from the previous experiment (Experiment 3) was 
diluted with buffer (2.0 cm 3 , 0.1 NI P 2 0 72 , 90% D20, pH 8.0) and 
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used as a test sample. Data was accumulated at 10°C with 12 H 
continuous decoupling, and a matrix for varying PW and SI (AQ) was 
constructed according to signal-to-noise over a fixed accumulation 
time of 4.5 minutes. The FID's were zero-filled to 16K (where 
appropriate) and exponentially multiplied with LB = 5 Hz prior to 
Fourier transformation. Signal-to-noise was measured on the peak 
of uro'gen I at 117.7 ppm. 




4 (0.1362 s) 	 36.7 	45.5 
8 (0.2703 s) 	54.7 	56.3 	32.1 	48.2 
16 (0.5407 s) 	52.4 	42.9 	56.6 	41.7 
While these, results exhibit the errors in making the signal-to-noise 
measurement, it was ascertained that PW = 750 and SI = 8K (AQ = 
0.270 s) were probably the best conditions for molecules of this 
sort. 
Experiment 5 
[3,5- 13C] - PBG (5 mg) was dissolved in buffer (0.4 cm i , 0.05 M 
90% D20, pH 8.5 plus 10 pL 3 M NaOH) and added to deaminase 
(1.6 cm3 , 3.37 U in the same buffer) and incubated at 37°C for 3.5 
minutes before 3 M NaOH (25 i.iL) was added. The spectrum obtained 
of HMB was unsatisfactory, so cosynthetase (78 U, in 0.05 M KPhos 
p1-I 8.0) was added and also 3 M HC1 (35 pQ with rapid mixing to 
bring to pH 8.1. Data was accumulated at 8°C over 90 minutes 
collecting every 4.5 minutes, with OP = 12 H continuous, SI = 8K, 
AQ = 0.270 s, PW = 750, NS = 1000, and the FID 1 s were zero-filled 
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to 16K, and exponentially multiplied with LB = 10 Hz prior to Fourier 
transformation. No new intermediates. HPLC analysis of products: 
13% I, 87% III. 
Experiment 6 
Deaminase (1.6 cm 3 , 272 U in 0.05 M P 2072 , 80% D20, pH 8.5) 
buffer was anal'sed for a baseline for 9 minutes at 8°C (NS = 2000) 
under essentially the same.conditions as Experiment 5. No extraneous 
peaks were detected in the areas of interest. t3,5 -13CJ - PBG (5mg) 
in buffer (0.05 M P 2072 ', 80% D20, pH 8.5.) was added to this deaminase 
solution, and the mixture. incubated at.37°C for 4 minutes. The pH 
was then adjusted to 12 with 3. N NaOH (25 L) and the mixture cooled 
to 0-5 °C. Data was accumulated at 3-7°C over 36 minutes with DP = 
12 H continuous, SI = 8K, AQ = 0.270 s, PW = 75°,NS = 10,000, and 
the FID was zero-filled to 32K, and subjected to Gaussian multiplica-
tion with a Gaussian broadening of 0.350 and LB = -3Hz prior to 
Fourier transformation (see Figure 2.19). Fully resolved spectrum 
of HMB obtained. 
Experiment 7 
To the foregoing solution of HMB, cosynthetase (0.3 cm3 , 30 U 
in 0.05 M KPhos pH 8.0 buffer) was added and 3 N HC1 (35 pL) with 
rapid mixing. Data was accumulated at ca. 4°C over 3 hours collect-
ing every 4.5 minutes, with DP = 12 H continuous, SI = 8K, AQ = 
0.270 s, PW = 750, NS = 1000, and the FID's were zero-filled to 16K 
and exponentially multiplied with LB = 5 Hz prior to Fourier trans-
formation. No new intermediates (see Figures 2.20, 2.21). HPLC 
analysis of products: 21% I, 79% III. 
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Experiment 8 
As a non-enzymic control for Experiment 7,.[3,5- 13C] - PBG (5 mg) 
in buffer (0.4 cm 3 , 0.05 M P 20 72 ,. 80% D 2 0, pH 8.5) was incubated 
with deaminase (368 U, 2.0 cm 3 in the same buffer) for 3 minutes at 
3.7 °C. before adding 3 M NaOH (25 tL) and cooling. Data was accumulated 
at 5°C over 90 minutes, with DP = 12 H continuous, SI = 2K, AQ = 
1.024 s, SW = 1000 Hz, PW = 90 0 , NS = 5300 and the FID was zero-
filled to 32K and exponentially multiplied with LB = 2 Hz prior to 
Fourier transformation (see Figure 2.22). 
Experiment 9 
The foregoing HMB solution was readjusted to pH 8.0 with 3 M 
HC1 (35 .iL) and data accumulated for 2 hours every 4.5 minutes at 
5°C, with DP = 12 H continuous, SI = 8K, AQ = 0.270 s, PW = 90 0 , 
SW = 15,151 Hz, NS = 1000 and the FID's were exponentially multiplied 
with LB = 5 Hz prior to Fourier transformation (see Figure 2.23). 
No new intermediates. HPLC analysis of products: 96% I, 4% III. 
95 13 NMR Studies of [2,11-13C]-PBG-Deaminase Complexes 
Experiments 1-13 were performed in a 5 mm probe at 75.5 MHz, 
14-29 in a 10 mm probe at 75.5 MHz, and 30-31 in a 5 mm probe at 
125.8 MHz. 
Experiment 1 
[2,11-13C]-PBG-deaminase complex (50 ig [ 13C] - PBG bound to 
3000 U partially purified deaminase without further purification 
dissolved in 0.5 cm 3 0.05 M P 20 72 , 10% D2 0, pH 8.0 buffer) was 
examined at 12.5°C, with DP = 12 H continuous, SI = 16K, AQ = 
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0.4925 s, PW = 900, NS = 51,351 and the FIB was exponentially 
multiplied with LB = 20 Hz prior to Fourier transformation. Protein 
background clearly visible, but no significantly enriched peaks. 
Experiment 2 
[2,11-3C.]-PBG-deaminase complex (as in Experiment 1) was 
examined at 12.5°C under different NMR conditions, with DP = 12 H 
continuous, SI = 32K, AQ = 0.983 s, PW = 72°, NS = 50,000 and the 
FIB was exponentially multiplied with LB = 20 Hz prior to Fourier 
transformation. While aromatic and carbonyl carbons more clearly 
visible, no detectable substrate. 
Experiment 3 
The foregoing complex (0.2 cm 3 , in.0.05 M P 20 2 , 10% D 20 1 
pH 8.0 buffer), after purification by electrophoresis (see Chapter 8), 
was studied at 12.5°C, with DP = 12 H continuous, SI = 32K, AQ = 
0.983 s, PW = 90 0 , NS = 154,805, and the first data points removed 
with NZP = 2. The FID was exponentially multiplied with LB = 20 Hz 
and Fourier transformed (see Figure 3.6). Substrate signal detected. 
Experiment 4 
Electrophoretically pure deaminase (0.2 cm 3 , in 0.05 M 
10% D20, pH 8.0 buffer) was analysed at 12.5°C with DP = 12 H 
continuous, SI = 32K, AQ = 0.983 s, PW 
	
90, NS = 90,002, and the 
first data points removed with NZP = 2. The FID was exponentially 
multiplied with LB = 20 Hz and Fourier transformed (see Figure 3.7). 
Experiment 5 
To the complex from Experiment 3, Pronase E (1.855 mg, ex 
Sigma, Type xiv) was added directly and studied at 12.5°C over 
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24 hours. Data was accumulated using the Carr-Purcell-Meiboom-Gill 
spin-echo pulse sequence with a. kinetics time-course, and DP = 12 H 
continuous, SI = 32K, AQ = 0.983 s, NS = 3600 (X 3). The pulse 
sequence involves (i) an initial delay of 5 times approx. T 1 ; 
(ii) a 90 1 pulse; (iii) a dephasing delay of 1 msec; (iv) an 1800 
pulse, phase-shifted 90° relative to the first pulse; (v) a dephasing 
delay of 1 msec and (vi) a loop to (iii)'to make 4 echoes. Three 
such FID's were gathered, added together, the first., points removed 
with NZP = 2, and the new FID exponentially multiplied with LB = 
20 Hz prior, to Fourier transformation (see Figure 3.8). 
Experiment 6 
The previous sample was analysed under standard conditions at 
12.5°C using DP = 12 H c,ontinuous, SI = 32K, AQ = 0.983 s, PW = 90 0 , 
NS = 18,001, and the first points of the FID were removed with NZP = 
2. The new FID was exponentially multiplied with LB = 20 Hz and 
Fourier transformed (see Figure 3.9 (i)). 
Experiment 7 
Electrophoretically pure deaminase (from Experiment 4) was 
incubated with Pronase E (0.9788 mg) in the NMR as in Experiment 5 
except that the data was accumulated under standard conditions at 
12.5°C using OP = 12 H continuous, SI = 32K, PW = 90°, AQ = 0.983 s, 
NS = 37,533,. and the first points of the FID removed with NZP = 2. 
The new FID was exponentially multiplied with LB = 20 Hz and Fourier 
transformed (see Figure 3.9 (ii)). 
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Experiment 8 
The sample used in Experiment 6 was diluted with, buffer (5.5 cm3 , 
0.01 M KPhos pH 7.6), incubated for 22 hours at 37°C and lyophilised. 
The residue was redissolved in D 2 
 0 (99%) and data. was accumulated 
with DP = 12 H continuous, SI = 32K, AQ = 0.983 s, 'PW = 90 ° , NS = 
17,333. and the first points of. the F.ID removed with NZP = 2 prior 
to exponential multiplication with LB = 20 Hz and Fourier transforma-
tion. The spectrum was too complicated for interpretation due to 
large number of f.ree amino acids present. 
Experiment 9 
[2,11 -13C] - PBG- deaminase. complex (192 jig bound. to 6000 U deami-
nase after gel-electrophoresis in 0.4cm 3 0.01 M P 2072 , 10% D 2 0, 
pH 8.0 buffer) was examined'a.t 11.0°C. Data was accumulated with 
DP = 12 H continuous, SI = 16K, AQ = 0.492 5, PW = 54°, NS = 79,203 
and the first points of the FID were removed with NZP = 2, the new 
FID zero-filled to 32K., and exponentially multiplied with LB = 20 Hz 
prior to Fourier transformation. .'The transformed spectrum was base-
line corrected. using a spline fit (see Figure 3.10 (ii)). Evidence 
of bound substrate/product. 
Experiment 10 
Electrophoretically pure deaminase (ca. 800 U, 63 U mg' in 
0.01 M P 2 0 72 , 10% D20, pH 8.0 buffer) was analysed using DP = 12 H 
continuous, SI = 16K, AQ = 0.492 s, PW = 540, NS = 136,803 and the 
first points of the FID removed with NZP = 2. The new FID was zero-
filled, to 32K, exponentially multiplied with LB = 20 Hz, and Fourier 
transformed. The spectrum was baseline corrected using a spline 
fit (see Fi.gure 3.10 (i)). 
229 
Experiment 11 
The foregoing enzyme was diluted with buffer (11 cm 3 , 0.01 11 
pH 8.0) and used to generate more t 13CJ -complex. This was 
concentrated (PM-b) directly to 0.4 cm 3 and examined at 11.0 °C. 
Data was accumulated with DP = 12 H continuous, SI = 16K, AQ = 
0.492 s, PW =54°, NS = 136,802 and the first points of the FID 
removed with NZP = 2. The new FID was zero-filled to 32K exponen-
tially multiplied with LB = 20 Hz, and Fourier transformed. The 
spectrum was baseline corrected using a spline fit (see Figure 
3.12 (ii)). 
Experiment 12 
[13C]-oligopeptide (Peptide 2) trypticdigestion of 
complex. (from Experiment 9) was examined at 25°C. Data was accumu-
lated with DP = 12 H continuous, SI = 16K, AQ 	0.492 s, PW = 90°, 
NS = 115,202, and the FID was zero-filled to 32K, exponentially 
multiplied with LB = 20 Hz and Fourier transformed. The spectrum 
was baseline corrected using a spline fit (see Figure 3.16). 
Experiment 13 
Peptide 3 from the tryptic-digested complex was examined at 
25°C with DP = 12 I-I continuous, SI = 16K, AQ = 0.492 s, PW = 90°, 
NS = 14,400 and the FID was zero-filled to 32K, exponentially multi-
plied with LB = 20 Hz, and Fourier transformed. The spectrum was 
baseline, corrected using a spline fit (see Figure 3.17). 
Experiment 14 
[12C]-PBG-deaminase complex (101 i.ig PBG bound to 4500 U partially 
purified deaminase without further purification, dissolved in 0.05 M 
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P20 72 , 20% D 20, pH 8.0 buffer) was examined, at 10.5 °C. Data was 
accumulated with DP 	10 H continuous, SI = 8K, AQ = 0.246 5, PW = 
90 0 , NS = 324,500, and the first points of the FID were removed with 
NZP = 2. The new FID was zero-filled to 16K and exponentially 
multiplied with LB = 20 Hz prior to Fourier transformation. 
Experiment 15 
[2,11- 13C, 3H] - PBG-deaminase. complex (generated identically to 
the complex in Experiment 14 and dissolved in the same buffer) was 
examined at 10.5°C. Data was accumulated and processed under identi-
cal conditions to Experiment 14. No significant difference detected 
(see Figure 3.18 (ii)). 
Experiment 16 
The previous sample was examined under identical conditions 
except NS = 10,000. 
Experiment 17 
One quarter of the previous sample was diluted 4 times with 
buffer (0.0125 M P 20 72 , 20% D20, pH .8.0) and examined under identical 
conditions to Experiment 16. There was 4 times less signal-to-noise, 
suggesting that no protein aggregation occurred at high concentra-
tions. 
Experiment 18 
The previous sample was made 0.05 M and then 0.1 M in KC1 and 
examined, under identical conditions. There was a marginal increase 
in signal-to-noise with increasing ionic strength. 
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Experiment 19 
The previous sample (with 0.1 M KC1) was examined with SI = 16K, 
AQ = 0.5 s, and then SI = 4K and AQ = 0.1 s. With AQ = 0.5 s, the 
signal-to-noise was better than both the case with AQ = 0.1 s and 
also all the previous conditions. 
Experiment 20 
Progressive saturation was carried out on the previous sample 
with SL.= 4K, AQ = 0.1 s, RD = 0, 0.1, 0.2, 0.4 and 0.9 s, PW = 90 0 , 
NS = 10,000. The FID's were zero-filled to 16K, exponentially 
multiplied with LB = 20 Hz and Fourier transformed. Selected protein 
resonances at 44, 54 and 130 ppm were used to calculate the following 
T 1  values: 0.12, 0.23 and 0.52 s, respectively. Using the equation 
CoSc0t = e _TW'Tl 
and a desired TR (repetition rate) of 0.25 s, the optimum flip angle 
a was calculated for each line as 83 0 , 70 0 and 52°, respectively. 
Experiment 21 
The sample from Experiment 14 was adjusted to pH 6.98 (by 
diluting and re-concentrating on a PM-lO Ultrafilter 3 times with 
0.1 M P 2 0 72 , 20% D20  pH 6.98 buffer) and analysed at 10.5°C. Data 
was accumulated with OP = 10 H continuous, SI = 8K, AQ = 0.246 s, 
PW = 90 0 , NS = 324,502, and the FID was zero-filled to 16K, exponeri-
tially multiplied with LB = 20 Hz and Fourier transformed. 
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Experiment 22 
The main sample from Experiment 15, conibinad with the aliquot 
removed for Experiments 17-20, was adjusted to pH 7.02 (by diluting 
and re-concentrating on PM-10 Ultrafilter 3. times with 0.1 11 
20% D2 0, pH 7.02 buffer) and data was accumulated and processed 
identically to Experiment 21 (see Figure 3.18 (i)). 
Experiment 23 
The previous sample was examined: with SI = 8K, AQ = 0.246 5, 
PW = 900, RD = 0.754 s, NS = 2000 (33 minutes) and the FID zero-
filled to 16K, exponentially multiplied. with LB = 20 Hz and Fourier 
transformed. 
Experiment 24 
The previous sample was examined with SI = 8K, AQ = 0.246 s, 
RD = 0, PW = 66°, which represents the average of the optimum flip 
angles calculated in Experiment 20, and NS = 2000 (8 minutes). The 
FID was processed as before, and the signal-to-noise was found to 
be comparable. When the sample was examined with NS = 8130 (33 
minutes), the signal-to-noise improved significantly. 
Experiment 25 
The previous sample was re-equilibrated at 30 9 C and data 
accumulated as before with SI = 8K, AQ = 0.246 s, RD = 0.754 s, PW = 
90 ° , NS = 2000. The FID was processed as in Experiment 23, and the 
signal-to-noise dramatically increased. When repeated with PW = 56°, 
RD = 0, and NS = 8130, signal-to-noise further increased slightly. 
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Experiment 26 
The previous sample wasexamined under the latter conditions 
(PW = 56 ° ) with NS = 452,000 and the FID. zero-filled to 32K, 
exponentially multiplied with LB = 20 Hz and Fourier transformed. 
No detectable substrate/product. 
Experiment 27 
The sample from. Experiment 21 was examined under identical 
conditions to. the previous experiment. Subtractions did not yield 
any substrate/product. 
Experiment 28 
The sample from. Experiment 26 was treated with 2 drops of 6 M 
HC1 and the precipitated protein collected by centrifugation and 
redissolved in 8 Ni urea (2.0 cm 3 + 10% 020)  and examined at 30°C, 
with OP = 10 H continuous, SI = 8K, AQ = 0.246 s, PW = 56°, NS = 
200,005. The first points of the FID were removed with NZP = 2, 
and the FID then zero-filled to 32K, exponentially multiplied with 
LB = 20 Hz and Fourier transformed. The spectrum was baseline 
corrected using a spline fit (see Figure 3.20 (ii)). 
Experiment 29 
The sample from Experiment 27 was treated identically as in 
the previous experiment and examined (NS = 218,130) and processed 
under identical conditions (see Figure 3.20 (i)). 
Experiment 30 
[.2,11 13C, 2 HJ - PBG- deaminase complex (5800 U of electrophoretically 
pure deaminase used, slightly contaminated with tritium, making 
radioassay of the amount of bound PBG impossible, and further 
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purified by electrophoresis) dissolved in buffer (0.5 cm3 , 0.1 M. 
90% D20, pH 7.0) was examined at 24°C. Data was accumulated 
with no decoupling, SI = 32K, AQ = 0.590 s, PW = 900 and NS = 264, 
812, and the first points of the FID removed with NZP = 2. The new 
FID was zero-filled to 64K, exponentially multiplied with LB = 50 Hz, 
Fourier transformed andthe spectrum baseline corrected with a spline 
fit. Substrate signals detected (see Figure 3.21). 
Experiment 31 
[12C]-PBG-deaminase complex (generated from 6500 U deaminase in 
a tritium preparation described in Section 9.8) was examined and 
processed under identical conditions to the previous experiment (see 
Figure 3.22). 
9.6 	13C NMR Studies of [3,5-13C]-PBG-Deaminase Complex 
All these experiments were Carried out in a 5 mm probe at 
75.5 MHz. 
Experiment 1 
[3,5-3C]-PBG-deamina5e complex (450 Pg bound to 8000 U partially 
purified deaminase and purified by electrophoresis) in buffer 
(0.05 M P 20 72 , 20% D20, pH 8.02) was examined at 3.7°C with DP = 
21 H (to maintain NOE's), SI = 8K, AQ = 0.246 s, PW = 900, SW = 
16,666 Hz, NS = 28,800 and the first points of the FID were removed 
with NZP = 2. The FID was then zero-filled to 32K, exponentially 
multiplied with LB =20 Hz and Fourier transformed (see Figure 3.23). 
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Experiment 2 
The previous sample was re-examined under identical conditions 
over a narrow spectral width, with SI = 10K, SW = 4716 Hz, AQ = 
1.077 s. The FID was zero-filled, to 16K, and exponentially multiplied 
with LB = 20 Hz prior to Fourier transformation. 
Experiment 3 
The previous sample was examined with SI = 2K, AQ = 0.250 s, 
SW = 4716 Hz, PW = 90°, NS = 115,200 and processed as in Experiment 
2 (see Figure 3.24 (i)). 
Experiment 4 
The previous sample was re-equilibrated to 13.5°C and examined 
and processed under identical conditions to Experiment 3. Slight 
improvement in signal-to-noise detected. 
Experiment S 
[12C]-PBG-deaminase complex (generated for a tritium study -. 
see Section 9.8) was examined (NS = 132,401) and processed under 
identical conditions to the previous sample (see Figure 3.24 (ii)). 
Experiment 6 
The previous sample was re-equilibrated to 21 .6°C and examined 
(NS = 87,083) and processed under identical conditions to Experiment 
5 (see Figure 3.25 (ii)). 
Experiment 7 
The sample from Experiment 4 was examined (NS = 69,707) and 
processed under identical conditions to the previous experiment 
(see Figure 3.25 (i)). 
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Experiment 8 
The foregoing samplewas adjusted to various pH values with 1 M 
-alanine pH 10.26 buffer, using the methods described in Section 
9.1. Data was accumulated and processed under identical conditions 
to those in Experimen.t 7. (see Figure 3.26). 
Experiment 9 
To the previous sample at pH 8.0 (adjusted by dilution and re-
concentration on a.PM-10 Ultrafilter twice with 0.05 M P 2072 , 20% 
D20, pH 8.0 buffer) unlabelled PBG (0.7744 mg in 50 pL 0.1 M 
90% D20, pH 8.0 buffer) and a kinetics time-course was started, 
collecting data every 30 minutes over 6 hours. Data was accumulated 
under identical conditions (NS = 7200) to Experiment 7, and the FID's 
were exponentially multiplied with LB = 10 Hz prior to Fourier trans- 
formation. 
Experiment 10 
The end-point of the. previous experiment was accumulated over-
night under identical conditions (NS = 299,602) to Experiment 9, and 
the first points of the FID removed with NZP = 2. The new FID was 
zero-filled to 32K and (i) exponentially multiplied with LB = 10 Hz, 
prior toFourier transformation (see Figure 3.27 (i)); and (ii) 
resolution-enhanced by Gaussian multiplication with a Gaussian 
broadening of 0.1, and LB = -0.5 Hz, prior to Fourier transformation 
(see Figure 3.27 (ii)). 
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9.7 1 H NMR Studies of the Deuteration of ALA 
ALA hydrochloride. (80 mg ex Sigma) was dissolved in D 20 (99.9%) 
and adjusted to pH 8.0 with solid anhydrousNa2CO 3 . Immediately 
an aliquot (0.5 cm3 ) was removed and examined at 300 MHz and 25°C. 
Data was accumulated in blocks of 15 minutes over a total of 180 
minutes with homonuclear irradiation of HOD line with DP = 346, and 
SI = 8K, AQ = 1.139s, PW = 90 0 , NS. 	420, and the FID's were 
exponentially multiplied with LB = 0 .5 Hz prior to Fourier trans- 
formation. 
The percentage deuteration at C-5 and C-3 was calculated from 
the peak intensities normalised to the intensity of C-2, which is 
not susceptible to exchange with deuterium (see Figure 4.1). 
9.8 3H NMR Studies of [2,6,11llJ-PBG-DeaminaSe Complexes 
All 3H NMR experiments were performed in a 5 mm probe at 320.2 
MHz. The indirect method of referencing was employed. [ 3H] - PBG 
containing TSP was examined by tuning the 3H coil to the 1 H NMR 
frequency, and the PBG resonances referenced relative to TSP. The 
coil was then re-tuned for 3H and the same tritiated resonances 
were assigned using the relationship SH = T 	
Since the field 
was locked onto the HOD line, all subsequent biological samples 
examined under similar conditions of pH, temperature and ionic 
strength would be referenced to an accuracy of ±5%. 
Experiment 1 
[3H]-PBG-deaminase complex (14 mCi bound to 6500 U of partially 
purified deaminase and further purified by electrophoresis) in buffer 
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(0.05 M P2072 , 50% D20, pH 8.0) was examined at 10.8°C. Data was 
accumulated with. DP 	12 H continuous, SI = 2K, AQ = 0.266 s, PW = 
90°, NS = 22,604 and the FID was exponentially multiplied with LB = 
6 Hz prior to Fourier transformation (see Figure 4.5 (i)). Data 
was accumulated for two further periods (uS = 26,500 and 34,313) and 
processed in the same way (see Figure 4.5 (ii)) and finally for a 
long run (NS = 43,200) and processed in the same way (see Figure 
4.5 (iii)). 
Experiment 2 
The previous sample was examined at 10.8°C with OP = 12 H 
continuous, SI = 8K, AQ = 1.065 5, PW = 90 0 , NS = 42,720 and the 
FID was exponentially multiplied with LB = 10 Hz priorto Fourier 
transformation (see Figure 4.6 (i)). 
Experiment 3 
The previous sample was re-equilibrated to Ca. 30°C and data 
accumulated with a kinetics time-course collecting data every hour, 
with SI = 8K, AQ = 1.065 s, PW = 90 0 , NS = 3600. The FID was 
exponentially multiplied with LB = 10 Hz and Fourier transformed 
(see Figure 4.6 (ii)). 
Experiment 4 
Progressive saturation was employed to determine the T 1 1 s of 
the resonances in the previous sample. Data was accumulated with 
SI = 1K, AQ = 0.133 s, PW = 90°, NS = 3600 and RD = 0, 0.4, 0.9, 1.4 
and 1.9 s. The FID's were zero-filled to 8K, exponentially multiplied 
with LB = 5 Hz and Fourier transformed. The resonances at 2.6 and 
3.6 ppm were used to calculate the values for T 1 s, both being 0.08 s. 
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Experiment S 
The previous sample was split into two portions, one being kept 
at 4°C, and the other examined, and processed under the same conditions 
as in Experiment 3 (see Figure 4.7 (i)). 
Experiment 6 
To the previous, sample, unlabelled. PBG (450 fig, in 100 pL 0.05 M 
90% D20, pH 8.0 buffer) was added and data. accumulated every 
30 minutes over 12 hours, with OP = 12 H continuous, SI = 8K, AQ = 
1.065 s, PW = 90 0 , NS = 1800. The FID's were exponentially multi-
plied with LB = 10 Hz and Fourier transformed. The linewidths did 
not seem to have changed significantly, so. the T 1 1 s were determined 
by progressive saturation exactly as in Experiment 4. Again a value 
of 0.08 s was obtained. 
Experiment 7 
To the previous sample, further unlabelled PBG (986 .ig  in 100 IiL 
0.05 M P 2 0 72 , 90% 020, pH 8.0 buffer) was added and examined under 
essentially the same conditions but with PW = 38 0 and NS = 45,489. 
The FID was processed as in Experiment 6, and a slight improvement 
in linewidth had taken place. Porphyrin was assayed spectrophoto-
metrically and this indicated that 20% of the formation expected 
had taken place. 
Experiment 8 
An aliquot (0.125 cm 3 ) of the previous sample was diluted 4 
times with buffer (0.375 cm 3 , 0.05 M P 2 0 72 , 90% D 20, pH 8.0) and 
incubated at 37°C for 10 minutes. Data was accumulated with SI = 4K, 
AQ = 0.532 s, PW = 38°, NS = 136,246 and processed as in Experiment 7 
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(see Figure 4.7 (ii)). Uro'gen I formation was evident (linewidth.s 
decreased) as well as some porphyrin formation (see Figure 4.7 (ii)). 
Experiment 9 
To the, previous sample, iodine (10 iL, 0.2 N 12  in 0.2 N KI) 
was added and the sample examined (NS = 268,830) and, processed under 
identical conditions (see Figure 4.7 (iii)). Porphyrin formation 
clearly took place. 
Experiment 10 
The other portion of complex from Experiment. 5 was re-examined 
with SI = 8K, AQ = 1.065 s, PW = 90 ° ,, NS = 52,387, and the FID 
exponentially multiplied with LB = 10 Hz prior to Fourier transforma-
tion (see Figure 4.8 (i)). 
Experiment 11 
The other portion of PBG-treated complex from Experiment •8 was 
re-examined. (NS = 83,230) and processed under identical conditions 
to the previous experiment (see Figure 4.8 (ii)). 
Experiment 12 
To the sample from Experiment 9, hydroxylamine hydrochloride 
(50 iL, 0.2 M in 0.2 M P 2 072W , 90% D20, pH 8.0 buffer) was added 
and data accumulated under identical conditions to Experiment 10, 
collecting data every hour. Since no changes really took place, 
the sample. was re-run for a longer time (NS = 55,815) and the FID 
processed as in Experiment 10. No decreases in linewidths of 
uro'gen I were detected. 
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Experiment 13 
To the sample from Experiment 10, solid urea was added to bring 	it 
the solution to 8 M, and examined (NS = 79,778) and processed under 
identical conditions to that of Experiment 10. Considerable 
sharpening of resonances (see Figure 4.9). 
Experiment 14 
[ 3H] - PBG- deaminase complex (16 mCi. bound to 4000 U of electro-
phoretically pure deaminase and purified by gel-filtration on G-50 
Sephadex) in buffer (0.4 cm 3 , 0.05 M P 20 72 , 90% D20  pH 8.0) was 
examined over 12 hours collecting data at 30 minute intervals, at 
5.5°C. Data was accumulated with DP = 12 H continuous, SI = 8K, 
AQ = 1.065 s, PW = 90°, NS =. 1800 and the FID's added, the first 
points removed with NZP = 2. The new FID was zero-filled to 16K, 
exponentially multiplied with LB = 10Hz, and Fourier transformed. 
The spectrurnwas baseline corrected. using a spline fit (see Figure 
4.10 (i)). 
Experiment 15 
The previous sampl.e was re-equilibrated to 14°C and examined 
under identical conditions (7 blocks of NS = 1800), and the FID's 
added and processed as in the previous experiment (see Figure 4.10 
(ii)). 
Experiment 16 
The previous, sample was split into two parts, one part being 
stored at 4°C, and the other' diluted with buffer (200 iiL, 0.05 M 
90% D20, pH 8.0 buffer) and re-equilibrated to 23°C. This 
was examined (9 X NS = 1800) and processed under identical conditions 
to the previous experiment (see Figure 4.10 (iii)). 
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Experiment 17. 
To the previous sample, unlabelled PBG. (950 pg)  in buffer (50. iL, 
0.1 M P 2 07 , 90% D20, pH 8.0) was added and data accumulated as in 
the previous experiment (at 23°C) except that 30. X NS = 900 (15 
minutes) were collected. The FID's were added in fives except for 
the first.one, and processed as in Experiment 14 (see Figure 4.11). 
Experiment 18 
The remaining portion from Experiment 16 was equilibrated at 
3.5°C, and re-examined with SI = 4K, AQ = 0.532 s, PW = 90 ° , NS 
900 and processed under identical conditions to Experiment 14 (see 
Figure 4.12 (i)). 
Experiment 19 
To the previous sample, unlabelled PBG (749 .ig) in buffer (50iL, 
0.1 M P2 072 , 90% D20, pH 8.0) was added and data accumulated in 
blocks of 7.5 minutes over 225 minutes with DP = 12 H continuous, 
SI =4K, AQ = 0.532 s, PW = 90°, NS = 900 and the FID's were added 
in fives, and the first points removed with NZP = 2. The new FID's 
were zero-filled to 16K, exponentially multiplied with LB = 10 Hz 
and Fourier transformed (see Figure 4.12). 
Experiment 20 
The previous sample was further examined under the same condi-
tions for another 30 X NS = 900, except that after 9 X NS = 900, 
the temperature was raised to 23°C. The FID's were added in pairs 




Relaxation and Linewidths in BioThgical NMR 
(1) Spin-lattice relaxation 
This process is due to a net loss of energy of the excited 
nuclei to the surrounding molecular environment, which can be 
regarded as an assembly of rapidly fluctuating local magnetic 
fields. The lost energy is transferred to the lattice as extra 
rotational or translational energy. The time constant for this 
process is designated T 1 , and it is made up of several components. 
In large biological molecules, the most dominant features of 
relaxation are from dipolar relaxation (T1DD) and chemical shift 
anisotropy (CSA). In dipolar relaxation, a nucleus such as 
may be attached to a 1 H atom, and here the two spins act as small 
dipoles located at the centre of the 13C and 1 H atoms. Consequently 
the 13C nucleus experiences a small magnetic field due to the di-
polar interaction with the proton, and this depends on the magnitude 
of the two dipoles (T.IC and 	and the orientation of their line of 
interaction relative to the applied field. As the molecule tumbles 
in solution, relaxation can be induced by the local oscillating 
magnetic field, which for small molecules (Mr <1000) and non-viscous 
solutions is a function of the correlation time -re, and the inverse 
sixth power of the distance between the two atoms. The correlation 
time is a measure of how rapidly the molecule undergoes reorienta- 
tions in solution. 
In CSA relaxation, if a non-protonated carbon is placed with 
its axis perpendicular to the external magnetic field, the shielding 
245 
of the carbon by the electrons will be different from that found if 
the axis is parallel to the field. Rotational motion then produces 
a fluctuating magnetic field and relaxation may occur by this 
mechanism.. While in many systems, GSA is a. negligible relaxation 
mechanism, at higher magnetic field strengths it becomes increasingly 
dominant, being the principal relaxation for sp2 carbons at fields 
>6 T. 
(ii) Spin-spin relaxation 
In spin-spin relaxation, two nuclear spins in close 
proximity interchange energy, with one another. This can occur 
because the magnetic field generated by a spinning nucleus has a 
component perpendicular, or transverse as it is known, to the main 
field, and thus is ideally set up for inducing transitions in the 
adjacent nuclear spin. The magnetic field produced by one nucleus 
will also cause a variation in the field experienced by. the other 
nucleus, and obviously the reverse is true. This process results 
in spin-spin or transverse relaxation, with an exponential time 
constant designated.T2 . The result is a spreading of the resonance 
frequency, which leads to a broadening of the resonance lines in 
the spectrum. 
Also dependent on the relaxation mechanisms is the nuclear 
Overhauser effect (NOE). An NMR spectrum of a nucleus such as 
obtaied with simultaneous proton irradiation often yields an improve-
ment in signal-to-noise of the carbon resonance in addition to 
removal of the 13C- 1 H scalar coupling. This is the NOE phenomenon., 
and is due to a favourable redistribution of the 
13  C energy level 
populations caused by irradiation of nearby protons. Therefore the 
NOE depends on the influence of these protons on the relaxation 
mechanisms. It should be emphasised that while 13C and I H are the 
most quoted examples of NOE, any two nuclear spins exhibiting 
coupling by a relaxation interaction show NOE's, and such nuclei 
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